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 Our own interest in the development of new and convenient protocols for the highly 
regioselective synthesis of (hetero)arylazoles via palladium-catalyzed intermolecular direct 
(hetero)arylation reactions of azoles with (hetero)aryl halides prompted us to design general 
and selective procedures for the synthesis of 5-aryl-1-methyl-1H-pyrazoles (21), 5-aryl-
oxazoles (30), 5-aryl-thiazoles (31) and 5-aryl-1-methyl-1H-imidazoles (32), that were 
obtained by regioselective Pd-catalyzed direct C-5 arylation reactions of the corresponding 
azoles. In particular, we demonstrated that a variety of 5-aryl-1-methyl-1H-pyrazoles (21) can 
be prepared in moderate-to-good yields by a highly regioselective procedure involving the 
Pd(OAc)2-catalyzed direct C-5 arylation of commercially available 1-methyl-1H-pyrazole 
(15) with activated, unactivated and deactivated, para- and ortho-substituted aryl bromides 26 
in the presence of Bu4NOAc as the base in DMA at 70 °C. 
 Then, we applied these unprecedented reaction conditions promoted by Bu4NOAc to 
the direct C-5 arylation of oxazole (4), thiazole (8) and 1-methyl-1H-imidazole (12). With our 
pleasure, we found that a variety of 5-aryl-oxazoles (30) and 5-aryl-thiazoles (31) can be 
prepared in high yields and selectivities performing the reactions at only 70 °C. Moreover, 5-
aryl-1H-imidazoles (32) can be efficiently synthesized in terms of activity and selectivity by 
using the same reaction conditions, but rising the reaction temperature at 110 °C. 
 Next, our attention was focused on a preliminary screening of the selective direct C-5 
arylation of 1-phenyl-1H-pyrazole (23) with bromotoluene 26a, chosen as model coupling 
partners. During this screening we observed the formation of three main products: 1-phenyl-
5-p-tolyl-1H-pyrazole (36a), 1-(4'-methyl-[1,1'-biphenyl]-2-yl)-1H-pyrazole (37a) and 1-(4'-
methyl-[1,1'-biphenyl]-2-yl)-5-(p-tolyl)-1H-pyrazole (38a). At the end of this in-depth study, 
we found that the best conditions for the C-5 direct arylation of commercially available 
compound 23 with bromotoluene 26a consist in the use of PdCl2(MeCN)2 as the precatalyst in 
the presence of K2CO3 as base, pivalic acid and Bu4NBr as additives in DMA at 110 °C. 
Under these conditions, the required 1-phenyl-5-p-tolyl-1H-pyrazole (36a) was obtained in 43 
% GLC yield with a selectivity higher than 80 %. 
 Direct arylation of azoles promoted by Bu4NOAc was also employed as key-step for the 
synthesis of useful organic materials. Firstly, we synthesized the 2,5-diaryl substituted 
oxazoles balsoxin (39a) and texaline (39b), two bioactive compounds isolated from the plant 
Amyris spp. in the Caribbean. In order to prepare these compounds, we tested a one-pot 
sequential diarylation of oxazole (4) with different aryl bromides by pairing the C-5 arylation 
procedure promoted by Bu4NOAc for the first step with the protocol for the direct C-2 
arylation mediated by CuI, previously reported by our research group, for the second-one. 
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Balsoxin (39a) and texaline (39b) were obtained with an overall yield of 39 and 38 %, 
respectively. 
After that, we focused our attention on the synthesis of resveratrol analogues 48 and 49. The 
2,5-diarylated imidazoles 48 were obtained by applying again the one-pot sequential 
procedure, this time starting from the 1-methyl-1H-imidazole (12). Compounds 49 (the 
relative unprotected derivatives of 2,5-diaryl-imidazoles 48) were also synthesized by 
reacting compounds 48 with BBr3 in CH2Cl2 at -60 °C. The biological activity of molecules 
48 and 49 was then evaluated and we found that they show cytotoxic activity against the 60 
human tumoral cell line panel of the National Cancer Institute of USA. Moreover, in a 
separate screening, compound 49b resulted to be a NQO2 inhibitor in vitro and showed 
cytotoxicity higher than resveratrol (44). 
Finally, we devoted part of our synthetic efforts to the preparation of new push-pull 
fluorophores, consisting in unsymmetrically substituted p-phenylene-linked imidazole-
benzimidazoles 50, imidazole-benzothiazoles 51 and thiazole-benzothiazoles 52. In this 
context, we used a two-step procedure that involved the palladium-catalyzed direct C-5 
arylation of azoles with aryl bromides promoted by Bu4NOAc developed in this Ph.D. work 
for the first step, and the ligandless direct arylation at the C-2 position promoted by CuI with 
aryl bromides previously developed by Bellina’s group for the second step. Afterwards, their 
spectroscopic properties were evaluated by analysing their absorbance and emission spectra. 
Compounds 50, 51 and 52 presented high quantum yields and Stokes shifts up to 114 nm. 
 As regards the final part of this Ph.D. work, it was carried out at the University of York, 
in collaboration with Professor Ian Fairlamb. We synthesize three new CuI-NHC: (1,3-
dibenzylbenzo[d]imidazolin-2-ylidene)copper(I) bromide (64a), (1,3-
diphenylbenzo[d]imidazolin-2-ylidene)copper(I) bromide (64b), and (1,3-bis(2,4,6-
trimethylphenyl)imidazolin-2-yliden)copper(I) chloride (65). We demonstrated that 64b 
undergoes a direct reaction with PhI (2), both in the presence and in the absence of Pd(OAc)2, 
to give the arylated product (1,3-diphenyl)-2-phenylbenzo[d]imidazolium bromide (86b). 
 
The studies summarized above have been the subject of the following publications and 
communications: 
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 Arylazoles are important structural units, frequently found in natural products 1 
pharmaceutics,2 agrochemicals3 and organic functional materials.4 Due to their widespread 
applications, the development of straightforward functional group-tolerant synthetic methods 
for their preparation has attracted considerable attention.5 
Many cross-coupling strategies have been developed so far for the formation of heteroaryl-
(hetero)aryl bonds, with high yields, excellent selectivities and high functional group 
tolerance under mild conditions. The most common approach was the use of the traditional 
cross-coupling reactions promoted by transition metal catalysts (Scheme 1a).6 However, these 
methods suffer from lack of atom- and step-economy, as they involve the preactivation of 
both the coupling partners that afterwards lead to the formation of additional waste. 
An alternative to this approach consists of a Pd-catalyzed decarboxylative cross-coupling 
reaction between haloarenes and heteroaryl carboxylic acids (Scheme 1b).7 In this case, the 
regioselectivity of the reaction is ensured by the carboxylic function and only carbon dioxide 
(apart from HX) is produced as waste. 
 
a. Traditional cross-coupling reactions: 
 
 
b. Decarboxylative cross-coupling reactions: 
 
 
c. Oxidative coupling: 
 
 
d. Direct arylation with (hetero)aryl halides: 
 
Scheme 1 
 
(Het)Ar1-M    +     (Het)Ar2-X
cat.
(Het)Ar1-Ar2(Het)    +    MX
M = B(OH)2, B(OR)2, SnR3, ZnX, SiR3, MgX
(Het)Ar1-COOH    +     Ar2-X
cat.
(Het)Ar1-Ar2    +    CO2
(Het)Ar1-H    +     Ar2-H
cat.
(Het)Ar1-Ar2    +    2H+
(Het)Ar1-H    +     (Het)Ar2-X
cat.
(Het)Ar1-Ar2(Het)    +    HX
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Recognizing the value of arylheteroarenes and the potential for improvement, several research 
groups have been looking for ways to reduce reliance in the substrate preactivation. Among 
the methodologies proposed, the oxidative coupling of heteroarenes8 represents the simplest 
and most convenient approach because it involves the coupling of two (hetero)aryl C-H bonds 
(Scheme 1c), especially when these transformations can be performed with molecular oxygen 
as the terminal oxidant. However, achieving regioselectivity in intermolecular oxidative 
arylation reactions still represents an obstacle. 
An eco-friendly and economic alternative to these approaches involves the use of a 
(hetero)arene and a (hetero)aryl halide (Scheme 1d). The development and applications of 
transition metal-catalyzed direct arylation reactions of heteroarenes with aryl halides or 
pseudohalides have attracted a great attention.9,10 In fact, these reactions do not involve the 
use of stoichiometric amounts of organometallic reagents and result in a smaller number of 
reaction steps to achieve the required cross-coupling products with a concurrent reduction of 
waste. 
 After the first examples of the Pd-catalyzed direct arylation that appeared in the 
1980s, 11  this synthetic approach has had a significant impact on the construction of 
(hetero)aryl-(hetero)aryl bonds over the last decade. 
This introduction is intended to enlighten the reader on the direct intermolecular transition 
metal-catalyzed arylation reactions of heteroaromatic compounds. The direct intermolecular 
arylation of π-electron-rich heteroarenes, in particular azoles, with aryl halides will be 
discussed in more details because it represents the main subject area of this Ph.D. thesis. 
 
 
1. Direct arylation of azoles with aryl halides: mechanistic pathways (and 
the regioselectivity quest). 
 
 Many transition metals were used so far in the direct arylation of azoles with aryl 
halides, as Pd,12 Cu,13 Ni,14 and Rh.15 Palladium-catalyzed arylation reactions have particularly 
been investigated and we decided to focus our attention on them in this Ph.D. work. As regard 
the direct arylation of π-electron-rich heteroaromatics, it should be noted that the electronic 
bias inherent in their structure is often enough to control the regioselectivity of the activation 
of heteroaryl C-H bonds and obviates the need for the presence of directing groups.9 
Consequently, the regioselectivity of these reactions primarily depends on the type of 
Introduction 
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heterocycle, but also on the electronic nature of the catalyst employed. However, other 
parameters such as the nature of the solvent, the additives and the steric characteristics of the 
catalyst have been used to affect the regioselectivity of direct arylation reactions.9 
As regards the azoles it is worthy of mention that, whereas few examples have been reported 
for the direct intermolecular arylation of π-deficient heteroaromatics such as pyridine,16 azine, 
and diazine N-oxides,17 the use of π-electron-rich heteroaromatics in these Pd-catalyzed Csp2-
Csp2 bond forming reactions has been featured prominently.9,10d,e In fact, from a strategic 
prospective, the latent reactivity of a C-H bond of an electron-rich nucleus may mimic that of 
an organometallic compound in the transmetalation step of the catalytic cycle of traditional 
cross-coupling reactions.18 
 Many research groups have devoted their efforts in last decade in the development of 
various methodologies for the direct arylations of π-electron-rich heteroaromatics with aryl 
halides, and in the mechanistic interpretation of the C-H bond cleavage.19 The first mechanism 
that has been suggested for the palladium-catalyzed direct arylation of heteroaromatics under 
the standard conditions (a metal-phosphine catalyst and carbonate/carboxylate base) was the 
electrophilic aromatic substitution (SEAr), as depicted for 1,3 azoles in Scheme 2.20 
 
 
Scheme 2 
 
Thus, according to this mechanistic hypothesis, the regioselectivity appears to be mainly 
governed by the electron density of the substrate, as demonstrated by the fact that the Pd-
catalyzed arylation reactions of electron-rich heteroarenes with aryl halides generally occur at 
the site with the highest nucleophilic character.20 
Ar-X    +    Pd(0)
Ar-Pd-X
N
Y
N
Y
H
Pd Ar
X
base
N
Y
Pd
Ar
+    base.HX
N
Y
Ar
Chiara Manzini 
 18 
 Nevertheless, another reaction mechanism, the concerted metalation-deprotonation 
pathway (CMD), has more recently suggested and it has become the considerable alternative to 
the electrophilic aromatic substitution for the direct arylation of electron-rich heteroaromatic 
nuclei (Scheme 3). 
 
 
Scheme 3 
 
In the CMD transition state (TS, Scheme 3), a carboxylate ligand of the metal catalyst 
abstracts a proton from a C-H bond while, at the same time, a metal carbon bond is being 
formed.19,21 
 From a distortion-interaction analysis performed for several C-H bonds of different 
(hetero)arenes by Fagnou and co-workers, it emerged that the CMD energy barrier in the Pd-
catalyzed direct arylation of heteroarenes depends on different contributions (Figure 1): an 
energetic cost (distortion energy, Edist) associated with the distortion of the catalyst and the 
(hetero)arene from their ground state structures (I and II) to their geometries (III and IV) in 
the TS structure V, and an energetic gain (electronic interaction energy, Eint) resulting from the 
electronic interaction of fragments III and IV to form the TS structure V. 
These factors allowed the authors to classify the (hetero)arenes into three categories (Figure 
2).19,21 Class I includes (hetero)arenes for which the regioselectivity of C-H bond metalation is 
controlled by the difference in the arene distortion energies, Edist(ArH). 1-Methyl-pyrazole, for 
instance, belongs to class I and its C5-H bond is more reactive than C3-H and C4-H bonds in 
the CMD process due to the lower distortion energy of this heterocycle at its C5 site. 
Class II includes (hetero)arenes for which catalyst-arene electronic interaction energies define 
the most reactive C-H bonds. The three 1,3-azoles 1-methyl-imidazole, oxazole and thiazole, 
belong to the second class, and calculations showed that their C5-H bonds are more reactive 
than the others in the CMD process due to a more negative interaction energy at their C5 site. 
Class III includes (hetero)arenes for which both the arene distortion and catalyst-arene 
interaction energies enhance the CMD cleavage of a given C-H bond. An example of such 
heteroarenes is thiophene, for which Cα-H bonds are more reactive than Cβ-H bonds in the 
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CMD process due to a lower arene distortion energy at the Cα site and the more favourable 
catalyst-arene interaction energy at the Cα site. 
 
 
Figure 1: Distortion-interaction analysis for the CMD transition states. The TS structure for the C-H bond 
cleavage at the C-2 site of azole is shown as an example. 
 
 Moreover, it can happen that in special situations when properties of the metal catalyst 
are tuned to lower the activation barriers for alternative reaction pathways and/or to increase 
the CMD activation barriers, other mechanisms can be at play. For example, it has recently 
been shown that Heck-type arylation becomes the lowest-energy pathway of thiophene using 
the Pd-catalyst with the bulky fluorinated phosphine ligand P(OCH(CF3)2)3.22 Instead of Cα 
arylation that is characteristic for the CMD pathway,21 this Heck-type arylation pathway leads 
to Cβ arylation. It cannot be excluded that other substrates as azoles may undergo this 
mechanism when an appropriate reaction system has been found. 
 From what has just reported above, it is clear that both of the hypotheses of SEAr 
and/or CMD mechanism would justify the observed C-5 selectivity on the azoles when they 
react with aryl halides in the presence of a palladium catalyst. On the other hand, since Miura 
and co-workers reported their seminal paper in 1998,20a it emerged that the selectivity on the 
azole nucleus could be addressed also on the C-2 site, by using Cu(I) as additive to palladium 
catalyst or even as catalyst itself. As just said, the addition of a stoichiometric or catalytic 
amount of Cu(I) salts to palladium catalyst significantly increases the reactivity of the C-2 
position providing the 2-arylated products.23 
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Figure 2: Classification of (hetero)arene substrates in terms of contributions to regioselectivity of C-H bond 
metalation via the CMD pathway based on their reactivity with the [Pd(C6H5)(PR’3)(OAc)] catalyst. C-H bonds 
with the lowest activation energies for the CMD cleavage are shown.19,21 
 
 Mechanistic proposal were made by our research group in 2006 in order to explain the 
selectivity showed by 1,3-azoles when they are reacted wit aryl halides under the classical 
direct arylation conditions but in the presence of a copper(I) salt.23c The C-2 selectivity is 
thought to derive from a more classical cross-coupling type mechanism which hinged upon the 
pre-coordination of the substrate to Cu(I), akin to alkyne coordination in the Sonogashira 
reaction. This complex is proposed to be in equilibrium with an organocuprate, which could 
undergo transmetalation with loss of CuX to produce the product after reductive elimination 
(Scheme 4).23a 
This proposed mechanism is supported by the influence of the electronic properties of the 
imidazole system upon reaction rates. For imidazoles bearing electron-withdrawing aryl 
groups, such as phenylmethylsulfinate, a rate enhancement was observed, whilst longer 
reaction times were required with electron-donating substituents. 
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Scheme 4 
 
The electronic effects of the substituent alter the acidity of the C2-H proton, and subsequently 
the rate of cuprate formation. The reduction in selectivity with an increased Pd loading also 
supports this, as the formation of the cuprate should be the rate determining step, due the high 
reactivity of organocopper reagents, for the C2-arylation pathway. This proposed mechanism 
suggests that the reaction should be catalytic in copper but upon lowering the copper(I) 
stoichiometry, a greatly increased quantity of C5-arylation is observed. An equilibrium 
between the imidazoylcuprate and free copper(I) iodide, which can be biased by using an 
excess of copper(I) iodide, was postulated to explain these observations. This would indicate 
that the equilibrium between the cuprated species and free copper(I) iodide, and the factors 
which affect this, are key to reaction progression.23a 
 
 
2. Pd-catalyzed direct arylation of 1,3-azoles with aryl halides. 
 
2.1. Oxazole derivatives. 
 
 The first examples of the selective C-5 arylation reaction of oxazole with 
chloropyrazines and pyridyl triflate in the presence of Pd(PPh3)4 as the pre-catalyst system and 
KOAc as the base in DMA at reflux were reported by Ohta24 in 1992. On the other hand, the 
C-2 phenylation of ethyl oxazole-4-carboxylate (1) reported by Hoarau’s group in 2005 
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represents the first example of a selective direct C-2 arylation of oxazole derivatives (Scheme 
5).25 
 
 
Scheme 5 
 
As this last example, most of the papers published so far were focused on the arylation at the 
C-2 position of oxazole and its benzocondensed derivative. In 2008, Doucet showed that 
oxazole is prone to be arylated with 4-t-butyl-bromobenzene in the presence of Cs2CO3 (2 
equiv), PdCl(C3H5)(dppb) (5 mol %) in DMF at 150 °C for 20 h, to give the 2-(4-t-
butylphenyl)-oxazole in 69 % yield,26 and Bhanage reported the arylation of oxazole with 4-
iodobenzene and 4-bromoanisole with K3PO4 (2 equiv), in the presence of palladium 
bis(2,2,6,6-tetramethyl-3,5-heptanedionate) (10 mol %) in NMP at 125 °C for 36 h, to give the 
2-arylated products in 62 and 63 % yield, respectively.27 
In the same year, Doucet reported another methodology for the arylation of heteroaromatics 
with aryl triflates, and he proposed that benzoxazole may undergo the C-2 arylation in the 
presence of 5 mol % Pd(OAc)2, 10 mol % PPh3, KOAc as base, in DMF at 150 °C giving the 
2-arylated benzoxazole derivatives in 57-86 % isolated yield.28 
 After these studies, Besselièvre and co-workers reported the arylation at the C-2 position 
of unsubstituted and 5-substituted aryl oxazoles with aryl bromides (Scheme 6a)29 and, in 
2011, Ackermann et al. showed that ethyl oxazole-4-carboxylate (1) reacts with several aryl 
bromides in the presence of 5 mol % of the palladium(II) complex 3 (Scheme 6b).30 
 
 
 
Scheme 6 
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 In 2008, Hoarau’s group reported a sequential C-2 and C-5 diarylation of 1. As regard 
the arylation at the C-2 position, the authors have extended the scope of the reaction to several 
aryl halides different from iodobenzene (2) (see Scheme 5).25 In the first step the oxazole 
reacted at its C-2 position in the presence of Pd(OAc)2 (5 mol %), Cs2CO3 as base, at 110 °C 
for 18 h. JohnPhos (10 mol %) in dioxane was employed as ligand when aryl bromides and 
iodides were used, while with aryl chlorides P(o-Tol)3 (10 mol %) in toluene was selected. 
The subsequent arylation on the 2-substitited azole obtained with aryl bromides and iodides 
was performed under the same reaction conditions, but using 10 mol % P(o-Tol)3 in toluene 
(Scheme 7).31 
 
 
Scheme 7 
 
 An eco-friendly procedure was reported by Doucet and co-workers for the C-2 arylation 
of (benz)oxazole using carbonates, that are polar, aprotic, nontoxic and biodegradable, as 
reaction solvents.32 In particular, they found that the benzoxazole reacts with electron-rich and 
electron-poor aryl bromides, para-, meta-, and ortho-substituted, in the presence of 
PdCl(C3H5)(dppb) (1 mol %) and Cs2CO3 as base, in diethylcarbonate at 130 °C (yields from 
25 up to 92 %).32 
 In 2010 Strotman and co-workers showed that it is possible to achieve a regioselective 
arylation at the C-5 or at the C-2 of unsubstituted oxazole (4) using aryl chlorides, bromides or 
triflates. They developed three different methods depending on the nature of the electrophile 
that reacts with compound 4 and on the arylation site (C-5 or C-2). These methods are 
summarized in Scheme 8.33 The authors reported that a good C-5 selectivity may be reached by 
using the method A with aryl chlorides and method B, which differs from the previous only for 
the nature of palladium ligand, with aryl bromides and triflates. 
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Scheme 8 
 
Otherwise, the C-2 selectivity can be achieved with aryl chlorides, aryl bromides and triflates 
by using the method C. The hypothesis of mechanism suggested by Strotman et al. involves 
two different pathways that may explain the selectivity (Scheme 9). They proposed that the C-
5 arylation goes through a CMD mechanism, which is thought to require the intermediacy of a 
Pd-carboxylate complex A (Scheme 9, left cycle)33  
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Moreover, they examined direct arylation of oxazole with bromobenzene using a variety of 
bases, with or without PivOH and they found that with strong bases like KOH or KOtBu, the 
reactions favoured the C-2 selectivity, regardless of the catalyst, solvent or presence of PivOH. 
Given the reasonable acidity of the C-2 proton of oxazole,34 the authors thought plausible that 
reaction at this center may occur through formal deprotonation.23d,35 Either the potassium 
oxazole species or the dominant ring-opened enolate tautomer36 could react with an ArPdX 
species. Therefore, they proposed the catalytic cycle reported in Scheme 9 (right cycle) to 
account for the differences in regioselectivity that they observed with different bases. Both 
catalytic cycles begin with oxidative addition of the aryl halide to a Pd(0) complex. In the 
presence of PivOH and weak bases, the ArPdX species would form an ArPd(OPiv) 
intermediate which could undergo CMD with oxazole at C-5. Alternatively, when strong bases 
are employed, a potassium-oxazole species (or ring-opened tautomer) may directly attack 
ArPdX, forming an ArPd(2-oxazole) intermediate. 
 Finally, it is worth mentioning that our research group dedicated several papers on the 
palladium/copper catalyzed direct arylation at the C-2 position of azoles. We found that the 
1,3-azoles and their benzocondensed derivatives can be selectivity arylated at their C2-H bonds 
in the presence of Pd(OAc)2 (5 mol%), CuI (2 equiv) in DMF at 140 °C with aryl iodides in 
moderate-to-very good yields (Scheme 10).23b,c37 
 
 
Scheme 10 
 
 
2.2. Thiazole derivatives. 
 
 In 1992, Ohta reported the first selective Pd(PPh3)4-catalyzed direct C-5 arylation of 
thiazole (8) with chloropyrazines in the presence of KOAc as base in DMA at reflux.24 Six 
years later, Miura found out that the treatment of thiazole (8) with iodobenzene (2) using 
Pd(OAc)2/PPh3 as the pre-catalyst system and Cs2CO3 as base afforded a mixture of 5-
monophenylated and 2,5-diphenylated products (Scheme 11).20a 
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Scheme 11 
 
Subsequently, in 2003, he showed that diarylation at the C-5 and the C-2 position of thiazole 
(8) can be achieved efficiently by Pd(OAc)2-catalyzed direct arylation with aryl bromides 
employing a bulky phosphine ligand such as P(t-Bu)3, in the presence of Cs2CO3 as base in 
DMF at 150 °C.38 
 As regards the selective monoarylation of thiazole ring, it should be noted that in 2000 
Kondo reported the selective monoarylation of 8 both at C-5 and C-2 positions using 
iodobenzoate immobilized on an insoluble polymer support.39 However it is worth noting 
that, save the selective C-5 arylation of thiazole with aryl iodides in the presence of KOAc as 
base and catalytic amounts of Pd(OH)2/C in DMA at 140 °C,40 most of the procedures 
developed for the direct C-5 arylation of thiazole ring with (hetero)aryl iodides,41 bromides,42 
chlorides43 and triflates28 involves 2-substituted thiazole derivatives. On the other hand, only 
one example of selective Pd-catalyzed C-2 arylation of thiazole has been reported (Scheme 
12).27 
 
 
Scheme 12 
 
As shown in Scheme 12, when the reaction of thiazole with iodobenzene and iodoanisole was 
carried out in the presence of palladium bis(2,2,6,6-tetramethyl-3,5-heptanedionate) as 
catalyst and K3PO4 in NMP at 125 °C, 2-monoarylation occurred selectively. 
 In 2008, Hourau and co-workers44 reported the Pd-catalyzed selective C-2 arylation of 
tert-butyl 4-thiazolecarboxylate (9) with (hetero)aryl halides (Scheme 13). 
Regarding the C-2 arylation, Ranu reported a methodology for the direct arylation of 
benzothiazole (10) with aryl iodides promoted by palladium(0) nanoparticles under ligand-
free conditions. The reaction system involves the use of Pd(OAc)2 as palladium source and 
TBAB (tetrabutylammonium bromide) as stabilizer for Pd nanoparticles formed in situ, 
S
N Pd(OAc)2 (10 mol %), PPh3 (20 mol %)
S
N
Ph
Cs2CO3 (2 equiv), DMF, 140 °C
+ Ph-I
Ph
+
S
N
Ph
(17 %) (35 %)8 2
S
N Pd(TMHD)2 (10 mol %), K3PO4 (2 equiv)
NMP, 125 °C
TMHD: 2,2,6,6-tetramethyl-3,5-heptanedione
+ Ar-I
S
N
Ar = C6H5 (67 %)
Ar = 4-MeO-C6H4 (40 %)
Ar = C6H5
Ar = 4-MeO-C6H4
Ar
8
Introduction 
 27 
K2CO3, AgOAc, molecular sieves (4 Å) in DMF at 120 °C to give the 2-aryl-benothiazole 
derivative (Scheme 14).45 
 
 
Scheme 13 
 
 
Scheme 14 
 
 In 2009, Doucet’s group showed that the 4-methyl-thiazole and C-unsubstituted thiazole 
can undergo monoarylation selectively at the C-5 position with aryl bromides when they are 
treated with Pd(OAc)2 and KOAc, in DMA at 130-150 °C for 20 h (Scheme 15).46 The 2-
arylated or 2,5-diarylated thiazoles were not detected. 
 
 
Scheme 15 
 
It is interesting to note that, in order to favour the monoarylated product and to increase the 
conversion of the reaction, 2 equiv of the azole were used though this substrate is more 
expensive than the aryl bromides used as coupling partners. 
 Rault and coworkers reported in 2009 that a small library of 5-arylthiazole might be 
regioselectively obtained in 27-63 % yields by reacting thiazole (8) with electron-rich, electron 
poor and heteroaryl bromides.47 The couplings were carried out in the presence of 5 mol % 
Pd(PPh3)4 and 3 equiv of KOAc. However, a strong molar excess (5 equiv) of azole was once 
again required to attain good regioselectivity, and drastic reaction conditions (150 °C in a 
sealed tube) were necessary to reduce reaction times. Interestingly, the same authors evidenced 
in their paper that the ligandless conditions previously reported for the same coupling (2 equiv 
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of 8, 1 equiv of aryl bromide, 2 equiv of KOAc, 0.4 mol % Pd(OAc)2, DMA, 130 °C in sealed 
tube) gave poorer results in their hands.46 
Moreover, Shi and co-workers published that 4-methyl-thiazole and thiazole can be selectively 
arylated ad the C-5 position when treated with Pd(OPiv)2 (10 mol %), Cs2CO3 (1 equiv), in 
DMF at 100 °C in the presence of aryl iodides and bromides (Scheme 16).48  
 
 
Scheme 16 
 
A wide variety of aryl iodides, regardless of the electron-deficient to -rich nature, were 
successfully applied for this regioselective arylation, along with sterically hindered aryl halides 
(isolated yields ranging from 24 to 93 %). Small amounts of the corresponding 2,5-diarylated 
derivatives as byproducts were also detected under these reaction conditions. Furthermore, it 
was found that the reaction proceed smoothly also in the presence of aryl bromides, giving the 
respective 5-aryl-4-methyl-thiazoles in 47-71 % yield. The C-unsubstituted thiazole was found 
to be reactive towards aryl iodides, giving the monoarylation products in 18-60 % isolated 
yield.48 
 It is interesting to note that several Pd- and Pd/Cu-catalyzed procedures developed for 
the direct arylation of thiazole derivatives have also been successfully employed for the 
synthesis of 2-arylbenzothiazoles by direct C-2 arylation of benzothiazole (10) with aryl 
halides.20a,20f,24,27,38,41,42a 
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As shown in Scheme 17, the Pd- and/or CuI-catalyzed direct C-2 arylation of benzothiazole 
have been found to invariably require stoichiometric amounts of a base, polar aprotic solvents 
and high reaction temperatures. 
 
 
2.3. Imidazole derivatives. 
 
 In 1984, Ames found that the Pd-catalyzed intramolecular arylation of N-(2- 
bromophenyl)benzamide (11) in 1-methyl-1H-imidazole (12) at 190 °C did not furnish the 
required phenanthridone but, surprisingly, gave a 2-arylated-1-methyl-1H-imidazole (Scheme 
18).11c 
 
 
Scheme 18 
 
Eight years later, the first important study on the Pd-catalyzed direct arylation of N- 
methylimidazole derivatives was reported by Ohta and co-workers24
 
who employed 
chloropyrazines as the arylating agents (Scheme 19). It should be noted that 1-methyl-1H-
imidazole (12) could be arylated with complete C-5 selectivity, albeit in modest yields.24 
 In 1998, Miura and co-workers performed an extensive study focused on the Pd-
catalyzed direct arylation of a variety of azoles, including imidazoles, thiazoles and oxazoles, 
with aryl halides.20a These authors observed that in the Pd(OAc)2/PPh3-catalyzed direct 
arylation of 1,2-dimethyl- and 1-benzyl-2-methyl-1H-imidazole in DMF at 140 °C, both aryl 
halide and base played an important role in the arylation. In particular, the relatively soluble 
base Cs2CO3 was effective when aryl iodides were used, while K2CO3 was as effective as 
Cs2CO3 for direct arylations performed with aryl bromides (Scheme 20).20a 
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Scheme 19 
 
 
Scheme 20 
 
Interestingly, they also found that the regioselectivity of the reaction between iodobenzene (2) 
and 1-methyl-1H-imidazole (12) could be controlled by the nature of the catalyst system 
(Scheme 21).20a In fact, in the presence of the sole palladium precatalyst, the arylation 
preferentially occurred at the C-5 position (Method A, Scheme 21), but the addition of a 
stoichiometric amount of Cu(I) salt significantly increased the reactivity of the C-2 position 
providing the 2-arylated product in 37 % yield (Method B, Scheme 21). Moreover, large 
amounts of 2,5-diphenyl-1-methyl-1H-imidazole were also obtained when the reaction was 
performed under the experimental conditions reported as Methods A and B (Scheme 21). 
Nevertheless, when the reaction was carried out with 2 equiv of CuI and in the absence of a 
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palladium salt, the C-2 arylated product was exclusively obtained (Method C, Scheme 21).20a  
 
 
Scheme 21 
 
 In 2000, Kondo et al.39 performed the regioselective palladium-catalyzed monoarylation 
of azoles including 1-methyl-1H-imidazole (12) using iodobenzoate immobilized on an 
insoluble polymer support. Similarly to what described by Miura in 1998,20a the positional 
selectivity for the coupling reactions was found to be dramatically influenced by the presence 
of CuI, and no diarylation was observed in both cases.39 
On the other hand, according to Miura’s results,20a
 
Mori recently found that the 
Pd(OAc)2/PPh3-catalyzed arylation of 1-methyl-1H-imidazole (12) with 2-iodotoluene (13) in 
DMSO at 140 °C provided a mixture of the corresponding 5-arylated and 2,5-diarylated 
products in 50 and 21% yield, respectively (Scheme 22).49 
 
 
Scheme 22 
 
 Between 2005 and 2009 our research group developed a generally applicable and 
selective method for the direct arylation of several N-substituted imidazoles at the C-5 position 
with aryl iodides and bromides. These conditions were suitable for N-methyl-, N-benzyl, N-
aryl-imidazoles and involved 5 mol % Pd(OAc)2, 10 mol % P(2-furyl)3, CsF as base for aryl 
iodides and K2CO3 for aryl bromides, in DMF or DMA as solvent at 110 °C for N-methyl-
imidazole and at 140°C for N-benzyl- and N-aryl imidazoles (Scheme 23).23b-d,37a,50 
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Scheme 23 
 
In the same years, the authors focused their attention also on the selective arylation of the 
imidazole ring at the C-2 position. Starting from Miura’s work of 1998 described above,20a and 
after an extensive optimization, they were able to find that by using a Pd(OAc)2/CuI system, 
N-substituted- and, for the very first time, free NH-imidazoles can be arylated at the C-2 
position even in the absence of an inorganic base (Scheme 24). The reactions can be performed 
both with aryl iodides and bromides, at 140 °C (if X = I) or at 160 °C (if X = Br).23b-d,37a,50a,b 
 
 
Scheme 24 
 
 In 2009, also Doucet and co-workers reported a methodology for the Pd-catalyzed direct 
arylation at the C-5 position of N-methyl-imidazole 12 with aryl bromides. By using ligandless 
conditions, Pd(OAc)2 (0.1 mol %) as a low amount of catalyst precursor, KOAc (2 equiv) as 
base, DMA as solvent, 150 °C as reaction temperature, they were able to synthesize several 5-
aryl-1H-imidazoles in moderate to good yields.51 
 
 
2.4. Pyrazole derivatives. 
 
 Compared to the 1,3-azoles, pyrazole has been scarcely studied to date in the area of 
transition metal-catalyzed direct arylation with aryl halides,52 because it is difficult to gain a 
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reasonable regioselectivity. In 2009, Sames and co-workers developed the first catalytic 
method for the intermolecular C-arylation of pyrazoles and explored its regioselectivity 
trends. 53  They chose to examine SEM-protected pyrazoles as the substrates [SEM: 2-
(trimethylsilyl)ethoxy-methyl] due to the stability of this protecting group under the catalytic 
arylation conditions as well as the ability of SEM group to be transposed from one nitrogen to 
another, enabling sequential arylations. Systematic examination of the reaction parameters 
(metal catalyst, ligand, base, and solvent) for the coupling of SEM-pyrazole and bromobenzene 
led the authors to develop a robust method which uses the following conditions: 5 mol % 
Pd(OAc)2, 7.5 mol % PBuAd2, 3 equiv K2CO3, 25 mol % PivOH in DMA as solvent and 
heating at 140 °C (Scheme 25).53 
 
 
Scheme 25 
 
The C-unsubstituted SEM-pyrazole when submitted to the catalytic conditions gave a mixture 
of mono- and diarylated products, whose relative amounts evidenced the higher reactivity of 
the 5-position in comparison with the 4-position, and the very low reactivity of the 3-position 
(C-H arylation: C-5 > C-4 >> C-3) (Scheme 25a). This trend was confirmed by examining the 
reaction of 1-SEM-3-phenylpyrazole, which gave a 5:2 ratio of 1-SEM-3,5-diphenylpyrazole 
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and 1-SEM-3,4,5-triphenylpyrazole (Scheme 25b). In contrast, 1-SEM-4-phenylpyrazole was 
arylated at C-5 with high selectivity to provide 1-SEM-4,5-diphenylpyrazole in 80 % yield 
(Scheme 25c). The regioisomer resulting from arylation at the C-3 was not detected, and only a 
small amount of the bisarylated product, 1-SEM-3,4,5-triphenylpyrazole, was formed. 
Arylation of 1-SEM-5-phenylpyrazole was also selective, taking place at the C-4 to afford 1-
SEM-4,5-diphenylpyrazole as the major product (Scheme 25d). These results demonstrated 
that arylation at the C-3 is ineffective, which is consistent with the low reactivity of this site, 
whereas arylation occurs at both C-4 and C-5, with a preference for the latter. According to 
Sames and co-workers, it is well established that C-4 of pyrazole is the most nucleophilic 
position and readily undergoes electrophilic substitution, whereas the 5-position carries the 
most acidic C-H bond which can be selectively deprotonated by strong bases.53,54 Then, by 
using the conditions reported above, they were able to synthesize various triarylated SEM-
protected pyrazoles exploiting the SEM-switch approach (Scheme 26).53 
 
 
Scheme 26 
 
 Between 2010 and 2012, Doucet and co-workers devoted their attention to the direct 
arylation at the C-4 position of 1,3,5-trisubstituted pyrazoles with aryl bromides.55 By using 
this strategy they assured the formation of only one product and avoided regioselectivity 
problems due to the arylation at the remaining C-H bonds of the pyrazole ring. Moreover, in 
the paper published in 2010,55a they showed that also 1-phenyl-3,5-dimethyl-pyrazole (14) can 
be arylated under their ligandless procedure to give the respective 4-arylated pyrazoles in 58-
80 % isolated yields without detecting any arylation product at the phenyl ring bound to the N-
atom due to the well-known ortho-directing properties of the pyrazole nucleus (Scheme 27). 
 In 2010, Mateos and Mendiola reported a methodology to quickly access 5-aryl-1-
methyl-pyrazoles. For that purpose, they started a research effort exploring the C-H activation 
methodology on the N-methylpyrazole ring mediated by Pd complexes.56 
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Scheme 27 
 
1-Methylpyrazole (15) was initially selected as starting material for direct C-H activation. 
Experimental conditions reported in the literature by Fagnou et al.57 were applied to 3-
bromochlorobenzene (16), and a mixture of three different arylated pyrazole derivatives were 
isolated (Scheme 28). 
 
 
Scheme 28 
 
A general reactivity rule could be stated for 15 based on experimental results: C-5 > C-4 >> C-
3 (the same relationship was found by Sames and co-workers with SEM-protected pyrazole, as 
reported above).53 
Afterwards, they were able to find a set of experimental conditions to successfully arylate 4-
chloro-1-methylpyrazole (17). With the objective of obtaining the best combination of 
conversion and selectivity, two different protocols were found: a) based on conversion: 
Pd(OAc)2, DavePhos, Bu4NOAc, isobutyric acid, NMP at 100 °C; b) based on selectivity: 
Pd(OAc)2, tBu3P⋅HBF4, Bu4NOAc, isobutyric acid, NMP at 100 °C (Scheme 29).56 These 
conditions were then applied to prepare a small library of 5-aryl-chloropyrazoles in moderate 
to excellent yields with both electron-rich and electron-poor aryl bromides (10-94 %). 
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Scheme 29 
 
 On the other hand, the Fagnou’s conditions57 were also applied by Gaulier’s group to the 
key step of their short synthetic route to Celecoxib 20 (Scheme 30).58 
 
 
Scheme 30: Reagent and conditions: a) CuI, N,N-dimethylcyclohexylamine, K3PO4, 1,4-dioxane, 115 °C, 50 h, 
73 %; b) 1-bromo-4-methylbenzene, Pd(OAc)2, PBuAd2, K2CO3, PivOH, DMA, 140 °C, 50 h, 66 %; c) 
H2SO4conc, rt, 2 h, 69 %. 
 
 Moreover, Doucet and co-workers reported the first optimized ligandless procedure for 
the Pd-catalyzed arylation of the C-unsubstituted 1-methyl pyrazole (15) with a wide variety of 
aryl bromides.59 They observed that the direct arylation favours the C-5 selectivity when 15 
was treated with an aryl bromide, in the presence of Pd(OAc)2 (1 mol %), KOAc (2 equiv) in 
DMA at 150 °C for 20 h (Scheme 31). 
 
 
Scheme 31 
 
However, despite the large excess of 1-methylpyrazole (4 equiv) employed, they observed the 
formation of a mixture of monoarylation products, the 5-arylated (21) and the 4-arylated 
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pyrazoles (22). Moderate to good yields were obtained (38-65 %), with a C-5 selectivity 
ranging between 51-87 %. 
Recently, the same research group showed that it is possible to achieve a double arylation of 1-
methylpyrazole (15) both at the C-4 and C-5 positions,60 changing a little the conditions 
reported in 2011.59 They modified the pyrazole/aryl bromide ratio from 4:1 to 1:3, then they 
used 2 mol % of PdCl(C3H5)(dppb) as catalyst precursor instead of Pd(OAc)2 and 6 equiv of 
KOAc instead of 2. With this methodology they synthesized several 4,5-diarylated 1-methyl-
pyrazoles in 28-81 % isolated yield. Moreover, in the same work, it is reported the first double 
arylation of 1-phenyl-pyrazole (23) with aryl bromides (Scheme 32). 
 
 
Scheme 32 
 
With these reaction conditions and a pyrazole/aryl bromide ratio 1:3, they synthesized three 
4,5-diaryl-1-phenyl pyrazoles in 40 to 78 % isolated yield.60 
 As regards the Pd-catalyzed direct C-H arylation of 1-phenyl-pyrazole (23) on the 
heteroaromatic ring, no paper was published so far about a specific procedure aimed at 
synthesizing a monoarylated 1-phenyl-pyrazole. The first example of direct monoarylation at 
the C-5 position of 23 was reported by Daugulis and co-workers in 2008 when they proposed a 
copper-catalyzed procedure for the arylation of several heteroarenes, including 23.13a This 
methodology involved the use of 10 mol % CuI/phenantroline catalyst system, Et3COLi as the 
base in DMPU at 125 °C for the arylation of 1-phenyl pyrazole (23) with iodobenzene (2), to 
give the 1,5-diphenyl pyrazole in 52 % isolated yield. 
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Two years later, René and Fagnou published a procedure for the C-H arylation of 
heteroaromatics with aryl iodides, and they found that 23 reacted with iodoanisole (24) in the 
presence of 5 mol % Pd(OAc)2, 10 mol % ligand 25, PivOH (30 mol %), K2CO3 (1.5 equiv), 
Ag2CO3 (0.5 equiv) in DMA at 100 °C for 16 h (Scheme 33).61 
 
 
Scheme 33 
 
 
3. Aims of this Ph.D. thesis. 
 
 This Ph.D. thesis was performed in order to broaden the substrate scope of the direct 
arylation reactions of azoles and, particularly, to design and develop convenient and efficient 
protocols for the highly regioselective synthesis of (hetero)arylazoles by Pd-catalyzed 
intermolecular arylation reactions of azoles with (hetero)aryl halides. 
Specifically, the aims of the present study were:  
1) to design and develop a general and highly selective procedure for the Pd-catalyzed 
direct C-5 arylation of 1-methyl-1H-pyrazole (15) with (hetero)aryl bromides; 
2) to acquire this new general method for the highly selective synthesis of 5-aryl-1-
methyl-1H-pyrazoles; 
3) to verify if the general method of Pd-catalyzed direct C-5 arylation of 1-methyl-1H-
pyrazole (15) can be also applied to the selective C-5 arylation of 1,3-azoles and to 
synthesize a small library of 5-aryl-oxazoles, 5-aryl-thiazoles and 5-aryl-1H-
imidazoles; 
4) to design a new general and selective procedure for the Pd-catalyzed direct arylation of 
1-phenyl-1H-pyrazole (23) with aryl bromides; 
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5) to apply the methodologies developed to the synthesis of compounds of interest as 
bioactive molecules and fluorophores; 
6) to synthesize N-heterocyclic copper carbenes and to study their role in the Pd/Cu 
mediated arylation with aryl iodides. 
For the sake of clarity, the data concerning the topics covered in this Ph.D. thesis have been 
organized in four chapters. The results of the study concerning the Pd-catalyzed C-5 arylation 
reactions of 1-methyl-1H-pyrazole (15) and 1-phenyl-1H-pyrazole (23), the synthesis of 5-
aryl-1-methyl-1H-pyrazoles, 5-aryl-oxazoles, 5-aryl-thiazoles and 5-aryl-1-methyl-1H-
imidazoles have been reported and commented in Chapter 1. In Chapter 2 we have reported 
the applications of the developed procedure for the selective C-5 direct arylation of 1,3-azoles 
with aryl bromides. Chapter 3 deals with the results obtained in the synthesis and the study of 
the role of NHC-copper carbenes in the Pd/Cu mediated arylation reaction. This part of the 
Ph.D. was carried out at the University of York (United Kingdom) under the supervision of 
Professor Ian J. S. Fairlamb. Finally, Chapter 4 deals with the Experimental Part. 
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Pd-catalyzed direct arylation of C-unsubstituted azoles with aryl 
halides62 
 
 As mentioned in the Introduction, there are relatively few methods that appear to be 
generally applicable to the palladium-catalyzed regioselective direct arylation of the broadest 
range of simple C-unsubstituted azoles. In contrast with methods that perform the direct 
arylation on C-substituted azoles,9,10b,23b,50c,54, 63  in which the desired groups have to be 
introduced at the early stage of the synthesis to grant the required selectivity, the arylation of 
unsubstituted azoles allows the introduction of aryl moieties on the parent azole frameworks in 
a late stage of the synthesis. 
In their seminal paper of 1998 on direct arylation of azoles, Miura and co-workers reported 
that 1-methyl-1H-imidazole (12) and thiazole (8) may be regioselectively arylated at their C-5 
position with aryl bromides or iodides at 140 °C in DMF in the presence of Pd(OAc)2 (10 mol 
%), PPh3 (20 mol %) and 2 equiv of K2CO3 (for bromides) or Cs2CO3 (for iodides) (see 
Scheme 20).20a However, this method suffers from regioselectivity problems and, as our 
research group demonstrated later,50e PPh3 may be involved in undesired aryl-aryl exchange 
reactions with the aryl moiety of the halides. In 2009 Fagnou and co-workers demonstrated 
that thiazole and 1-benzyl-1,2,3-triazole are able to undergo regioselective C-5 arylation when 
treated with aryl bromides and K2CO3 in DMA at 100 °C, in the presence of 2 mol % 
Pd(OAc)2 and 4 mol % PCy3⋅HBF4.57 The coupling required also 30 mol % of pivalic acid 
which, according to the authors, granted faster reactions. Unfortunately, very low yields were 
observed when 1-methyl-1H-imidazole was used as the coupling partner, and the protocol 
proved to be unsuitable for the direct arylation of imidazole, 1-benzyl-1H-imidazole and 
isoxazole. Finally, it is worth mentioning that in a series of papers Doucet and co-workers 
described a phosphine-free method for the direct C-5 arylation of 1-methyl-1H-imidazole 
(12),51 thiazole (8)46 and 1-methyl-1H-pyrazole (15)59 with aryl bromides, in the presence of 2 
equiv of KOAc, and with a low loading of Pd(OAc)2 (0.1-1 mol %). This method provides the 
required 5-arylated azoles in low to satisfactory yields, but it suffers in general from 
regioselectivity problems when the arylation involves 1-methyl-1H-pyrazole (15) despite a 4:1 
molar ratio between this expensive azole and aryl bromides.59 Moreover, this protocol shares 
with all the others high reaction temperatures (130-150 °C), which constitute a serious issue 
when thermolable substrates have to be used,64 and may cause security problems during scale-
up because sealed vessels are generally required. 
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 As reported in the Introduction, recent theoretical investigations revealed that a 
concerted metalation/deprotonation (CMD) pathway is of relevance for the Pd-catalyzed direct 
arylation of azoles.19,65 In this mechanistic hypothesis, Pd(OAc)2 is generally the transition-
metal precatalyst, and a carboxylate (or carbonate) anion plays a fundamental role in the C-H 
cleavage, which occurs in the rate-determining step of this model, simultaneously with carbon-
palladium bond formation. In the light of these theoretical findings, and based on our 
knowledge of Pd-catalyzed direct arylations of π-electron-rich heteroarenes,23c-d,34,50c-e we 
reasoned that common reaction conditions should be found for different azoles if they really 
share the same mechanistic pathway when treated with aryl halides. In the CMD mechanism 
the choice of an appropriate base represents an important element of catalyst design. For this 
reason, in this Ph.D. work we decided to devote particular attention to study the influence of 
the anionic base and its counter cation66 on the outcome of the direct arylation of azoles during 
a re-examination of all the reaction parameters. More specifically, we focused our attention on 
the development of an efficient procedure for the palladium-catalyzed direct arylation of 1-
methyl-1H-pyrazole (15), oxazole (4), thiazole (8) and 1-methyl-1H-imidazole (12) with aryl 
bromides. We were also aware that, often, the presence of substituents of different nature on 
the N-atom of the heterocycles, as alkyl or aryl groups, can influence the reactivity of the 
whole catalytic systems.23b,23d,37a,50a,50c-d In fact, in order to get the best efficiency and 
selectivity for a specific N-substituted heteroarenes, we often need to find a specific 
solvent/catalyst/base reaction system. For this reason we devoted the last part of the thesis also 
on the preliminary screening of the direct arylation of 1-phenyl-1H-pyrazole (23). 
 
 
1. Synthesis of 5-aryl-1-methyl-1H-pyrazoles (21) via Pd-catalyzed direct 
arylation of 1-methyl-1H-pyrazole (15).62 
 
 At the outset of our studies, we decided to investigate the synthesis of 5-aryl-1-methyl-
1H-pyrazoles (21) starting from the Pd-catalyzed direct C-5 arylation of 1-methyl-1H-pyrazole 
(15) with aryl bromides. As mentioned in the Introduction, the regioselective synthesis of C-
monoarylated pyrazoles represents a challenging target, and previous studies by Sames on 
SEM-protected pyrazole,53 by Mateos and Mendiola56 and by Doucet59 on 15 clearly indicated 
the difficulties in performing a clean monoarylation on simple C-unsubstituted pyrazoles. In 
fact, the different protocols used so far to perform the direct C-5 arylation reactions of 15 meet 
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with limited success because of modest yields,53,56 low regioselectivity53,56 or the use of a large 
excess of the expensive precursor.59 
 With the aim to overcome these limitations, at the beginning of this Ph.D. work, we 
focused our attention on the Pd-catalyzed direct arylation of 1-methyl-1H-pyrazole (15) with 
4-bromotoluene (26a), chosen as a model-coupling partner. We decided to perform the 
reactions starting from 1 mmol of 15 and 1.5 equiv of 26a in the presence of 5 mol % of the 
catalyst precursor, 2 equiv of a suitable base, in 5 mL of an appropriate solvent. We also set the 
reaction temperature at 140 °C and the reactions were followed for 24 h. 
At first the impact of the base was evaluated, using Pd(OAc)2 (5 mol %) as the catalyst and 
DMA as the solvent (Scheme 34). 
 
  
Scheme 34 
 
The results of this preliminary screening are reported in Table 1. A mixture of the 5-arylated 
pyrazole 21a and the corresponding 4,5-diarylated derivative 27a was invariably observed 
when the GLC yield of 21a was higher than 10 % (entries 5-9, Table 1), while 27a was not 
detected in the crude reaction mixtures when lower GLC yields were recorded (entries 1-4 and 
10-11, Table 1). Moreover, the crude reaction mixtures were found to be contaminated by 
significant amounts of 4,4’-dimethyl-1,1’-biphenyl (28a), derived from a Pd-catalyzed 
Ullmann-type reductive coupling of 26a (Figure 3).67 The structures of the products 21a, 27a 
and 26a were all confirmed by 1H-NMR, 13C-NMR and GC-MS analyses. 
These results, along with the detection of traces (if any) of the other two isomeric 3- and 4-
monoarylated pyrazoles (29a and 22a respectively, Figure 3), confirmed the higher reactivity 
of the 5-position relative to the 4-position, while the 3-position resulted essentially 
unreactive.53 
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Table 1: Screening of the bases for the direct C-5 arylation of 1-methyl-1H-pyrazole (15) with 4-bromotoluene 
(26a). 
  
 
Entry[a] Base Yield of 21a (%)[b] 21a:27a 
1 NaOAc 6 100:0 
2 KOAc 8 100:0 
3 CsOAc 7 100:0 
4 AgOAc 1 100:0 
5 Bu4NOAc 49 86:14 
6[c] Bu4NOAc 44 89:11 
7 K2CO3 19 85:15 
8 KHCO3 18 86:14 
9 K3PO4 24 90:10 
10 KF 4 90:10 
11 KOtBu 6 100:0 
[a] Unless otherwise stated, the reactions were carried out using 15 (1.0 mmol), 
26a, (1.5 equiv), Pd(OAc)2 (5 mol %), DMA (5 mL) for 24 h at 140 °C. [b] 
GLC yield. [c] Reaction carried out in the presence of 0.3 equiv of pivalic acid. 
 
 
Figure 3: 4,4’-Dimethyl-1,1’-biphenyl (28a), 1-methyl-3-(p-tolyl)-1H-pyrazole (29a) and 1-methyl-4-(p-tolyl)-
1H-pyrazole (22a). 
 
 Although the selectivity of the arylation was little influenced by the base, its chemical 
nature had a deep impact on the efficiency of the coupling reaction. In particular, the yield of 
21a seems to be related to a specific cation/anion pair and not to a particular anion or cation 
(compare for example, entries 1-5, or entries 2 and 7-11, Table 1). From these data it clearly 
emerges that Bu4NOAc represents the best choice in terms of chemical yield (49 %) for the 
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regioselective direct 5-arylation of 15 with 26a in DMA (entry 5, Table 1). Potassium-
containing bases K2CO3, KHCO3, and K3PO4 also showed activity, albeit with a significant 
lower product yields (entries 7-9, Table 1). All the other bases were ineffective at 140 °C in 
DMA, including KOAc, a base frequently used to promote the direct arylation of azoles and 
that, in particular, was previously employed in the direct arylation of 15 with aryl bromides at 
150 °C in the same solvent.59 Note also the result obtained when Bu4NOAc was used in 
combination with 30 mol % of pivalic acid (entries 6, Table 1), which as already stated at the 
beginning of this chapter, is an additive commonly used in direct arylation reactions in 
combination with inorganic bases.9,10b,23b,50c,50e,54,57 In this case we observed a yield lower than 
that obtained when the same reaction was carried out in the absence of this carboxylic acid 
(entries 5, Table 1). 
 Then, we attempted to improve the yield of the arylation reaction, so the effects of the 
nature of the solvent were examined. The reaction temperature for this second screening was 
set at 110 °C to allow a better comparison between solvents with boiling points lower than 140 
°C. We also tried to compare the three bases that gave the best results in terms of efficiency in 
order to observe if the trend of the results reported in Table 1 could be kept also in solvents 
different from DMA (Table 2). 
 From the data summarized in Table 2, it clearly emerges that the N,N-dimethylacetamide 
(DMA) is a better solvent than toluene and dioxane for all the three bases (entries 1, 5 and 9, 
Table 2). In light of the results obtained in the reactions with K3PO4 and K2CO3 in toluene 
(entries 2 and 6, Table 2), we thought that the low solubility of the inorganic bases in this 
solvent could influence the effectiveness of the arylation; therefore we tried to exploit the 
capability of a transfer agent to improve the solubility of inorganic bases in organic solvents68 
as we previously reported in the procedure for the direct C-3 arylation of (NH)-indoles with 
aryl bromides.69 The use of a lipophilic quaternary ammonium salt such BnBu3NCl could have 
favoured the solubility of K3PO4 and K2CO3 in toluene. Unfortunately, both the catalytic 
systems resulted inactive with these reaction conditions (entries 3 and 7, Table 2). It is clear 
that Bu4NOAc results the most efficient base in promoting this arylation and it is interesting to 
observe that, when we used this organic base, the 21a:27a molar ratio was always higher than 
80 % (entries 9-13, Table 2). Furthermore, DMA gave the best result in terms of efficiency 
among the polar solvents as N-methyl-pyrrolidone (NMP) and dimethylformamide (DMF) 
(entries 9, 12-13, Table 2). Finally, we tried to improve the low efficiency demonstrated by 
KOAc (entry 2, Table 1) by performing the arylation of 15 in the presence of 1.0 equiv of 
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Bu4NCl (entry 14, Table 2), but the yield of 21a remained lower than that obtained by using 
Bu4NOAc. 
 
Table 2: Screening of the solvents for the direct C-5 arylation of 1-methyl-1H-pyrazole (15) with 4-
bromotoluene (26a). 
 
 
Entry[a] Base Solvent Yield of 21a (%)[b] 21a:27a 
1 K3PO4 DMA 15 89:11 
2 K3PO4 Toluene 3 100:0 
3[c] K3PO4 Toluene 3 100:0 
4 K3PO4 Dioxane - - 
5 K2CO3 DMA 19 83:17 
6 K2CO3 Toluene 9 80:20 
7[c] K2CO3 Toluene - - 
8 K2CO3 Dioxane - - 
9 Bu4NOAc DMA 52 (52)[d] 82:18 
10 Bu4NOAc Toluene 45 93:7 
11 Bu4NOAc Dioxane 39 92:8 
12 Bu4NOAc NMP 50 (47)[e] 83:17 
13 Bu4NOAc DMF 34 91:9 
14[f] KOAc DMA 34 88:12 
[a] Unless otherwise stated the reactions were carried out using 15 (1.0 mmol %), 26a, (1.5 equiv), 
Pd(OAc)2 (5 mol %), solvent (5 mL), for 24 h at 110 °C. [b] GLC yield. In parentheses, isolated 
yield. [c] Reaction was carried out in the presence of 0.2 equiv of BnBu3NCl. [d] 1-Methyl-4,5-di-
(p-tolyl)-1H-pyrazole (27a) was also isolated in 12 % yield. [e] 1-Methyl-4,5-di-(p-tolyl)-1H-
pyrazole (27a) was also isolated in 10 % yield. [f] Reaction carried out in the presence of 1.0 equiv 
of Bu4NCl. 
 
 Taking into account these results, we studied the influence of the palladium pre-catalyst 
and the ligand on the efficiency and selectivity of our model reaction (Table 3). As regards the 
catalyst precursor, the best results were obtained by using Pd(OAc)2 (entry 9, Table 2) and 
PdCl2 (entry 3, Table 3), with poorer results in terms of yield obtained with Pd2(dba)3 and 
PdCl2(MeCN)2 (entries 1 and 2, Table 3). The reaction was also successful with reduced 
palladium loading (entry 4, Table 3), but we proceeded with 5 mol % of Pd(OAc)2 for 
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convenience. Afterwards, we examined the role of the ligand and we observed that 
monodentate phosphines (entries 5-12, Table 3) were found to be more efficient than bidentate 
ligands (entries 13-16, Table 3). However, in general, their presence did not increase the 
activity and the selectivity of the catalytic system, irrespective of the electronic and/or steric 
properties of the ligand itself. 
 
Table 3: Screening of the catalyst precursors, the ligands and the reaction temperature for the direct C-5 
arylation of 1-methyl-1H-pyrazole (15) with 4-bromotoluene (26a). 
 
 
Entry[a] Catalyst Ligand 
Temperature 
(°C) 
Yield of 21a 
(%)[b] 21a:27a 
1 Pd2(dba)3 - 110 38 91:9 
2 PdCl2(MeCN)2 - 110 46 87:13 
3 PdCl2 - 110 52 (51)[c] 84:16 
4[d] Pd(OAc)2 - 110 40 75:25 
5 Pd(OAc)2 PPh3 110 42 85:15 
6 Pd(OAc)2 P(o-Tol)3 110 50 87:13 
7 Pd(OAc)2 P(tBu)2biphenyl 110 39 68:32 
8 Pd(OAc)2 PCy3 110 42 78:22 
9 Pd(OAc)2 P(tBu)3⋅HBF4 110 30 79:21 
10 Pd(OAc)2 PBuAd2 110 47 77:23 
11 Pd(OAc)2 P(2-furyl)3 110 14 93:7 
12 Pd(OAc)2 AsPh3 110 39 83:17 
13 Pd(OAc)2 Xantphos 110 38 76:24 
14 Pd(OAc)2 dppb 110 40 76:24 
15 Pd(OAc)2 dppf 110 28 82:18 
16 Pd(OAc)2 Oxydiphenylene(PPh2)2 110 38 76:24 
17 Pd(OAc)2 - 70 62 (58)[e] 84:16 
18 Pd(OAc)2 - 40 - - 
[a] Unless otherwise stated the reactions were carried out using 15 (1.0 mmol %), 26a, (1.5 equiv), Pdcat (5 
mol %), ligand (10 mol %) (if any), DMA (5 mL), for 24 h at 110 °C. [b] GLC yield. In parentheses, 
isolated yield. [c] 1-Methyl-4,5-di-(p-tolyl)-1H-pyrazole (27a) was also isolated in 10 % yield. [d] Reaction 
performed by using 1 mol % of Pd(OAc)2. [e] 1-Methyl-4,5-di-(p-tolyl)-1H-pyrazole (27a) was also 
isolated in 12 % yield. 
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 Due to the fact that the yield obtained with Bu4NOAc as the base was slightly higher at 
110 °C than at 140 °C (compare entry 9, Table 2 with entry 5, Table 1), we decided to lower 
further the reaction temperature and we found, with our pleasure, that an even better chemical 
yield was obtained when 15 was treated with 26a in the presence of Bu4NOAc and Pd(OAc)2 
in DMA at only 70 °C (entry 17, Table 3). However, an attempt to carry out the same reaction 
at 40 °C was unsuccessful, and the precursors were recovered unchanged after 24 h (entry 18, 
Table 3). 
 The good results obtained in the preparation of 21a from 15 and 26a under the 
experimental conditions reported in entry 17 of Table 3 prompted us to extend this mild 
procedure to the selective preparation of 5-aryl-1H-pyrazoles 21 starting from 15 and 
commercially available para- and ortho-substituted aryl bromides 26a-q by using 5 mol % 
Pd(OAc)2 as the catalyst and 2 equi Bu4NOAc as the base in DMA at 70 °C (Scheme 35). The 
results are reported in Table 4. 
 
 
Scheme 35 
 
Good chemical yields and C-5 regioselectivity were observed with electron-rich para-
substituted aryl bromides 26a and 26b (entries 1 and 2, Table 4), and similar C-5 
regioselectivity but slightly lower yields were observed with electron-poor para-substituted 
aryl bromides 26e-g as the electrophilic partners (entries 5-7, Table 4). Similarly to our 
observations during the preliminary screenings, the crude reaction mixtures were contaminated 
by the corresponding 4,5-diarylated pyrazoles 27 (detected by GLC and GC-MS); smaller 
amounts (16-18%) of 27 were produced with deactivated bromides 26a-b than with activated 
bromide 26e-g (20-30 %). 
In contrast to the results reported by Doucet and coworkers,59 a good selectivity was observed 
irrespective of the electronic nature of the para-substitutent on the aryl bromide 26. In fact, we 
argued that the possibility of lowering the reaction temperature from 150 °C to 70 °C due to 
the successful use of Bu4NOAc enhanced the kinetic discrimination among the C-H bonds 
with different dissociation energies (ΔGact at 298 K for C-H bond cleavage in 15: C-3 31.3, C-
4 28.5, C-5 27.3 kcal⋅mol-1).19  
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Table 4: Scope of the ligandless Pd-catalyzed direct C-5 arylation of 1-methyl-1H-pyrazole (15) with aryl 
bromides 26a-q promoted by Bu4NOAc. 
 
 
Entry[a] Aryl bromide 
(26) 
Reaction 
time (h)[b] 
Product 21 Yield 
(%)[c] 
C-5 
Selectivity[d] 
1 26a 
 
24 21a 
 
58 0.84 
2 26b 
 
23 21b 
 
58 0.84 
3 26c 
 
48 21c 
 
28 1.00 
4 26d 
 
24 21d 
 
- - 
5 26e 
 
46 21e 
 
46 0.70 
6 26f 
 
48 21f 
 
30 0.70 
7 26g 
 
48 21g 
 
41 0.80 
8 26h 
 
24 21h 
 
47 0.78[e] 
9 26i 
 
24 21i 
 
42 0.73[f] 
10 26j 
 
24 21j 
 
- - 
11 26k 
 
24 21k 
 
50 0.76[e] 
12 26l 
 
24 21l 
 
- - 
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13 26m 
 
24 21m 
 
- - 
14[g] 26n 
 
65 21n 
 
33 0.60 
15 26o 
 
24 21o 
 
- - 
16 26p 
 
24 21p 
 
- - 
17 26q 
 
72 21q 
 
11 0.88 
[a] The reactions were carried out by using pyrazole 15 (1 mmol) and aryl bromide 26 (1.5 equiv) at 70 °C in the 
presence of Pd(OAc)2 (5 mol %) and Bu4NOAc (2 equiv) in DMA (5 mL). [b] The reactions were stopped when the 
conversion was higher than 95 %, or when they did not progress further. [c] Isolated yield. [d] 5-Arylated pyrazole 21 
(% GLC) with respect to all arylated products formed. Unless otherwise stated, the main byproduct was the 
corresponding diarylated pyrazole 27. [e] The crude reaction mixture was contaminated by ca. 7 % of a regioisomeric 
monoarylated derivative. [f] The crude reaction mixture was contaminated by ca. 14 % of a regioisomeric 
monoarylated derivative. [g] The reaction was performed at 110 °C. 
 
As a consequence, a strong molar excess of 15 was not necessary to secure a high 
regioselectivity. This simple combination of Pd(OAc)2 and Bu4NOAc proved to be tolerant to 
some sterically hindered bromides without the need to force reaction conditions. In fact, 2-
bromotoluene (26h), 2-chloro-1-bromobenzene (26i), and 1-naphthyl bromide (26k) reacted 
readily with 15 at 70 °C to give the corresponding 5-arylated pyrazoles 21h, 21i and 21k in 47, 
42 and 50 % isolated yields, respectively (entries 8-9 and 11, Table 4). Note, in these reactions, 
variable amounts (7-14 %) of a monoarylated regioisomeric pyrazole (presumably the C-4 
isomer)59 were also detected in the crude reaction mixtures. 
On the other hand, methyl-2-bromobenzoate (26j), 2-bromoanisole (26l) and 5-bromo-1,2,3-
trimethoxybenzene (26m) (entries 10 and 12-13, Table 4) did not react in this mild conditions 
with 1-methyl-pyrazole as well as 5-bromopyrimidine (26o) and the NH-free 5-bromo indole 
(26p) (entries 15-16, Table 4). No monoarylation product was also detected employing 
unprotected 4-bromoaniline (26d) (entry 4, Table 4). Otherwise, it is worth of noting that, for 
the first time, unprotected 4-bromophenol (26c) was used in a Pd-catalyzed direct arylation and 
4-(1-methyl-1H-pyrazol-5-yl)-phenol (21c) was isolated in 28 % yield (entry 3, Table 4) by the 
reaction of 26c with 1-methyl-pyrazole (15) after 48 h at 70 °C. Finally, heteroaryl bromides as 
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3-bromopyridine (26n) and 2-bromo-5-methylthiophene (26q) also reacted with compound 15 
even if with low reactivity, giving 33 and 11 % isolated yields respectively. 
 
 
2. Synthesis of 5-aryl-oxazoles (30), 5-aryl-thiazoles (31) and 5-aryl-1-
methyl-1H-imidazoles (32) via Pd-catalyzed direct arylation of oxazole 
(4), thiazole (8) and 1-methyl-1H-imidazole (12) promoted by 
Bu4NOAc.62 
 
 Having successfully demonstrated the viability of the Pd(OAc)2-catalyzed regioselective 
direct 5-arylation of 15 with bromides 26 in the presence of Bu4NOAc as base, we proceeded 
to broaden the scope of this arylation reaction by applying the optimized reaction conditions of 
entry 17 of Table 3 to the synthesis of different classes of monoarylated azoles (Scheme 36). 
 
  
Scheme 36 
 
 We found that 1,3-azoles can react at the 5-position with a variety of activated and 
deactivated aryl bromides 26 (Table 5 and Table 6). 
In detail, oxazole (4) and thiazole (8) were efficiently and regioselectively converted into the 
corresponding 5-arylated derivatives 30 and 31, respectively, by reacting with 1.5 equiv of aryl 
bromides 26a-c, 26e and 26h. Deactivated bromides 26a-b, activated 1-bromo-4-nitrobenzene 
(26e) and ortho-substituted bromotoluene (26h) gave yields ranging from 49 to 72 % and high 
selectivities when treated with 4 (entries 1-2 and 4-5, Table 5), whereas the corresponding 5-
arylated thiazoles 31a-b, 31e and 31h were obtained in isolated yields of 59-70 % with C-5 
selectivities up to 100 % (entries 6-7 and 9-10, Table 5). 
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Table 5: Scope of the ligandless Pd-catalyzed direct C-5 arylation of oxazole (4) and thiazole (8) with aryl 
bromides 26a-c, 26e and 26h promoted by Bu4NOAc. 
 
 
Entry[a] Time (h)[b] Product Yield (%)[c] C-5 Selectivity[d] 
1 5 30a 
 
58 0.86 
2 24 30b 
 
49 0.88 
3 48 30c 
 
36 0.95 
4 24 30e 
 
57 0.89 
5 24 30h 
 
72 0.83 
6 21 31a 
 
65 0.86 
7 48 31b 
 
67 1.00 
8 48 31c 
 
17 1.00 
9 48 31e 
 
70 0.94 
10 29 31h 
 
59 0.89 
[a] The reactions were carried out by using azoles 4 and 8 (1 mmol) and aryl bromide 26 (1.5 equiv) at 70 
°C in the presence of Pd(OAc)2 (5 mol %) and Bu4NOAc (2 equiv) in DMA (5 mL). [b] The reactions 
were stopped when the conversion was higher than 95 % or when they did not progress further. [c] 
Isolated yield. [d] 5-Monoarylated azole (% GLC) with respect to all arylated products formed. 
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Even with these two azoles, unprotected 4-bromophenol (26c) was used for the Pd-catalyzed 
direct arylation and 4-(oxazole-5-yl)phenol (30c) and 4-(thiazole-5-yl)phenol (31c) were 
isolated in 36 and 17 % yield, respectively (entries 3 and 8, Table 5) by the reaction of 26c 
with oxazole (4) and thiazole (8) after 48 h at 70 °C. 
 Note that this convenient synthetic method for the direct 5-arylation of 4 and 8 competes 
favourably with previously reported protocols. In fact, as reported in the Introduction, 
Strotman et al. investigated the regioselective direct 5-arylation of oxazole (4) with 
(hetero)aryl bromides in DMA for 16 h at 110 °C in a sealed vial in the presence of Pd(OAc)2 
(5 mol %), 3 equiv of K2CO3 and 0.4 equiv of pivalic acid, but a two-fold excess of 4 was 
required to gain high regioselectivities (90-100 %) and 10 mol % of the air sensitive di(1-
adamantyl)-n-butylphosphane (5) was employed as the Pd ligand (see Scheme 8).33 As regards 
thiazole (8), Rault and co-workers reported a small library of 5-arylthiazole 31 regioselectively 
obtained (27-63 % isolated yields) by treating 8 with electron-rich, electron-poor and 
heteroaryl bromides.47 However, a strong molar excess of 5 equiv of 8 was once again required 
to attain good regioselectivity and drastic reaction conditions were necessary to reduce reaction 
times. 
 A highly efficient direct 5-arylation was also achieved when 1-methyl-1H-imidazole 
(12) was treated with several aryl bromides using the same reaction conditions promoted by 
Bu4NOAc but setting the reaction temperature to 110 °C (Table 6). 
Yields higher than 80 % resulted from the reaction of 12 with electron-rich 4-bromotoluene 
(26a) and 4-bromoanisole (26b) (entries 1-2, Table 6); however electron-neutral 
bromobenzene (26r), electron-poor 4-bromobenzonitrile (26s), and 1-bromo-4-nitrobenzene 
(26e) were also used as coupling partners (75, 69 and 45 % isolated yields, respectively; entries 
6, 7 and 4, Table 6). As we observed for pyrazole 15 and also the parent 1,3-azoles 4 and 8, the 
reaction proved to be tolerant towards the ortho-substituted aryl bromide, 2-bromotoluene 
(26h); in fact, 1-methyl-5-(2-methylphenyl)-1H-imidazole (32h) was isolated in a satisfactory 
68 % yield (entry 5, Table 6). Invariably, very good regioselectivity was observed, with 
typically less than 10 % (GLC) of the corresponding 2,5-diarylated imidazoles found to 
contaminate the crude reaction mixtures. Finally, the reaction between the unprotected 4-
bromophenol (26c) and 1-methyl-1H-imidazole (12) did not occur (entry 3, Table 6). 
 Note that this new protocol for the regioselective 5-arylation of 12 gave identical 
regioselectivities but higher isolated yields than the procedure reported by our research group 
in 2008, in which we employed Pd(OAc)2 (5 mol %) and P(2-furyl)3 (10 mol %) as catalyst 
system, 2 equiv of K2CO3 as base, and DMF as solvent at 110 °C.50c 
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Table 6: Scope of the ligandless Pd-catalyzed direct C-5 arylation of 1-methyl-1H-imidazole (12) with aryl 
bromides 26a-c, 26e, 26h and 26r-s promoted by Bu4NOAc. 
 
 
Entry[a] Time (h)[b] Product Yield (%)[c] C-5 Selectivity[d] 
1 22 32a 
 
81 0.90 
2 24 32b 
 
82 0.97 
3 24 32c 
 
- - 
4 24 32e 
 
45 1.00 
5 24 32h 
 
68 0.91 
6 24 32r 
 
75 0.97 
7 23 32s 
 
69 0.92 
[a] The reactions were carried out by using azole 12 (1 mmol) and aryl bromide 26 (1.5 equiv) at 
110 °C in the presence of Pd(OAc)2 (5 mol %) and Bu4NOAc (2 equiv) in DMA (5 mL). [b] The 
reactions were stopped when the conversion was higher than 95 % or when they did not progress 
further. [c] Isolated yield. [d] 5-Monoarylated azole (% GLC) with respect to all arylated products 
formed. 
 
For comparison, imidazole 32b was obtained in 49 % yield by applying our older method, and 
ortho-substituted aryl bromides did not react at all. The use of Bu4NOAc at 110 °C in DMA 
also gave better results than those reported by Doucet and co-workers in 2009.51 In that case, 
their harsh low catalyst loading method [Pd(OAc)2 (0.5-0.01 mol %), 2 equiv of KOAc in 
DMA at 150 °C] gave significantly lower yields when electron-rich aryl bromides 26a and 26b 
were used (40 and 42 % isolated yields, respectively), whereas results similar to those reported 
N
N
+ Ar-Br
N
N
H Ar
12 32
Pd(OAc)2 (5 mol %)
Bu4NOAc (2 equiv)
DMA, 110 °C
26
Me Me
N
N
Me
Me
N
N
MeO
Me
N
N
HO
Me
N
N
O2N
Me
N
N
Me
Me
N
N
Me
N
N
NC
Me
Chapter 1 
 57 
here were described when a typical electron-poor aryl bromide, 4-bromobenzonitrile (26s), was 
used (76 % yield). 
 
 
3. Mechanistic hypothesis of the palladium-catalyzed direct arylation of 
azoles with aryl bromides promoted by Bu4NOAc.62 
 
 From our data it emerges that the experimental order of reactivity for the three 1,3-
azoles, that is oxazole > thiazole > 1-methyl-1H-imidazole, parallels the calculated Gibbs free 
energy for the cleavage of the C5-H bond for a CMD reaction mechanism19 (ΔGact at 298 K: 
oxazole 23.5, thiazole 23.7, 1-methyl-1H-imidazole 25.0 kcal⋅mol-1). This experimental order 
of reactivity is distinctly different to that reported for common electrophilic substitution 
reactions carried out in nonacidic media (1-methyl-1H-imidazole > oxazole > thiazole),70 
which allows us to reasonably exclude an alternative SEAr mechanistic pathway, which has 
also been postulated for direct arylations involving these heteroaromatics.20a 
 Undoubtedly, the efficiency and very high regioselectivity demonstrated by this ligand-
free protocol at mild reaction temperatures and without the need of employing a strong molar 
excess of the heteroaromatic partner has to be attributed to the use of Bu4NOAc as the base. Its 
efficacy in promoting such ligand-free direct arylations, in our opinion, may be motivated not 
only by the well-known ability of ammonium salts to act as metal stabilizers in the absence of 
phosphines or other ancillary ligands (the so-called “Jeffery conditions”),69,71,72 but also by the 
fact that organic ionic bases have good solubility and are fully ionized in organic solvents.73 In 
fact, we noted that arylations involving Bu4NOAc gave yellow to deep-orange solutions 
(Figure 4), in contrast to the reactions carried out in the presence of inorganic bases, which 
usually give dark-brown heterogeneous reaction mixtures. These last features may lead, as a 
consequence, to an improved availability in solution of the acetate anion,74 which can then play 
better its key-role in the concerted metalation/deprotonation pathway (CMD) postulated for 
these Pd-catalyzed reactions (Figure 5), as already mentioned.19 
In particular, the role of Bu4NOAc may be of relevance in the anionic ligand-exchange step 
that may occur at the aryl palladium intermediate I, producing the palladium acetate 
intermediate II, which then may follow the CMD pathway via a six-membered transition state 
TS. DFT calculations evidenced that this path is energetically more favourable than a pathway 
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involving a σ-bond metathesis, in which the bromine atom induces deprotonation via TS-I 
(Figure 6).75 
 
 
Figure 4: A typical crude reaction mixture from a Bu4NOAc-promoted direct arylation, after 24 h at 110 °C. 
 
 
Figure 5: Proposed CMD pathway for the ligand-free Pd-catalyzed direct 5-arylation of azoles with aryl 
bromides mediated by Bu4NOAc. Coordinating species around Pd (such as solvent molecules or ammonium 
salts) have been omitted for semplicity. 
 
 
Figure 6: Structure of intermediate TS-I. 
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Hence, if the lower-energy pathway involves a bromine/acetate exchange, this may become a 
limiting step for the entire process when bases that are poorly soluble in the reaction media are 
employed, and may explain the efficiency of Bu4NOAc in promoting this class of C-C bond-
forming reaction. 
 
 
4. Preliminary screening on the palladium-catalyzed direct arylation of 1-
phenyl-1H-pyrazole (23). 
 
 Our next challenge, after the study of the reactivity of the 1-methyl-1H-pyrazole with 
aryl bromides, was to focus our attention to the direct arylation of 1-phenyl-1H-pyrazole (23). 
To the best of our knowledge, nothing about the palladium-catalyzed direct arylation of 
compounds 23 with aryl bromides to give the monoarylated product has been reported so far. 
This compound presents increased regioselectivity challenges in the reaction of palladium-
catalyzed direct arylation, because the pyrazole nucleus is a well-known ortho-directing 
substrate and, as a consequence, also the ortho C-H bonds of the N-1 phenyl ring may be 
involved in carbon-carbon bond forming reactions with aryl halides. Actually, most of the 
publications on the ortho-direct arylation of 23 with aryl halides does not involve palladium, 
but describes successful ruthenium-76 and rhodium-catalyzed77 cross couplings. For examples, 
Dixneuf and co-workers reported that 5 mol % [{RuCl2(p-cymene)}2] catalyst can efficiently 
perform the direct ortho-arylation of 1-phenyl-pyrazole 23 with aryl chlorides in refluxing 
water in the presence of KOPiv (20 mol %) and K2CO3 (3 equiv) to give the diarylated 
products 33 (Scheme 37).76a 
 
 
Scheme 37 
 
 In 2009, Chang’s group developed a procedure for a rhodium-catalyzed chelation-
assisted direct arylation at the sp2 C-H bonds of N-based arenes with aryl bromides.77 The 
reactivity of rhodium catalyst was dramatically increased by the simultaneous employment of 
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an electron-rich N-heterocyclic carbene and PCy3 ligands as reported in Scheme 38. The 1-
([1,1':3',1''-terphenyl]-2'-yl)-1H-pyrazole (34) was obtained in 98 % isolated yield with these 
reaction conditions. 
 
 
Scheme 38 
 
The direct arylation at the ortho-position of the phenyl ring of compound 23 can be achieved 
also with a palladium catalyst, as it has been described by Daugulis in 2005.78 He reported that 
1-phenyl-1H-pyrazole (23) can be monoarylated at the C-1’ position of the phenyl ring when it 
is treated with 5 equiv of aryl iodide in the presence of 3 mol % Pd(OAc)2, 2 equiv AgOAc in 
acetic acid as the solvent for 120-160 h at 130 °C. The monoarylated products 35 were 
obtained in 59 and 61 % isolated yields (Scheme 39). 
 
 
Scheme 39 
 
 On the other hand, nothing about the C3-H, C4-H or C5-H direct arylation on the C-
unsubstituted 1-phenyl-pyrazole 23 has been published. Only Doucet and co-workers reported 
the diarylation of 23 with aryl bromides in a paper published very recently in 2014,60 (see 
Scheme 32) but no regioselective monoarylation has been achieved. 
N
N
23
(1 equiv)
+
[Rh2(OAc)4] (2.5 mol %)
IMes⋅HCl (5 mol %)
PCy3 (10 mol %)
tBuONa (3 equiv)
toluene, 80 °C, 10 h
(98 %)
N
N
26r
(3 equiv)
34
Br
N N
H
Me
Me
Me
Me
Me
Me
Cl
IMes⋅HCl
N
N
23
+
Pd(OAc)2 (3 mol %)
AgOAc (2 equiv)
130 °C, CH3COOH
120-160 h
N
N
ArAr-I
Ar = 4-MeC6H4
Ar = 3-COOCH3C6H4
35a: 4-MeC6H4; (61 %)
35b: 3-COOCH3C6H4; (59 %)
Chapter 1 
 61 
 For these reasons, in the last part of this Ph.D. work, we focused our attention on a 
preliminary screening of the palladium-catalyzed direct arylation of 23 with aryl bromides. 
More specifically, we chose the palladium-catalyzed direct arylation of 1-phenyl-1H-pyrazole 
(23) with 4-bromotoluene (26a) as a model reaction. We decided to perform the reactions 
starting from 1 mmol of 23 and 1.5 mmol of 26a in the presence of 5 mol % of the catalyst 
precursor, 2 equiv of a suitable base, in 5 mL of an appropriate solvent. We also set the 
reaction temperature at 140 °C and the reactions were followed for 48 h. 
 At first the impact of the base was evaluated, using Pd(OAc)2 (5 mol %) as the catalyst 
precursor and DMA as the solvent (Scheme 40). 
 
 
Scheme 40 
 
The results of this preliminary screening are reported in Table 7. A mixture of the 5-arylated 
pyrazole 36a, the corresponding ortho-arylated-pyrazole 37a and the ortho-5-diarylated 
derivative 38a was invariably observed when the GLC yield of 36a was higher than 10 % 
(entries 4-6 and 9-10, Table 7), while 38a was not detected or detected in a very small amount 
in the crude reaction mixture when lower GLC yields were recorded (entries 1-3 and 7, Table 
7). Moreover, the crude reaction mixtures were found to be contaminated by significant 
amounts of 4,4’-dimethyl-1,1’-biphenyl 28a, derived from the Pd-catalyzed Ullmann-type 
reductive coupling of 26a (see Figure 3).67 
From the data summarized in Table 7, it clearly emerged that carbonates (Ag2CO3 excluded) 
are the best in terms of efficiency (entries 5-6 and 9-10, Table 7). In contrast to that observed 
for 1-methylpyrazole, Bu4NOAc resulted ineffective for the direct arylation of 23, and with 
KOAc gave yield lower than 10 % (entries 1-2, Table 7). The addition of pivalic acid did not 
contribute to an increase of the chemical yield but it enhanced the selectivity of the 5-arylated 
product 36a both with KOAc and K2CO3 (entries 3 and 6, Table 7). Interestingly, K3PO4 
seemed to promote the arylation at the ortho-position of the phenyl ring of 23 (entry 4, Table 
7) while a stronger base, as tBuOLi, did not result effective for this reaction (entry 11, Table 
7). 
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Table 7: Screening of the bases for the direct C-5 arylation of 1-phenyl-1H-pyrazole (23) with 4-bromotoluene 
(26a). 
 
 
Entry[a] Base Yield of 36a (%)[b] 36a:37a:38a 
1 Bu4NOAc < 10 72:28:0 
2 KOAc < 5 68:32:0 
3[c] KOAc < 5 100:0:0 
4 K3PO4 11 22:52:26 
5 K2CO3 (22) 49:23:28 
6[c] K2CO3 24 57:14:29 
7[d] K2CO3 < 10 39:56:5 
8 Ag2CO3 - - 
9[c] Na2CO3 17 49:37:14 
10[c] Cs2CO3 19 51:40:9 
11 tBuOLi - - 
[a] Unless otherwise stated, the reactions were carried out using 23 (1.0 
mmol), 26a (1.5 equiv), Pd(OAc)2 (5 mol %), base (2.0 equiv) in DMA (5 
mL) for 48 h at 140 °C. [b] GLC yields. In parenthesis, isolated yields. [c] 
Reaction was carried out in the presence of 30 mol % PivOH. [d] Reaction 
was carried out in the presence of 10 mol % CuI. 
 
 In light of the better chemical yields and the regioselectivity obtained with K2CO3 in this 
preliminary screening, we decided to study the influence of the solvent and a possible role of 
the ligand on the efficiency and selectivity of our model reaction (Table 8). The reaction 
temperature for this second screening was kept at 140 °C except for toluene and dioxane 
wherein the reactions were performed at 110 and 100 °C, respectively. 
From the results reported in Table 8, it clearly emerges that toluene, dioxane, NMP and 
dimethylsulfoxide (entries 1-4, Table 8), resulted ineffective in this reaction. Chlorobenzene 
and DMF showed a slight activity, giving both the 5-arylated products 36a in 18 % chemical 
yields (entries 5-6, Table 8). Anyway, from the data summarized in Table 7 and Table 8 it is 
clear that the dimethylacetamide (DMA) is the best solvent in terms of efficiency and 
regioselectivity (entries 5-6 and 10, Table 7). Afterwards we examined the influence of the 
ligand on the palladium-catalyzed direct arylation of 23 with 26a in DMA in the presence of 2 
N
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equiv of K2CO3. Low-to-moderate yields were obtained both with monodentate phosphines 
(entries 7-13, Table 8) and bidentate phosphines (entries 14-15, Table 8).  
 
Table 8: Screening of the solvents and the ligands for the direct C-5 arylation of 1-phenyl-1H-pyrazole (23) with 
4-bromotoluene (26a). 
 
 
Entry[a] Ligand Solvent 
Yield of 36a 
(%)[b] 36a:37a:38a 
1[c] - Toluene[d] - - 
2 - Dioxane[e] < 2 100:0:0 
3 - NMP < 5 49:51:0 
4 - DMSO - - 
5 - Chlorobenzene 18 100:0:0 
6 - DMF 18 48:37:15 
7 PPh3 DMA 21 40:27:33 
8 P(o-Tol)3 DMA 10 15:74:11 
9 P(2-furyl)3 DMA 17 38:43:19 
10 PCy3 DMA 23 44:26:30 
11 P(tBu)3⋅HBF4 DMA 20 40:36:24 
12 PBuAd2 DMA 21 58:31:11 
13[c] PBuAd2 DMA (21) 57:18:25 
14 dppf DMA 22 48:34:18 
15 Xantphos DMA 21 44:32:24 
[a] Unless otherwise stated, the reactions were carried out using 23 (1.0 mmol), 26a 
(1.5 equiv), Pd(OAc)2 (5 mol %), ligand (10 mol %) (if any), K2CO3 (2.0 equiv) in 
solvent (5 mL) for 48 h at 140 °C. [b] GLC yields. In parenthesis, isolated yields. [c] 
Reaction was carried out in the presence of 30 mol % PivOH. [d] Reaction was carried 
out at 110 °C. [e] Reaction was carried out at 100 °C. 
 
Among the monodentate, PPh3, PCy3 and PBuAd2 resulted the most efficient, giving 36a in 21, 
23 and 21 % chemical yields, respectively (entries 7, 10 and 12, Table 8). Bidentate 
phosphines also gave similar results, but just PBuAd2 showed the highest C-5 selectivity (58 
%). The addition of 30 mol % of pivalic acid in the presence of PBuAd2 did not contribute to 
rise the chemical yield, but changed the 37a/38a ratio with a higher production of compounds 
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38a (entry 13, Table 8). Anyway, the yields and the selectivities obtained in entries 12 and 13 
of Table 8 were perfectly comparable with the reactions performed without the ligand of Table 
7 (entries 5 and 6).  
 At the end of this second screening we argued if it might be possible to achieve better 
yields and selectivities by lowering the reaction temperature, and afterwards we observed the 
role of the palladium precatalyst in this reaction. The results of the third screening were 
reported in Table 9. We decided to add a 30 mol % PivOH to the reactions we performed for 
this last screening because it resulted to be beneficial for the selectivity, even if it did not 
contribute effectively to enhance the chemical yield of 5-arylpyrazole 36a. Moreover, as we 
can observe from entries 5 and 6 of Table 7 or entries 12 and 13 of Table 8, pivalic acid 
increases the production of diarylated derivative 38a relative to the ortho-arylated derivative 
37a, and this fact can be exploited from a purification point of view. In fact, the diarylated 
product 38a is easier to separate from compound 36a than the isomer 37a. 
 At the beginning of this last screening we decided to set the reaction temperature at 110 
°C. We had an increase of both the yield and the selectivity of compound 36a with a 
regioselectivity higher than 71 % (entry 1, Table 9). Taking into account this result, we studied 
the influence of the palladium precatalyst on the model reaction.  
 All the palladium complexes we tried showed a catalytic activity. More specifically, 
Pd(PPh3)4 and PdCl2(dppb) gave product 36a in 16 and 19 % chemical yield, respectively, with 
a selectivity of 61 and 48 % (entries 2-3, Table 9). Then, we used PdCl2(MeCN)2 and, with our 
pleasure, we observed that it led to a yield of 29 % for the 5-arylated-pyrazole 36a with a 
selectivity (82 %) higher than all the other trials we performed so far for 1-penyl-1H-pyrazole 
(23) (entry 4, Table 9). In light of these results, we decided to proceed with the screening by 
using the PdCl2(MeCN)2 as the palladium source for the direct arylation of 23 with 26a. 
 After that, we wanted to verify if modifying the 23/26a ratio it was possible to achieve 
better performances in terms of efficiency and regioselectivity. Unfortunately, the presence of 
2 equiv of the aryl bromide 26a did not influence the yield of the product 36a (entry 5, Table 
9) and, on the other hand, acted on the selectivity favouring the formation of the diarylated 
derivative 38a. Then, we note with our delight that the difficult substrate 23 could be 
converted in 36a with a better chemical yield by adding a phase transfer reagent (20 mol %). 
Both BuBu3NCl and Bu4NBr can promote the direct arylation of 23 with 4-bromotoluene (26a) 
with 35 and 38 % GLC yield, respectively, if the 23/26a ratio is 1/1.5 (entries 6 and 9, Table 9) 
and with 40 and 43 % GLC yield, respectively, when the 23/26a ratio is 1/2 (entries 7 and 10, 
Table 9). 
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Table 9: Screening of the reaction temperature, the palladium precatalyst, the presence of additive and 23/26a 
molar ratio for the direct arylation of 1-phenyl-1H-pyrazole (23) with 4-bromotoluene (26a). 
  
 
Entry[a] Catalyst Base Additive 23/26a 
ratio 
T 
(°C) 
Yield of 
36a (%)[b] 
36a:37a:38a 
1 Pd(OAc)2 K2CO3 - 1/1.5 110 29 71:22:7 
2 Pd(PPh3)4 K2CO3 - 1/1.5 110 16 61:28:11 
3 PdCl2(dppb) K2CO3 - 1/1.5 110 19 48:40:12 
4 PdCl2(MeCN)2 K2CO3 - 1/1.5 110 29 (27) 82:13:5 
5 PdCl2(MeCN)2 K2CO3 - 1/2 110 28 73:14:13 
6 PdCl2(MeCN)2 K2CO3 BnBu3NCl 1/1.5 110 35 69:14:13 
7 PdCl2(MeCN)2 K2CO3 BnBu3NCl 1/2 110 40 77:15:8 
8 PdCl2(MeCN)2 K2CO3 BnBu3NCl 1/1.5 70 - - 
9 PdCl2(MeCN)2 K2CO3 Bu4NBr 1/1.5 110 38 (29) 78:11:11 
10 PdCl2(MeCN)2 K2CO3 Bu4NBr 1/2 110 43 70:12:18 
11 PdCl2(MeCN)2 K2CO3 Bu4NBr 1/1 110 31 80:10:10 
12[c] PdCl2(MeCN)2 K2CO3 Bu4NBr 1/1.5 110 33 78:12:10 
13 PdCl2(MeCN)2 K2CO3 Bu4NBr 2/1 110 43 (38) 83:17:0 
14 PdCl(C3H5)dppb KOAc - 1/1.5 150 6 69:31:0 
[a] Unless otherwise stated, the reactions were carried out using 23 and 26a with the ratio 
reported for each entries, Pdcat (5 mol %), ligand (10 mol %) (if any), base (2 equiv), PivOH (30 
mol %), additive (if any) (20 mol %) in DMA (5 mL) for 48 h at 110 °C. [b] GLC yields. In 
parenthesis, isolated yields. [c] Reaction was carried out in the presence of 10 mol % Pd(OAc)2.  
 
We also tried to lower further the reaction temperature to 70 °C by using BuBn3NCl as phase 
transfer agent that could have favoured the solubility in these conditions. Unfortunately, the 
system resulted ineffective (entry 8, Table 9). Afterwards, among the two-phase transfer 
agents, we decided to keep going with the Bu4NBr, that gave a better yield and the best 
selectivity for compound 36a. We changed again the 23/26a ratio and we found that when this 
was 1/1, the yield of the 5-arylated-pyrazole 36a resulted to be 31 % with a selectivity of 80 % 
(entry 11, Table 9), while when it was 2/1 the yield of 36a reached the 43 % with a 
regioselectivity of 83 % and no detection of diarylated product 38a (entry 13, Table 9). 
Moreover, the addition of a double amount of PdCl2(MeCN)2 did not contribute to an increase 
of the chemical yield of derivative 36a (entry 12, Table 9). 
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 Finally, with the recent publication of Doucet’s work on the palladium catalyzed direct 
arylation of pyrazoles with aryl bromides in hands,60 we wanted to verify if the conditions they 
reported for 1-phenyl-1H-pyrazole (23) could be suitable for our substrate (see Scheme 32). 
Hence, 1 mmol of 23 and 1.5 equiv of 4-bromotoluene (26a) reacted in the presence of 2 mol 
% PdCl(C3H5)dppb as the catalyst that we previously synthesized in our lab. Then, 2 mmol of 
KOAc were also added in DMA and the reaction was carried out at 150 °C for 72 h. 
Nevertheless, we got the product 36a in only 6 % chemical yield (entry 14, Table 9). 
Therefore, the conditions we finally obtained from this long screening involved 2 equiv of 1-
phenyl-1H-pyrazole (23), 1 equiv of aryl bromide (26a), 5 mol % PdCl2(MeCN)2, 30 mol % 
PivOH, 20 mol % Bu4NBr, 2 equiv K2CO3 in DMA at 110 °C (Scheme 41). 
 
 
Scheme 41 
 
 A scope of the reaction will be planned in the future in order to verify the viability of our 
new procedure, when ortho- and para-substituted electron-rich and electron-poor aryl 
bromides are used with several 1-aryl-1H-pyrazoles. 
 
 
5. Conclusions. 
 
 In conclusion, we have successfully established a new and versatile procedure for the 
regioselective synthesis of 5-aryl-1-methyl-1H-pyrazoles (21) by using a Pd-catalyzed direct 
arylation reaction promoted by Bu4NOAc as base. In particular, we showed that a large 
number of 5-aryl-1-methyl-1H-pyrazoles (21) can be prepared by reacting 1 equiv of the 
heterocycle with 1.5 equiv of the aryl bromide of interest (26) in the presence of Bu4NOAc as 
base in DMA at 70 °C. 
 Then, with our pleasure, we found that the reaction conditions developed for the 
synthesis of 5-aryl-1-methyl-pyrazoles (21) could be used for the preparation of 5-aryl-
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oxazoles (30), 5-aryl-thiazoles (31) and 5-aryl-1-methyl-1H-imidazoles (32). More 
specifically, we synthesizes a small library of 5-aryl-oxazoles (30) and 5-aryl-thiazoles (31) by 
using the reaction conditions promoted by Bu4NOAc and performing the reactions at 70 °C; on 
the other hand, we were also able to prepared several 5-aryl-1-methyl-1H-imidazoles (32) by 
using this new methodology, carrying out the reactions at 110 °C. 
 We have also hypothesized a possible mechanism that involves a CMD pathway for the 
Pd-catalyzed direct arylation reaction of azoles promoted by Bu4NOAc. We attributed the 
efficiency and the very high regioselectivity demonstrated by this ligand-free protocol at mild 
reaction temperatures to the efficacy of Bu4NOAc in promoting such ligand-free direct 
arylations, for the well-known ability of ammonium salts to act as metal stabilizers in the 
absence of phosphanes or other ancillary ligands and also by the fact that organic ionic bases 
have good solubility and are fully ionized in organic solvents. 
 Finally, we undertook a preliminary screening for the development of a regioselective 
procedure for the palladium-catalyzed direct arylation of 1-phenyl-1H-pyrazole (23) with aryl 
bromides. We chose the reaction between 23 and 4-bromotoluene (26a) as a model reaction 
and we found that they can react in the presence of PdCl2(MeCN)2 as catalyst precursor, 
pivalic acid and Bu4NBr as additives, with K2CO3 as the base in DMA at 110 °C with a 
selectivity of the 5-aryl-1H-pyrazole 36a of 83 %, with a chemical yield of 43 %. 

CHAPTER 2 
 

Chapter 2 
 71 
Applications of the palladium-catalyzed regioselective direct 
arylation of azoles with aryl bromides promoted by Bu4NOAc 
 
 As a consequence of the development of the new procedure for the direct arylation of 
pyrazole and the three 1,3-azoles promoted by Bu4NOAc, we decided to focus our attention 
also on the possible applications of this methodology to the synthesis of useful organic 
materials. However, in order to achieve these purposes we had also to take into account other 
synthetic procedures, in particular the methodology that our research group previously 
reported for the arylation of 1,3-azoles at the C-2 position. 
 
1. One-pot synthesis of bioactive Balsoxin (39a) and Texaline (39b).62 
 
 We started our purpose with the synthesis of two bioactive compounds, balsoxin (39a) 
and texaline (39b), (Figure 7).  
 
 
Figure 7: Structures of balsoxin (39a) and texaline (39b). 
 
Balsoxin and texaline are natural products isolated from the plant species Amyris in the 
Caribbean, 79  with texaline reported to have antimycrobacterial activity against 
Mycrobacterium tuberculosis, M. avium and M. kansasii.80 These molecules are often used as 
classical models of application of new procedures for direct arylation of azoles.14c,31,81  For 
example, in 2008 Greaney and co-workers reported a three-steps synthesis of 39a and 39b in 
which they proposed, for the last step, a new Pd-catalyzed methodology for the C-5 arylation 
of the 2-arylate oxazoles carried out in water (Scheme 42).81a In the first reaction, they 
functionalized the 2-position of the oxazole (4) using a Negishi cross-coupling protocol 
developed by Reeder and co-workers.82 Following lithiation with nBuLi at -78 °C, solid 
ZnCl2 was added to form the zincate 40, which subsequently underwent Pd-catalyzed 
coupling with the appropriate aryl iodides at 60 °C to give the 2-arylated products 41. Then, 
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they reacted compounds 41 with the suitable aryl iodides that yielded balsoxin (39a) and 
texaline (39b) in 68 and 58 %, respectively (Scheme 42). 
 
 
Scheme 42 
 
Another example was reported by Hoarau’s group that used the methodology showed in 
Scheme 7 of Introduction.31 They proposed a three-steps procedure to synthesize balsoxin 
(39a) and texaline (39b) starting from the ethyl oxazole-4-carboxylate (1) that reacted with 
the appropriate aryl halides and gave the 2-arylated oxazoles 42. These compounds reacted in 
the second step with the respective aryl bromides to yield the 2,5-diarylated products 43. The 
final products balsoxin (39a) and texaline (39b) were obtained after decarboxylation reaction 
with an overall yield of 43 and 62 %, respectively (Scheme 43).31 
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 Therefore, since the two compounds are 2,5-diaryl substituted oxazoles, we argued that 
it might be possible to achieve the one-pot sequential 5- and 2-diarylation of 1,3-azoles with 
different aryl bromides by pairing the C-5 arylation procedure promoted by Bu4NOAc for the 
first step with the protocol for the direct C-2 arylation mediated by CuI, previously reported 
by Bellina and co-workers, for the second one.23c-d,37 
To probe the feasibility of this approach, we attempted the one-pot synthesis of the two 
bioactive natural 2,5-diaryloxazoles, balsoxin (39a) and texaline (39b) (Scheme 44). 
 
 
Scheme 44 
 
In the first step, 1.1 equiv of oxazole (4) were treated with 1 equiv of 4-bromo-1,2-
dimethoxybenzene (26t) or 5-bromobenzo[d][1,3]dioxole (26u) at 70 °C in DMA in the 
presence of Pd(OAc)2 as catalyst and Bu4NOAc as base. The reactions were carried out for 24 
h. After that, without any purification of the intermediates 30, we added 1.5 equiv of 
bromobenzene (26r) or 3-bromopyridine (26n) along with 2 equiv of CuI. The use of 5 mol % 
Pd(OAc)2 and 2 equiv of Bu4NOAc as initial quantities proved to be effective for the 
sequential reactions, and no additional catalyst or base was necessary in the second step. After 
24 h at 110 °C, the required balsoxin (39a) and texaline (39b) were isolated in 39 and 38 % 
yield, respectively (Scheme 44). 
The analysis 1H-NMR, 13C-NMR and GC-MS confirmed the structure of compounds 39. 
It is noteworthy that the second step of the procedure was carried out at only 110 °C instead 
of 140 °C, that is the temperature generally used in the Pd/Cu catalyzed direct arylation of 
1,3-azoles.23c-d,37 
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2. One pot synthesis of resveratrol derivatives (48). 
 
 Once we found that it was possible to achieve the one-pot sequential 5- and 2-
diarylation of oxazole (4), we dedicated part of our efforts in the synthesis of imidazole 
analogues of resveratrol (44). 
Resveratrol or ((E)-5-(4-hydroxystyryl)benzene-1,3-diole (44) is a natural fitoalexine that 
shows beneficial effects on the human health, including anti-oxidant,83 anti-obesity,84 anti-
viral, 85  anti-diabetic, 86  anti-inflammatory, 87  cardiovascular protective 88  and anti-tumoral 89 
effects based on in vitro and animal models90,91 (Figure 8). It is produced by at least 72 
species of plants distributed among 31 genera and 12 families in response to stress, injury, 
fungal infection, and UV irradiation.89a,90 Anyway, the problem to use resveratrol is connected 
to its easy degradation after it has been assumed, for instance, with the nutrition. In fact, many 
biological matrices convert in vivo the hydroxy groups into derivatives that are rapidly 
metabolized, or the double bond may undergo reduction or stereomutation from trans to cis 
isomer. 
 
 
Figure 8: Structure of resveratrol (44). 
 
A method to avoid these problems could be to convert resveratrol in its respective analogues. 
One of the simplest synthetic strategies to get resveratrol analogues is the conversion of one 
or more hydroxy groups in the respective methylethers. This can obviate the formation in vivo 
of conjugates and enhance the biological availability of the molecule. For instance, the 3,5,4’-
trimethoxy-stylbene (45) (Figure 9) is one of the analogues that has been recently prepared 
and tested on the cell line HL-60 of human promyelocytic leukemia and has shown cytotoxic 
activity higher than resveratrol.92 
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Figure 9: 3,5,4’-Trimethoxy-stylbene (45), a resveratrol analogues with protected hydroxy groups. 
 
Otherwise, analogues in which the double bond is substituted by unsaturated systems more 
resistant to reduction, or in which the double bond is embedded in stable cyclic structure has 
been reported in literature. Anyway, the trans configuration of the two aromatic moiety was 
always kept, being fundamental for the maintenance of the biological activity.93 
 In order to avoid the chemical modification of the trans double bond, we decided to 
prepare cyclic analogues of resveratrol (44), in which this stereodefined bond has been 
embedded into an imidazolic nucleus (Scheme 45).94 
 
 
Scheme 45 
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In particular, our research group focused the attention on the synthesis of 1,4-diaryl-1H-
imidazoles (46), 2,4-diaryl-1-methyl-1H-imidazoles (47) and 2,5-diaryl-1-methyl-1H-
imidazoles (48) (Figure 10). In these three classes of compounds, the aryl groups are linked in 
a 1,3-fashion, in order to keep the required trans geometry.94 
 
 
Figure 10: Structures of 1,4-diaryl-1H-imidazoles (46), 2,4-diaryl-1-methyl-1H-imidazoles (47) and 2,5-diaryl-
1-methyl-1H-imidazoles (48). 
 
As regard this Ph.D. work, we decided to focus our synthetic efforts on compounds 48 
(Figure 10) and then to evaluate their biological activity. 
 The 2,5-diaryl-1-methyl-1H-imidazoles (48) were already synthesized in our laboratory 
by using a simple two-steps procedure starting from 1-methyl-1H-imidazole (12) (Scheme 
46). The first reaction consisted in a C-5 direct arylation of 12 with aryl bromides that, as 
reported by our research group in 2008, involved the use of Pd(OAc)2 and P(2-furyl)3 as 
catalytic system, K2CO3 as base, DMA as solvent, at a reaction temperature of 110 °C.50c The 
required 2,5-diarylated imidazoles 48 were then obtained by base-free and ligandless C-2 
direct arylation of the prepared 5-arylated imidazoles 32 with an aryl bromide, in the presence 
of a Pd/Cu catalyst system at 160 °C (Scheme 46).23c-d,37 
 
 
Scheme 46 
 
 In light of the fact that we succeeded in the synthesis of balsoxin (39a) and texaline 
(39b) with a one-pot approach, by applying the reaction conditions promoted by Bu4NOAc, 
we decided also to try a one-pot sequential C-5 and C-2 diarylation sequence starting from 1-
methyl-1H-imidazole (12), in order to synthesize the resveratrol analogues. In this way, we 
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would have shorted the preparation time and, more likely, enhanced the isolated yield by 
avoiding one of the two purification steps (see paragraph 1 of Chapter 2). 
In particular, the resveratrol analogues 48a-b that have been prepared are reported in Figure 
11. 
 
 
Figure 11: 2,5-Diaryl-1-methyl-1H-imidazoles 48: resveratrol analogues. 
 
 The approach we used was the same adopted for the synthesis of balsoxin and texaline, 
as reported in paragraph 1 of this chapter. We started the synthesis by using the reaction 
conditions developed during this Ph.D. work. In details, 1 equiv of imidazole 12 was treated 
with 1.1 equiv of 4-bromoanisole (26b) or 5-bromo-1,3-dimethoxy-benzene (26v) at 110 °C 
in DMA in the presence of Pd(OAc)2 as catalyst and Bu4NOAc as base. The reactions were 
carried out until the disappearance of the precursors. After this time, without any purification 
of the intermediates 32, 1.5 equiv of 5-bromo-1,3-dimethoxy-benzene (26v) or 4-
bromoanisole (26b) were added along with 2 equiv of CuI. The use of 5 mol % Pd(OAc)2 and 
2 equiv of Bu4NOAc as initial quantities proved again to be effective for the sequential 
reactions, and no additional catalyst or base was necessary in the second step. After 24 h at 
110 °C, the required resveratrol analogues 48a and 48b were isolated in 48 and 38 % yield, 
respectively (Scheme 47). The analysis 1H-NMR, 13C-NMR and GC-MS confirmed the 
structure of compounds 48. 
 The yields obtained with this one-pot approach resulted better than those resulting from 
the application of the two-steps method shown in Scheme 46. This last procedure led to 
compounds 48a and 48b in 21 and 24 % of overall yields, respectively.94 Therefore, our better 
results confirmed the efficiency of the one-pot methodology. 
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Scheme 47 
 
Finally, compounds 48 were unprotected to give resveratrol analogues 49. To a solution of 
derivatives 48 in CH2Cl2, 6.75 equiv of BBr3 in CH2Cl2 were added at -60 °C. Then the 
mixtures obtained were heated and left at room temperature for 48 h. The resveratrol 
analogues 49a-b were isolated by crystallization after work-up in 80 and 65 % of yield 
(Scheme 48). 
 
 
Scheme 48 
 
 Compounds 48a and 49a and others prepared in our laboratory by using the two-steps 
procedure, with the Pd(OAc)2 / P(2-furyl)3 system (Figure 12, compounds 48c-e), were sent to 
the National Cancer Institute (NCI, Bethesda, USA).  
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Figure 12: Structures of compounds 48c, 48d and 48e. 
 
They verified the cytotoxicity of molecules 48 and 49 in vitro applying them to their 60 
human tumoral cell line panel representing leukemia, melanoma, cancer of the lung, colon, 
brain, ovary, breast, prostate and kidney.94,95 Compounds 48 and 49 were tested initially at a 
single high dose (10-5 M) in the full NCI 60 cell panel. Then, those-ones that satisfied pre-
determined threshold inhibition criteria in a minimum number of cell lines should have been 
advanced to the full 5-dose assay. The threshold inhibition criteria for progression to the 5-
dose screen was selected to efficiently capture compounds with anti-proliferative activity 
based on careful analysis of historical DTP screening data (the threshold criteria is 
periodically updated by NCI as additional data becomes available). 
The results of the one-dose assay are reported in Figure 13 as the mean graph mid-point 
(MGM) values, which are based on a calculation of the percent average of growth of the 
treated cells compared to the untreated control cells. Results from Figure 13 indicate that 
compound 48a was found to be the most cytotoxic against the NCI panel, but none of these 
compounds was further evaluated in the following 5-doses assay. It is interesting to observe 
that the only presence of free phenolic groups typical of 44 does not secure the bioactivity of 
these analogues. In fact, as demonstrated by the results for compound 49a, the presence of 
free hydroxy groups may also deplete the activity when compared to that displayed by the 
corresponding O-methylated analogue 48a. 
The data summarized in Figure 14 allow a in-depth analysis of the one-dose screening results, 
and put better in evidence the fact that 48a is the most active compound among the selected 
five derivatives, against all the nine different types of human tumors. 
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Figure 13: NCI 60 human tumor cell line screening (one dose): mean growth (%) for all tested cell lines. 
 
 
Figure 14: NCI 60 human tumor cell lines screening (one dose): mean values (%) for the nine tumor panels. 
 
All the compounds we sent showed growth-inhibition of one or more cell line. 
 Moreover, compound 49b resulted a NQO296 inhibitor in vitro, as confirmed by 
Professor Ian Stratford of University of Manchester. He evaluated the ability of resveratrol 
analogues 48a-e, 49a-b and 48f (see  Figure 15) to inhibit the NQO2, in order to identify a 
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pharmacological tool useful to study the physiological role of this protein in the tumoral cells. 
Compound 49b showed the ability to inhibit NQO2 at nano-molar concentrations. The IC50 
value for 49b was 613.4 nM ± 1.4 while resveratrol (44) showed IC50 891 nM ± 1.9. It is 
noteworthy that the analogues containing methoxy groups did not showed any activity toward 
NQO2.94 
 
 
 Figure 15: Structure of 48f. 
 
 
3. Synthesis and optical properties of fluorophores 50, 51 and 52. 
 
 Another application of our methodology was the synthesis of fluorophores, that are 
fluorescent molecular entities97 and show a wide range of uses from technology to chemical 
and biological analysis. This is due to the properties of the fluorescence emission, which are 
strongly influenced by structural modifications and surrounding media, allowing a precise and 
selective tuning and monitoring thereof. The properties usually observed are spectrum shape, 
peak position, quantum yield and lifetime; more specific techniques make use of other 
properties, such as quenching, fluorescence anisotropy and excimer formation.98 
Especially the dependence of the fluorescence emission from the micro-environment around 
the fluorophores (type of solution, presence of other interacting species, polymer surfaces, 
crystalline structures) and any possible interaction of the excited species therewith is largely 
employed to get information on local parameters: physical, structural or chemical. In this 
context it is used the term fluorescent probe (or indicator in the case of chemical parameters 
like pH and the concentration of a species). When the fluorophores is covalently bound to a 
target molecule, and the aim is to visualize or localize such species, the term fluorescent label 
or tracer is used. Fluorescent probes and tracers provide a wealth of information on various 
subjects: polymers, solid surfaces, surfactant solutions, biological membranes, vesicles, 
proteins, nucleic acids and living cells.98 The most typical applications of fluorescent probes 
and tracers are: pH indicators, probes for polarity, molecular thermometers, pressure sensitive 
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paints, molecular sensors for ion and molecule recognition and autofluorescence and 
fluorescent labels in biology. 
 Fluorophores are largely used as probes and tracers, but there is also a wide range of 
applications in materials science. The so-called push-pull fluorophores are a particular class 
of compounds in this context. The “model” of push-pull compounds is a D-π-A fluorophore 
composed of a π-conjugated backbone end-capped with two different groups: a strong 
electron-donor group D (usually -OR or -NR2 groups) and a strong electron-acceptor group A 
(usually -CN, -COR or -CF3 groups) (Scheme 49). Polarizability and optical properties of 
these systems depend primarily on their chemical structure, in particular the electronic 
behaviour of the A and D groups and the nature and length of the π-linker.4c 
 
 
Scheme 49: Typical structure of push-pull fluorophores. 
 
This type of structure and functionalization allows intramolecular (or internal) charge transfer 
(ICT) between the D and the A moieties during electron transitions.98,99 Excitation of the 
fluorophores induces the promotion of one electron from an orbital to another. If the initial 
and final orbitals are separated in space, condition reachable with push-pull fluorophores for 
the presence of the D and A groups, the electronic transition occurs with an almost 
instantaneous change in the dipole moment of the fluorophores. This causes a different range 
of responses of the system depending on the degree of polarity of the solvent employed. 
Furthermore, relaxation towards an ICT state can be accompanied by conformational changes 
of the fluorophore. 
The D-π-A structure provides interesting advantages over other similar materials; first of all 
ease of synthesis and possibility to tune properties like absorption spectra, HOMO-LUMO 
levels and degree of ICT from proper choices of D-A couples, a π-skeleton and substitutions. 
Furthermore, they usually show chemical and thermal stability, good solubility in organic 
solvents and/or polymeric matrices and ease of chemical ligation to polymer support.4c,100 
 In the design of push-pull systems, great attention has been given to five- and six-
membered heterocycles, used as suitable π-conjugated backbones. Heteroaromatic 
fluorophores with electron-donor and -acceptor architectures have attracted growing interest 
for both understanding of fundamental chemistry and physics and promising applications in 
A π−linker D
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diverse fields, ranging from solar energy conversion,100 to optoelectronic devices101 and 
chromogenic materials.102 The main advantages lie in their high chemical and thermal 
robustness, good solubility in common organic solvents and availability. Furthermore, 
heteroatoms can enhance the donor/acceptor character of the groups (playing the part of 
auxiliary donors or acceptors) and improve the overall polarizability of the chromophore. 
 Imidazole in particular has been studied as part of π-conjugated backbones. The role of 
imidazole in π-backbones and synthetic routes towards these systems have been recently 
reviewed by Bureš and Kulhánek.4c It possesses two nitrogen atoms of different electronic 
nature, has good characteristic of stability and can be easily synthesized and further 
functionalized at positions N-1, C-2, C-4 and C-5. Other azoles, like oxazole and thiazole, 
have similar properties and could thus be substitutes of imidazole. The most important factors 
that affect D-A interactions are the extent of electronic donation or attraction by the D/A 
groups (i.e. the strength of the groups), the length and electronic nature of the a π-linker and 
the fluorophores overall planarity, thus these are properties most often tuned to obtain the 
desired behaviour. The entire azole moiety may behave as an electron donor or acceptor 
depending on the D/A substitutions. 
 Our proposal in this Ph.D. work was to exploit again the methodologies developed for 
the transition metal catalyzed regioselective C-H functionalization of the azole nuclei (among 
which the procedure promoted by Bu4NOAc), and to apply them to the construction of novel, 
previously difficulty accessible complex azole-based molecular structures. In particular, we 
focused our attention on the synthesis of unsymmetrical derivatives of structure 50, 51 and 52 
(Figure 16) and to characterize the main spectroscopic properties thereof. 
 
  
Figure 16: General structures of push-pull fluorophores 50, 51 and 52. 
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 Azoles possess a wide range of interesting properties such as acid-base character, 
transition metal-binding activity, thermal and chemical robustness, and tautomerism. 
Imidazole and benzimidazole moieties have been utilized as suitable π-conjugated spacers in 
charge-transfer chromophores and useful DNA-binding probes for fluorescence microscopy 
and flow cytometry.103 
To the best of our knowledge, no study has been published on unsymmetrically substituted p-
phenylene-linked bis-imidazoles and thiazoles. Nevertheless, they seems promising in terms 
of optical properties, such as large Stokes shifts and high fluorescence quantum yields, as can 
be inferred by comparison with similar compounds already described in literature. 104 
Moreover, unsymmetrical derivatives are likely to have enhanced ICT upon excitation in 
comparison to symmetrical compounds. 
 In our research group, we focused our attention on the synthesis of compounds 50,105 51 
and 52 (Scheme 50). We decided to modify the structures by changing the azoles in these 
three derivatives with the aim of evaluating the influence of the presence of two nitrogen 
atoms and of their partial or total replacement with sulphur on the physical and spectroscopic 
properties of the resulting fluorophores. 
We selected a methyl, a methoxy and a cyano group as substituents on the terminal phenyl 
ring of compounds 50-52, since they are typical examples of electron-neutral, electron-
releasing and electron-withdrawing groups, respectively (Hammett’s σp constants:106 CN 
+0.66; Me -0.17; MeO -0.27). For this reason, they are likely to be representative of other 
similar substituents as concerns both synthetic issues and spectroscopic properties. We 
focused on p-substituted derivatives to avoid synthetic complications due to the steric 
hindrance while keeping conjugation between the X group and the π-skeleton. 
 For the synthesis of the 5-aryl-thiazoles 31 and 5-aryl-imidazoles 32 (see Scheme 50) 
we used the palladium-catalyzed direct C5-H arylation reaction mediated by Bu4NOAc 
developed in this Ph.D. work.62 We started from 1 equiv of thiazole (8) or 1-methyl-1H-
imidazole (12) and 1.5 equiv of 4-bromotoluene (26a), 4-bromoanisole (26b) and 4-
bromobenzonitrile (26s) that reacted in the presence of 2 equiv of Bu4NOAc in DMA at 70 
and 110 °C (see Chapter 1). The 5-arylated products, 31 and 32, were purified and isolated 
after flash chromatography with the yields reported in Table 10. 
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Scheme 50 
 
 As regards the preparation of the brominated benzimidazole derivative 54, which 
represents the common precursor to compounds 50, we chose to follow the procedure 
described by Chakrabarty and co-workers107 because of its simplicity, mild conditions, 
efficiency and atom economy. The authors used cetylpyridinium bromide (CPB) as a phase 
transfer catalyst, but we decided to replace it with cetyltrimethylammonium bromide (CTAB), 
which was available in our laboratory. The reaction so conducted failed to give reasonable 
amounts of pure product. Although the conversion was quantitative, it only afforded mixtures 
of the required compound 54 and of the non-aromatic benzimidazoline 55 (identified by the 
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means of 1H-NMR analyses) which could not be separated by fractional crystallization from 
common solvents (Scheme 51). 
 
Table 10: Synthesis of 5-aryl-thiazoles (31) and 5-aryl-imidazoles (32) with the ligandless Pd-catalyzed direct 
C-5 arylation of thiazole (8) and 1-methyl-1H-imidazole (12) with aryl bromides 26a, 26b and 26s promoted by 
Bu4NOAc (for the conditions, see Chapter 1). 
 
 
Aryl bromide (26) 5-aryl-azole Reaction time (h) Isolated yield (%) 
26a 
 
31a 
 
21 65 
26b 
 
31b 
 
48 67 
26s 
 
31s 
 
56 61 
26a 
 
32a 
 
22 81 
26b 
 
32b 
 
24 82 
26s 
 
32s 
 
24 69 
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It is worth mentioning that we were unable to distinguish 54 from 55 by TLC or by GLC. We 
guessed that 55 aromatizes to give the corresponding benzimidazole 54 at high temperatures 
(e.g. in the GLC injector) or under air on TLC plates. 1H-NMR spectroscopy was thus to be 
used to follow the progress of the reaction. The aromatization of benzimidazolines is indeed a 
thermodynamically favoured process. For example, 1,3-dimethyl-2-phenylbenzimidazoline 
(56) is known to spontaneously lose molecular hydrogen at room temperature in the presence 
of metallic Pd, Pd(OAc)2 or Wilkinson’s catalyst in protic solvents, to give the corresponding 
imidazolium salt (57), and it has also been investigated as an hydrogen storage medium 
(Scheme 52).108 
 
 
Scheme 52 
 
Since the separation of compound 54 from the byproduct 55 was neither easily accomplished 
nor desirable in terms of atom economy, we investigated the possibility of oxidizing the crude 
mixture of products to convert 55 in 54. 
Considering that Lin and Yang109 obtained excellent yields of benzimidazoles by simple 
heating o-phenylenediamines with aldehydes in dioxane at 100 °C in the presence of air, we 
refluxed overnight the crude reaction mixture containing 54 and 55 dissolved in the minimum 
amount of dioxane sparged with air. The required product 54 was thus successfully recovered 
in 79 % yield after recrystallization from CH2Cl2/hexane. 
 On the other hand, as regards the 2-(4-bromophenyl)benzo[d]thiazole (53), which 
represents the most common precursor to compounds 51 and 52, Qin and Yang in 2007110 
(Method A) and Ji in 2010111 (Method B) reported two efficient protocols for its preparation 
trough a condensation of o-aminothiophenol (58) with p-bromobenzaldehyde (59) in DMSO 
(reflux at 190 °C). The two conditions differ for concentration and reaction time, as reported 
in Scheme 53. 
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Scheme 53 
 
We chose to follow the method used by Ji for its simplicity and efficacy (Method B). The 
condensation was carried out with 5 mmol of 59, 6.25 mmol of 58 and 150 mL of DMSO, at 
190 °C for 2 h, that gave a 92 % isolated yield of 53. 
The products 53 and 54 were both characterized by 1H-NMR, 13C-NMR and GC-MS analysis. 
 Following the previously reported good results obtained by our research group with the 
C-2 arylation of imidazoles under base-free conditions in ligandless Pd-catalysis,23c,37,50d we 
also performed the reactions without any added base. Compounds 50, 51 and 52 were purified 
and isolated after flash chromatography with the yields reported in Table 11. 
Even though the temperature had to be raised to 160 °C, the reactions were remarkably clean 
and no difficulty removable byproducts were detected in the crude reaction mixture. 
All the intermediates were characterized by NMR spectroscopy and mass spectrometry, with 
satisfactory results. 
 Emission and absorption have been obtained for compounds 50, 51 and 52. For 
compounds 50 the measurements were performed both in THF105 and CHCl3 while for 51 and 
52 just in CHCl3 because of solubility problems of these compounds in THF. 
As regards the bis-imidazoles derivatives 50, we can observe that, when the measurement are 
performed in THF, there is a little difference in the absorption spectrum between derivatives 
50a and 50b, while 50s is red-shifted of about 10 nm (Figure 17, Table 12). The emission 
spectrum becomes progressively red-shifted in order 50a and 50b and the Stokes shift 
increases in the same direction (95 nm and 103 nm, respectively). The cyano derivative 50s 
displays a significantly lower Stokes shift (82 nm) in comparison with the other two 
compounds. 
Absorption maximum wavelengths (λabs), fluorescence maximum wavelengths (λem), Stokes 
shifts (S), molar extinction coefficients (ε), fluorescence quantum yields (Φf) and brightness 
values (B) for compounds 50 are summarized in Table 12. 
NH2
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58 59
Method A: concentration 2 mL / mmol, under Ar, 30 min., yield 92 %
Method B: concentration 30 mL / mmol, 2 h, yield 88 %.
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Table 11: Synthesis of 2,5-diaryl-azoles 50, 51 and 52 with the ligandless Pd/Cu-catalyzed direct C-2 arylation 
of 5-aryl-azoles 31 and 32 with aryl bromides 53 and 54. 
 
 
5-aryl-azole 2,5-diarylazole Isolated yield (%) 
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Me
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32b: Y = OMe
32c: Y = CN
43
Pd(OAc)2 (5 mol %)
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N
N
N
Me Me
Y
38a: Y = Me; (88 %)
38b: Y = MeO; (66 %)
38s: Y = CN; (42 %)
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Figure 17: Absorbance (left) and emission (right) spectra of 5 µM compounds 50 solutions in THF; absorbance 
and emission values are normalized. 
 
The same tendency for the absorption spectrum still remains when the values were 
determined in CHCl3. The red-shift has again the order 50a, 50b and 50s as we can see from 
Figure 18 and the 50s resulted to be shifted of about 8 nm. The emission spectra also showed 
the same trend of THF analyses. Their three fluorescence maximum wavelengths are red-
shifted again in order 50s, 50a and 50b, even though in this case the values of 50s and 50a 
differ for only 1 nm. The Stokes shift increases in the direction: 50s, 50a and 50b (87 nm, 100 
nm and 107 nm, respectively) (Table 12). 
 The fluorescence quantum yields (Φ) of the three fluorophores were also determined in 
order to have a quantitative picture but, at the moment of the writing of this thesis, it could be 
detected only for THF (Table 12). All molecules resulted strong emitters with quantum yields 
comprised between 83 % and 90 %. The lowest Φ corresponds to 50s, which is characterized 
by the lowest S (82 nm) and the highest overlapping between absorbance and emission 
(Figure 17). The product of ε and Φ was also calculated for making comparisons between the 
different fluorophores. This parameter is defined as the brightness (B) of the dye, which 
accounts for both the amount of light absorbed and the quantum efficiency of the fluorophore. 
B values of around 30000 M-1cm-1 are among the highest calculated for fluorophores in the 
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same wavelength region (for example, pyrene brightness = 32000 M-1cm-1).112 As regards the 
quantum yields in CHCl3 we are waiting the results very soon in order to complete the table 
of values. 
 
 
Figure 18: Absorbance (left) and emission (right) spectra of 5 µM compounds 50 solutions in CHCl3; 
absorbance and emission values are normalized. 
 
 Absorption and emission spectra for the 51 and 52 series were measured in CHCl3 as 
stated before (Figure 19 and Figure 20). Compounds 51 and 52 show a little difference in 
their absorption spectra between compounds of the same series, while there is a big difference 
in the position of the peak of absorbance between the two series 51 and 52. 
Compounds 51 display the maximum of absorbance around 345 nm while compounds 52 
display the maximum at about 370 nm. We can also observe a big difference with the series of 
derivatives 50 that showed their maximum around 315 nm. Emission spectra are instead 
approximately in the same region, giving to compounds 51 a greater Stokes shift than 52 (see 
Table 12). A common trend can be observed in the two series on the positions of the emission 
maximum: 51b and 52b with the methoxy group on the phenyl substituent show the greater 
shifts, that decrease passing to 51a and 52a with the methyl group and then to 51s and 52s 
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with the cyano group. The electronic effect of these substituents on the Stokes shift is the 
similar effect observed for compounds 50 in THF.105 
 
Table 12: Spectroscopic properties of fluorophores 50, 51 and 52 dissolved in CHCl3. 
 λabs [nm] ε [M-1cm-1] λem [nm] S [nm] Φf[a] B [M-1cm-1][b] 
50a 
316 27600 416 100 n.d.[c] n.c.[d] 
320[e] 31000[e] 415[e] 95 0.88 27280 
50b 
320 24900 427 107 n.d.[c] n.c.[d] 
325[e] 36000[e] 428[e] 103 0.90 32400 
50s 
328 25300 415 87 n.d.[c] n.c.[d] 
335[e] 39000[e] 397[e] 82 0.83 32370 
51a 342 32000 442 100 0.81 25920 
51b 345 32000 457 112 0.90 28800 
51s 343 42000 426 83 0.80 33600 
52a 367 43000 443 76 0.59 25370 
52b 372 38800 460 88 0.55 21340 
52s 372 47500 436 64 0.61 28975 
[a] Fluorescence quantum yield (Φ) was determined relative to quinine sulphate in 0.1 M H2SO4 (Φ = 
0.54). [b] The brightness (B) values of fluorophores were calculated as the product of the absorption 
coefficient ε and Φ. [c] Φ values in CHCl3 not detected. [d] B values in CHCl3 not calculated. [e] 
Absorbance, emission and ε values were determined in THF. For compounds 51 and 52 the values were 
determined only in CHCl3 because of solubility problems in THF. 
 
From Table 12 it emerges that compounds 51 possess higher quantum yields with bigger 
Stokes shifts than 52, but generally lower molar extinction coefficients. The lower quantum 
yields of compounds 52 may be ascribed to the “heavy atom effect”: it is well known that the 
presence of heavy atoms in aromatic molecules results in fluorescence quenching, making 
non-radiative relaxation pathways easier, and this may be the effect of the additional sulphur 
atom.98  
Compounds 50 showed Stokes shifts, molar extinction coefficients and quantum yields 
comparable with those obtained for compounds 51. However, spectra of compounds 51 are 
slightly red-shifted compared to those of compounds 50.105 
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Figure 19: Absorbance (left) and emission (right) spectra of 5 µM compounds 51 solutions in CHCl3; 
absorbance and emission values are normalized. 
 
 
Figure 20: Absorbance (left) and emission (right) spectra of 5 µM compounds 52 solutions in CHCl3; 
absorbance and emission values are normalized. 
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 The idea of designing fluorophores of structure 50-52 was directed in the prospective of 
improving the characteristic of standard photovoltaic (PV) systems, and the sunlight 
concentration is one of the most promising approaches. Luminescent solar concentrators 
(LSCs) have been proposed as alternative photovoltaic (PV) devices, as they require less 
semi-conductor material per unit of generated power, compared with conventional PV-
technologies. While initially introduced as a means for better exploitation of high efficiency 
solar cells and therefore for cost reduction, recently the focus has shifted towards LSCs as a 
promising concept for integration of PV into buildings.113 LSCs are essentially thin sheets of 
transparent plastics, in which luminescent species are dispersed (Figure 21). 
 
a)                                
 
b)                       
Figure 21: a) Schematic representation of a LSC; b) Examples of LSC of fluorophores of different nature. 
 
Long and slim solar cells are attached to the small side faces such that their collection surface 
is directed to the plastic plate. Sunlight enters the sheet through the large top face and is 
absorbed by the dispersed fluorophore in polymeric matrix, which re-emit light (Figure 21a). 
The wavelength of the re-emitted light is different from the incoming wavelength, just like the 
propagation direction. Because of this change in direction a large fraction of the re-emitted 
light cannot leave the plate through the plastic-air interface, as it is in the regime of total 
internal reflection (TIR). Therefore the light is wave-guided until it reaches the solar cell. The 
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wavelength of the re-emitted light depends on the choice of the fluorophore, which has to be 
ideally chosen such that the emission band matches the maximum of the spectral response of 
the solar cell (Figure 21b). The solar cell will thus operate with a higher efficiency than under 
broad-spectrum illumination.  
Despite several attempts, LSC power conversion efficiency (~7%) remains too low for most 
practical applications due to a number of loss mechanisms attributed to non-radiative energy 
dissipation and self-absorption by the fluorophore. In the perspective of extensive LSC 
applications, the fundamental open issue is the development of high quantum yield and photo-
stable dyes, which can meet the LSC requirements for commercialization. 
 As regards our compounds, fluorophores 50 exhibit bright blue-green emissions in the 
solid state (Figure 22 and Figure 23). Powders of 50a and 50s emit significantly red-shifted 
fluorescence relative to 50b and the THF solutions. This phenomenon may be attributed to the 
higher electronic coupling resulting from aggregation of their respective molecules or 
planarization of their chromophoric backbone owing to the increased conjugation. 
 
 
Figure 22: Normalized emission spectra of solid dyes 50. 
 
 
                                                      50b               50a              50s 
Figure 23: Pictures of the different solid samples of compounds 50 taken under illumination at 366 nm. 
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Fluorescence is well retained in the solid state even for derivatives 51 and 52 (bright blu-
green colour under UV exposure). 
 As a last application of this Ph.D. work, we synthesized two compounds, 50w and 51w 
(Figure 24) with the (2-ethyl)-hexyloxy substituent, in order to obtain a better solubility in 
organic solvents and to achieve good affinity with polymeric matrices. We did not focus on 
the synthesis of the bis-thiazole compounds because derivatives 52 showed lower quantum 
yields and Stokes shifts than the relatives 50 and 51. 
 
 
Figure 24: Structures of compounds 50w and 51w. 
 
Once more, we wanted to apply the one-pot approach used for balsoxin (39a) and texaline 
(39b) and the resveratrol analogues 48 (see paragraphs 1 and 2 of Chapter 2) for the 
synthesis of 50w and 51w. 
Hence, 1 equiv of 1-methyl-1H-imidazole (12) was treated with 1.1 equiv of 4-bromo-(2-
ethyl)-hexyloxybenzene (26w) at 70 °C in DMA in the presence of 5 mol % Pd(OAc)2 as 
catalyst and Bu4NOAc as base. The two reactions were carried out for 24 h. After that, 
without any purification of the intermediates 32w, 1.5 equiv of 2-(4-bromophenyl)-1-methyl-
1H-benzo[d]imidazole (50) or of 2-(4-bromophenyl)benzo[d]thiazole (49) were added along 
with 2 equiv of CuI. The use of 5 mol % Pd(OAc)2 and 2 equiv of Bu4NOAc as initial 
quantities proved to be effective for the sequential reactions, and no additional catalyst or 
base was necessary in the second step. After 24 h at 110 °C, the required compounds 50w and 
51w were isolated in 18 and 40 % yield, respectively (Scheme 54). 
Compounds 50w and 51w were purified by crystallization and the analysis 1H-NMR and 13C-
NMR confirmed the structure of these compounds. Optical properties of 50w and 51w were 
evaluated and are reported in Table 13. 
These results are perfectly concordant with those found for 50 and 51 series (see Table 12). 
N
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N
O
Me Me
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N
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Scheme 54 
 
Table 13: Spectroscopic properties of fluorophores 50w and 51w. 
 λabs [nm] ε [M-1cm-1] λem [nm] S [nm] Φf[a] B [M-1cm-1][b] 
50w 321[c] 30000[c] 426[c] 105 0.99 29700 
51w 343[d] 30000[d] 457[d] 114 0.76 22800 
[a] Fluorescence quantum yield (Φ) was determined relative to quinine sulphate in 0.1 M H2SO4 (Φ = 
0.54). [b] The brightness (B) values of fluorophores were calculated as the product of the absorption 
coefficient ε and Φ. [c] Absorbance, emission and ε values were determined in THF. [d] Absorbance, 
emission and ε values were determined in CHCl3. 
 
Compound 50w properties were determined in THF solutions. It shows an absorbance 
spectrum with a maximum around 321 nm, very similar to 50a and 50b with the methyl and 
the methoxy group; its emission spectrum resulted with the fluorescence maximum 
wavelength around 426 nm, with a Stokes shift of 105 nm, higher than the other 50 
compounds, as well as the quantum yield (Table 13). As regards compounds 51w, its optical 
properties were determined in CHCl3 because of solubility problems. Even for compound 
51w the results were concordant with those reported in Table 12. The absorbance spectrum 
has the maximum wavelength of about 343 nm, perfectly overlapping with the absorbances 
found for compounds 51. The fluorescence emission has the maximum around 457 nm, giving 
the highest Stokes shift detected so far for all the compounds 50-52 (114 nm). Its quantum 
yield resulted to be slightly lower than the others of the 51 series (0.79) (Table 13). 
Pd(OAc)2 (5 mol %)
Bu4NOAc (2 equiv)
DMA, 110 °C, 24 h
N
N
N
N
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12 32w
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+
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50w: X = N-Me; (18 %)
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4. Conclusions. 
 
 In conclusion, we applied the palladium-catalyzed direct arylation of azoles with aryl 
bromides mediated by Bu4NOAc to the synthesis of some biologically active compounds and 
organic functional materials. 
 We firstly tried to synthesize two natural compounds, balsoxin (39a) and texaline (39b), 
that are 2,5-diaryl-oxazoles. We decided to use a one-pot approach by applying the reaction 
conditions promoted by Bu4NOAc, as regarded the first step, and the ligandless procedure for 
the direct arylation at the C-2 position of 1,3-azoles with aryl bromides in the presence of CuI 
developed by our group, for the second one. We were able to synthesized compounds 39a and 
39b in 39 and 38 % yield, respectively, with only one purification step. 
 Then, by using the same one-pot methodology, we prepared two resveratrol analogues 
48a and 48b, starting from 1-methyl-1H-imidazole (12). The compounds were synthesized in 
48 and 38 % isolated yield, respectively; we also prepared the relative unprotected derivatives 
49a and 49b that we got in 89 and 65 % yield. Molecules 48 and 49 showed cytotoxic activity 
against the 60 human tumoral cell line panel of the National Cancer Institute of USA and 
moreover, compound 49b resulted to be a NQO2 inhibitor in vitro as confirmed by Professor 
Ian Stratford of University of Manchester and showed cytotoxicity higher than resveratrol 
(44). 
 As last application, we devoted a part of our synthetic efforts to the preparation of new 
push-pull fluorophores 50, 51 and 52. We used a two-step procedure, that involved the 
palladium-catalyzed direct arylation of azoles with aryl bromides in the presence of Bu4NOAc 
for the first step and the ligandless direct arylation at the C-2 position promoted by CuI with 
aryl bromides of Bellina’s group for the second step. We synthesized compounds 50-52 with 
overall yields ranging from 16 to 71 %. Then, we evaluated their spectroscopic properties, by 
analysing their absorbance and emission spectra. Molecules 50-52 presented quantum yields 
comprise between 55 and 99 % with Stokes shifts up to 114 nm. They will be used in the 
development of luminescent solar concentrators (LSC) that represents an attractive alternative 
to the standard photovoltaic systems (PV) because their simplicity of the materials and their 
low costs.  
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Synthesis of N-heterocyclic copper carbenes and study of their role in 
Pd/Cu mediated systems 
 
This part of the Ph.D. thesis was carried out at the University of York, in collaboration with 
Professor Ian J. S. Fairlamb. 
 
 The development of Pd/Cu-mediated approaches for the functionalization of 
(benz)azoles and related purines has greatly diversified the arylated derivatives that can be 
accessed.23a-b,50a For these processes, it is often beneficial to use stoichiometric quantitites of a 
Cu salt with Pd acting as a catalyst; however, the mechanism of these reaction is not fully 
understood. 
As already discussed in the Introduction of this thesis, our research group have developed a 
procedure for the functionalization of imidazoles to synthesize 2-arylimidazoles, which 
proceed in DMF at high temperatures (Scheme 55a).23c-d,37,50c-e Another example of reaction 
involving a Pd/Cu catalytic system was reported by Fairlamb’s group in 2008. Here, 
adenosine 60 can be functionalized using a similar route to give 8-aryladenosine 61 (Scheme 
55b).64,114  
 
 
Scheme 55: Leading examples of C-H bonds functionalization reactions at heteroarenes. 
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Moreover, the functionalization of a benzimidazole (62) to give a 2-arylbenzimidazole (63) 
has been shown to proceed in the absence of Pd and using 1 equiv of CuI, though higher 
reaction temperatures were employed in this reaction (Scheme 55c).13b Interestingly, Miura 
and co-workers commented in their work that the arylation of 1-methyl-benzimidazoles works 
considerably better with CuI alone than using Pd/Cu together (the reason for this outcome was 
stated as unclear at the time).20a 
 As reported in the Scheme 4 of Introduction a mechanism for the Pd/Cu-mediated 
reactions have been proposed, with suggestions of initial intermediates involving N-
coordination of CuI to imidazole, organocuprate formation and the involvement of CuI-
NHCs.23c-d,37,50c-e,64,114 Metal-NHCs have also been postulated in intramolecular Rh-catalyzed 
C-H functionalization of benzimidazoles, 115  and in intermolecular Rh-catalyzed C-H 
functionalization of heterocycles. 116  A pathway bringing the proposed Pd/Cu-mediated 
mechanism together is shown in Scheme 56, which involves the transmetalation of an NHC 
ligand from CuI to PdII, allowing reductive elimination to form the arylated imidazole. It has 
also been established that well-defined Pd nanoparticles are forms under these reaction 
conditions, with their role most likely as a reservoir of Pd0,117 akin to Heck-type coupling 
reactions.118,119 
 
 
Scheme 56: Proposed reaction mechanism for the C-H bond functionalization of (benz)imidaoles/purines, 
mediated by Pd and Cu. The Pd0L2 is likely in equilibrium with higher order Pd nanoparticles (not shown).117 
 
Unfortunately, under working conditions the proposed intermediate species in Scheme 56 are 
difficult to detect and synthesize, especially at CuI. Very recent studies by Hahn and co-
workers have demonstrated that related organoplatinate caffeine-derived species can be 
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formed by an alternative synthetic route involving oxidative addition of Pt0 into a C-Br 
bond.120 Subsequent protonation gave an PtII-NHC complex of the type PtII(X)2(NHC)L. 
While this study confirms the potential of such M-NHC species as intermediates, the 
reactivity of these complexes toward aryl halides, for example, has not been studied so far. 
 In order to verify if CuI-NHC species can be arylated by reaction with aryl iodide (in 
the presence and absence of Pd), we decided to synthesize and study compounds 64a, 64b and 
65 as model systems (Figure 25). In compound 64a, the N-benzyl substituent provides modest 
steric protection at the carbene centre, and is similar to typical substrates (see compound 62 in 
Scheme 55). The second benzyl substituent, however, takes the place of a proton. Then, the 
effect of steric bulk around the carbene centre was investigated by exchanging the benzyl 
substituent with phenyl (compound 64b) and the mesityl group (compound 65). 
 
 
Figure 25: CuI-NHC complexes 64a, 64b and 65 examined in C-2 functionalization. 
 
 
Figure 26: Reaction of CuI-NHC complexes with PhI (2) in the presence and absence of Pd(OAc)2 (the latter via 
a CuIII species). 
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A key question arising from this study is whether the NHC ligand acts in either a non-
interfering and supporting manner as a spectator ligand or participates as an actor and hence 
substrate. Although metal NHC complexes are generally robust species, reductive elimination 
can occur from NiII and PdII complexes containing NHC and aryl or alkyl ligands.121 
Therefore, this study would allow us to understand whether reductive elimination is feasible 
at Cu via a higher oxidation state intermediate (Figure 26) 
 
 
1. Synthesis and characterisation of CuI-NHC complexes 64a, 64b and 65. 
 
 NHC-CuI complexes have been shown to have important roles in catalysis,122 and 
demonstrated cytotoxic activity. 123  The first NHC-CuI complex (67) was isolated by 
Arduengo and co-workers starting from carbene 66 and CuIOTf (Scheme 57).124 Nolan and 
co-workers have used similar complexes, with PF6 or BF4 as counter anions, as very efficient 
and selective pre-catalysts for the hydrosilylation of carbonyl compounds.125  
 
 
Scheme 57 
 
 The first monocarbene complex was studied by Raubenheimer and co-workers. These 
thiazole-derived carbene complexes (68) existed as chloride dimers in the solid-state (for an 
example see Scheme 58). This methodology was extended to a greater variety of 
thiazolylidene and N-methylimidazolylidene scaffolds.126 
 
 
Scheme 58 
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In 2001, Danopoulous and co-workers synthesised pyridine-N-functionalised CuI complexes 
from imidazolium bromides and Cu2O.127 Dependent on substituents and recrystallisation 
conditions, these complexes existed as monomers, dimers and polymers. Douthwaite and co-
workers used this method in the synthesis of carbene-phenoximine complexes.128 Cazin and 
co-workers demonstrated that this “green” approach (the only by-product being water) to 
Cu(NHC)s 70 formation could be applied to a variety of imidazolium salts 69, including Mes, 
Pr, and Cy as R substituents in different solvents (CH2Cl2, toluene, H2O) (Scheme 59).129 
 
 
Scheme 59 
 
 Buchwald and co-workers synthesised the first NHC-Cu complex of the form 
(NHC)CuX (71), where X is a halide, via the simple reaction of free carbene with CuICl 
(Scheme 60).130  The resulting complex was found to be air and moisture stable, and 
demonstrated to be useful as a catalyst in the conjugative reduction of α,β-unsaturated 
carbonyl compounds.  
 
 
Scheme 60 
 
In similar work by Nolan and co-workers, the reduction of carbonyls was performed by 
(NHC)CuCl complexes formed in situ from the parent imidazolium salt.131 Lebel has utilized 
Nolan’s catalysts in the synthesis of styrenes and aliphatic alkenes from carbonyls.132 Nolan 
later demonstrated the utility of Cu(NHC)X complexes in the hydrosilylation of ketones and 
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“click” chemistry,133 and in the direct C-H bond carboxylation of arenes.134 
 Albrecht and co-workers, after a study of a comprehensive library of bis-NHC-CuI 
complexes, demonstrated that substituents play an important role in stability. 135  Their 
complexes demonstrated that aryl (Mes or Dipp) produced the most stable CuI complexes, 
whilst alkyl substituents (including seemingly more hindered NHCs such as iPr) induced 
rapid demetallation in the presence of water. Albrecht used these complexes in a novel ligand 
transfer to Ru. Furst and Cazin demonstrated that Cu(NHC)X complexes could also be used 
as carbene transfer reagents to AuI and PdII.136 
 Tsubomura and co-workers have synthesised a bi-metallic NHC-CuI complex 72 
(Scheme 61). 137  They also demonstrated these complexes could be produced via 
transmetallation from AgI. These complexes were considered for applications as luminescent 
materials in light emitting diodes. Similar bi-metallic complexes with a carbene/metal ratio 
1:1 were reported by Hoffman and co-workers.138 
 
 
Scheme 61 
 
1.1. Synthesis of the (benz)imidazolium salts 73a, 73b and 74. 
 
 We began the synthesis of compounds 64a, 64b and 65 by preparing the relative 
(benz)imidazolium salts 73a, 73b and 74 (Figure 27). 
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Figure 27: Structures of (benz)imidazolium salts 73a, 73b and 74. 
 
 As regard the dibenzylbenzo[d]imidazolium bromide 73a, it was achieved by reacting 
the benzimidazole (75) (1 equiv) and 2 equiv of benzyl bromide (76) with 1.6 equiv of K2CO3 
in acetonitrile as the solvent at room temperature for 3 days (Scheme 62).139 After a simple 
aqueous work-up, we were able to isolate the benzimidazolium bromide 73a in 99 % 
chemical yield. The structure of 73a was confirmed by 1H-NMR, 13C-NMR and ESI-MS 
analyses. 
 
 
Scheme 62 
 
 For the synthesis of 1,3-diphenyl-1H-benzo[d]imidazol-3-ium bromide (73b), we 
needed to prepare the N,N-diphenylbenzene-1,2-diamine (78) as the reaction precursor. 
Initially, we tried to synthesize 78 starting from benzene-1,2-diamine (77) and bromobenzene 
(26r) as reported by Sun and co-workers in 2013.140 Hence, 1 equiv of compound 77 and 2 
equiv of 26r reacted under nitrogen atmosphere in the presence of 5 mol % of Pd2(dba)3, 7.5 
mol % BINAP as ligand, 3 equiv of NaOtBu in toluene at 110 °C as reported in Scheme 63. 
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The reaction was followed by TLC and compound 78 was obtained in only 16 % isolated 
yield after work-up and a difficult purification by flash cromatography. 
 
 
Scheme 63 
 
Because of the scarce chemical yield of N,N-diphenylbenzene-1,2-diamine (78), we thought 
to change the procedure and decided to apply the Harlan’s group methodology reported in 
2004 that started from the inverted substrates. 141  More specifically, under nitrogen 
atmosphere, 1 equiv of 1,2-dibromobenzene (79) reacted with 3 equiv of aniline (80) in the 
presence of 2.5 mol % Pd(OAc)2, 7.5 mol % PtBu3 and 3 equiv NaOtBu in toluene at reflux 
temperature. The reaction was left overnight and after work-up and a recrystallization process, 
compound 78 was isolated in 78 % yield (Scheme 64). The structure of 78 was then 
confirmed by the analysis of 1H-NMR, 13C-NMR and ESI-MS spectra. 
 
 
Scheme 64 
 
 Once we prepared the precursor 78 we had to synthesize the relative benzimidazolium 
bromide 73b. The procedure we exploited to have the cyclization of the diamine 78 was 
reported by Zou and co-workers in 2005 where they reported the preparation of 1,3-diphenyl- 
benzimidazolium chloride.142 They reacted compound 78 with trimethyl ortoformate (81) in 
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the presence of HClconc and catalytic HCOOH. Hence, we wondered if replacing the HClconc 
with HBrconc it might be possible to get the same product, but as a bromide salt. For this 
reason, at a solution of N,N-diphenylbenzene-1,2-diamine (78) in trimethyl orthoformate (81), 
HBrconc and catalytic HCOOH were added and the reaction mixture was heated at 80 °C for 2 
h as reported in Scheme 65. Afterwards, the product 73b was purified by crystallization and 
isolated with 99 % chemical yield. Its structure was then confirmed by the analysis of 1H-
NMR, 13C-NMR and ESI-MS spectra. 
 
 
Scheme 65 
 
 The 1,3-dimesityl-1H-imidazol-3-ium chloride (74) was not prepared in our laboratory 
because it was commercially available; for this reason it was used directly as a precursor for 
the synthesis of copper carbene 65. 
 We devoted part of our synthetic efforts also on the preparation of the relative 
benzocondensed derivative of compound 74, the 1,3-dimesityl-1H-benzo[d]imidazol-3-ium 
bromide (73c) (Figure 28), in order to add compound 64c to the library of benzimidazolium 
copper-carbenes to study. 
 
                                
Figure 28: Structure of 1,3-dimesityl-1H-benzo[d]imidazol-3-ium bromide (73c) and its relative copper-carbene 
64c. 
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Having successfully verified the viability of Harlan’s procedure for the synthesis of N,N,-
diphenyl-1,2-diamine (78) , we applied the same reaction conditions to the preparation of 
N,N-dimesythylbenzene-1,2-diamine (83), that should have been used afterwards as precursor 
of compound 73c. This time we started from 1 equiv of 1,2-dibromobenzene (79) and 3 equiv 
of 2,4,6-trimethylaniline (82) as reported in (Scheme 66).141,143 Compound 83 was achieved 
after work-up and recrystallization step in 74 % isolate yield. The structure of 83 was then 
confirmed by 1H-NMR, 13C-NMR and ESI-MS analyses. 
 
 
Scheme 66 
 
Therefore, we repeated again the cyclization reaction we applied for the preparation of 
compound 73b, by adding the N,N-dimesythylbenzene-1,2-diamine (83) in trimethyl 
orthoformate (81) with HBrconc and catalytic formic acid at 80 °C for 2 h.142 Unfortunately, 
we were not able to synthesize the benzimidazolium bromide 73c with this procedure, even 
though we tried to extend the reaction time. We also tried to perform the reaction in the 
microwave, setting the standard reaction time and temperature and even increasing them until 
24 h and 110 °C. Compound 73b was not reachable again, more likely because of the steric 
hindrance of the ortho-substituent of the mesytil rings that obstruct the cyclization of the 
trymethyl orthoformate 81. For these reasons we decided to focus our attention only on the 
imidazolium chloride 74. 
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1.2. Synthesis of copper carbenes 64a, 64b and 65. 
 
 The copper carbenes 64a, 64b and 65 were all synthesized in a quantitative manner by 
reacting the (benz)imidazolium salts 73a, 73b and 74 with Cu2O in anhydrous CH2Cl2 as 
reported in Scheme 67. 
 
 
Scheme 67 
 
Products 64a, 64b and 65 were all characterized by 1H-NMR, 13C-NMR and mass-spectra 
analyses. 
 Single crystals of complex 64b suitable for X-ray diffraction analysis were grown via 
the vapour diffusion of diethyl ether into a solution of the product in dichloromethane. The 
molecule crystallizes as a one-dimensional polymer propagated by the formation of bromide 
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bridges (µ2-Br) along the chrystallographic b-axis between neighbouring NHC-Cu-Br units 
(Figure 29).  
 
 
 
Figure 29: Single crystal X-ray structure of 64b. Hydrogen atoms are omitted for clarity. Thermal ellipsoids are 
set to 50 % probability. 
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Each monomer of the polymer is separated by a distance of 3.89 Å, corresponding to the 
length of the b-axis of the unit cell. Such ligand-unsupported zigzag (metal-halide)n chains are 
rare and, to our knowledge, are unprecedented in CuI-NHC chemistry. Moreover, π-π stacking 
interactions between the phenyl rings are evident throughout the crystal lattice. 
 
 
2. Reaction of CuI-NHC complexes 64a, 64b and 65 with PhI (2), with and 
without Pd(OAc)2. 
 
 Reactions of NHC with (hetero)aryl halides have been of interest since the early work 
of Arduengo and co-workers who showed that an imidazole-2-ylidene in the presence of 
iodopentafluorobenzene (84) is in equilibrium with an iodoimidazolium adduct (Scheme 
68a).144 Arnold et al. studied a more structurally complex system resulting in cleavage of the 
C-I bond in 84, leading to C-I bond formation at the carbene carbon.145 However, no reaction 
was noted with PhI (2), which contains a slightly stronger C-I bond. On the other hand, 
Henkel and co-workers observed displacement of the 4-fluoro substituent in perfluoropyridine 
(85) by an imidazole-2-ylidene (Scheme 68b).146 
 
 
Scheme 68: Examples of previous work assessing the reactivity of NHCs toward aryl halides in the absence of 
transition metal.144,146 
 
 In order to understand whether CuI-NHC 64a, 64b and 65 can enter into a reaction with 
PhI (2), reactions of CuI-NHCs with PhI were conducted in benzene at 90 °C, in the absence 
(Method A) and presence (Method B) of Pd(OAc)2 (Scheme 69).  
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Arylations of compound 64a with the two methods were already performed before this Ph.D. 
work started.147 When compound 64a was treated with Method A, three species were observed 
in the 1H-NMR spectrum: compound 64a it-self (54.3 %), the arylated product 86a (30.5 %) 
and the side-product 1,3-dibenzyl-2-benzimidazolone (88) (15.2 %) (Figure 30). On the other 
hand, the same reaction in the presence of Pd(OAc)2 produced compound 86a in 42.6 % 
(conversion by 1H-NMR). Moreover, in this latter reaction 6.4 % 1,3-dibenzyl-2-
benzimidazolone (88) was detected by NMR analysis together with a signal attributable to a 
cis-Pd(NHC)2Br2 complex (89), with the diastereotopy determined by molecular simmetry, 
that is with the two NHC ligands in cis-arrangement (Figure 30).147 
 
 
Scheme 69: Assessing the reactivity of CuI-NHCs toward PhI (2). Method A: 2 (5 equiv), C6H6, 90 °C, 24 h. 
Method B: 2 (5 equiv), Pd(OAc)2 (1 equiv), C6H6, 90 °C, 24 h. Note that the anion, here depicted as I-, could also 
be either Br-, CuX2 or Cu2X4 anions (where X = Br or I). 
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This observation provides evidence that, in the presence of Pd(OAc)2, the CuI-NHC acts as a 
transmetallating agent, with arylation likely occurring from Pd. The formation of imidazolone 
compounds in CuI-NHC chemistry has been observed previously, and is thought to occur due 
to trace oxygen in the reaction.148 
 
 
Figure 30: On the left: structure of 1,3-dibenzyl-2-benzimidazolone (88); on the right: postulated structure of 
cis-Pd(NHC)2Br2 (89) obtained from the transemtallation reaction of Pd(OAc)2 with complex 64a in benzene.147 
 
 In this Pd.D. work, we focused our attention on the arylation of copper carbenes 64b 
and 65 with PhI (2) in the absence and presence of Pd(OAc)2. The reagents were added to a 
Young’s NMR tube under anhydrous conditions, heated at 90 °C, and followed by 1H-NMR 
spectroscopy. After 24 h, the benzene was removed from the reaction in vacuo and the 
reaction mixture was analysed in CD3CN to enable direct comparison with authentic starting 
material and product. 
Firstly, the arylation of 64b in the absence of Pd(OAc)2 (Method A) was carried out. The 1H-
NMR spectra are reported in Figure 31. We observed the depletion of CuI-NHC 64b after 24 
h in C6D6 at 90 °C in the presence of 5 equiv of PhI (2) (Figure 31d) and the formation of the 
precipitating product 86b from the solution as a white solid. 
As regard the arylation in the presence of Pd(OAc)2 (Method B), we could observe that after 
the addition of the palladium complex there is a rearrangement of the signals of the carbene 
64b (Figure 32c). Arylation was found to proceed with complex 64b at 90 °C, with starting 
complex 64b being fully consumed after 2 hours (Figure 32d). The arylated imidazolium 
product 86b precipitated from solution in quantitative yield (isolated yield > 99 %). 
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Figure 31: 1H-NMR spectra showing reaction outcome of CuI-NHC 64b with PhI (2) in the absence of 
Pd(OAc)2. a) 1H-NMR spectrum of compound 64b in C6D6; b) 1H-NMR spectrum of compound 64b after the 
addition of PhI in C6D6 (2) at room temperature; c) 1H-NMR spectrum of compound 64b with PhI (2) after 2 h at 
90 °C in C6D6; d) 1H-NMR spectrum of compound 64b with PhI (2) after 24 h at 90 °C in C6D6. 
 
In the absence of Pd(OAc)2 a similar outcome was recorded, with quantitative conversion to 
86b after 24 h. A single crystal of 86b was grown from acetonitrile and the X-ray diffraction 
structure determined (Figure 33). The unit cell contains two independent molecules, with each 
positively-charged arylated imidazolium species being charge balanced by a CuI-containing 
Cu2I42- anion. The bonds connecting the phenyl moieties to the imidazolium rings were 
measured as 1.480(7) and 1.472(7) Å for C(7)-C(8) and C(32)-C(33) respectively. The bond 
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angles around N(2)-C(7)-C(8) and N(3)-C(32)-N(33) are 126.2(5) and 127.8(5)° respectively. 
The N(2)-C(7)-C(8)-C(9) and N(3)-C(32)-C(33)-C(38) torsion angles lie at 63.8(8) and 
68.5(7)° respectively. 
 
 
 
Figure 32: 1H-NMR spectra showing reaction outcome of CuI-NHC 64b with PhI (2) in the presence of 
Pd(OAc)2. a) 1H-NMR spectrum of compound 64b in C6D6; b) 1H-NMR spectrum of compound 64b after the 
addition of PhI in C6D6 (2) at room temperature; c) 1H-NMR spectrum of compound 64b with PhI (2) after the 
addition of Pd(OAc)2 in C6D6 at room temperature; d) 1H-NMR spectrum of compound 64b with PhI (2) in the 
presence of Pd(OAc)2 after 2 h at 90 °C in C6D6; e) 1H-NMR spectrum of compound 64b with PhI (2) in the 
presence of Pd(OAc)2 after 24 h at 90 °C in C6D6. 
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Figure 33: Single crystal X-ray structure of 86b (two indipendent organic fragments accompany the Cu2I42- 
anion shown in the figure above). Hydrogen atoms are omitted for clarity. Thermal ellipsoids are set to 50 % 
probability. 
 
On the other hand, studying reactions with complex 64b at room temperature, a different 
outcome was recorded. Although no reaction was observed in the absence of Pd(OAc)2 
(Figure 31b), in the presence of Pd(OAc)2 trans-[Pd(NHC)-κ1-Br-µ2-Br]2 (90) was formed 
quantitatively (as shown by 1H-NMR spectroscopic analysis). Single crystals of the PdII-NHC 
complex were grown via slow evaporation from dichloromethane. The structure shows a 
dinuclear PdII-NHC complex, with each PdII center coordinated by one carbene, one terminal 
bromide atom and two µ-bromide atoms (Figure 34). The C(1)-Pd(1) and C(20)-Pd(2) bond 
distances were measured at 1.941(6) and 1.931(6) Å respectively, which are comparable to 
other Pd-NHC complexes exhibiting bridging bromide atoms in the solid-state.149 The trans-
C(1)-Pd(1)-Br(2) angle is 176.56(17)° and C(20)-Pd(2)-Br(1) is 176.44(16)°. 
 We then applied the two reaction conditions to complex 65. Arylation in the absence of 
Pd(OAc)2 did not occur after 24 h at 90 °C as we can see from Figure 35d. The 1H-NMR and 
the mass-spectroscopy analyses of the NMR sample confirmed the results. 
As we saw for compound 64b, we observed the depletion of 65 when we applied Method B in 
the presence of Pd(OAc)2 as soon after 2 hours at 90 °C in C6D6 (Figure 36d). ESI-MS of the 
dried reaction mixture after 24 hours confirmed that at least a partial arylation of compound 
65 occurred. The NMR analysis of the crude product was not helpful to confirm the structure 
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of the product 87 and further investigations will be planned in order to have a quantification 
of the yield. 
 
 
Figure 34: Single crystal X-ray structure of trans-[Pd(NHC)-κ1-Br-µ2-Br]2 (90). Hydrogen atoms are omitted for 
clarity. Thermal ellipsoids are set to 50% probability. 
 
 However, considering the a-values (describing the steric effects for various substituents) 
for benzyl and phenyl groups, the latter is considerably larger (Bn = 1.35 and Ph = 3).150 It is 
therefore surprising that arylation occurs in higher yield for the N-phenyl derivative 64b to 
give 86b. Furthermore, increasing the steric bulk to N-mesityl hinders the arylation reaction. 
This indicates that the electronic effects of the N-substituent are likely to play an important 
part in the arylation reaction. 
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Figure 35: 1H-NMR spectra showing reaction outcome of CuI-NHC 65 with PhI (2) in the absence of Pd(OAc)2. 
a) 1H-NMR spectrum of compound 65 in C6D6; b) 1H-NMR spectrum of compound 65 after the addition of PhI 
in C6D6 (2) at room temperature; c) 1H-NMR spectrum of compound 65 with PhI (2) in the presence after 2 h at 
90 °C in C6D6; d) 1H-NMR spectrum of compound 65 with PhI (2) after 24 h at 90 °C in C6D6. 
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Figure 36: 1H-NMR spectra showing reaction outcome of CuI-NHC 65 with PhI (2) in the presence of 
Pd(OAc)2. a) 1H-NMR spectrum of compound 65 in C6D6; b) 1H-NMR spectrum of compound 65 after the 
addition of PhI in C6D6 (2) at room temperature; c) 1H-NMR spectrum of compound 65 with PhI (2) after the 
addition of Pd(OAc)2 in C6D6 at room temperature; d) 1H-NMR spectrum of compound 65 with PhI (2) in the 
presence of Pd(OAc)2 after 2 h at 90 °C in C6D6; e) 1H-NMR spectrum of compound 65 with PhI (2) in the 
presence of Pd(OAc)2 after 24 h at 90 °C in C6D6. 
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3. DFT calculations – assessment of the reaction pathway for arylation in 
the absence of Pd. 
 
 Given that the direct reaction of CuI-NHC complexes with iodobenzene (2) is possible 
in the absence of Pd to give arylated products (reactivity order 64b > 64a >> 65), density 
functional theory (DFT) was used to understand potential reaction pathways for this process. 
The first pathway that we consider was a carbene insertion mechanism (via I, Scheme 70) 
akin to that reported by Pérez and co-workers.151 A second plausible pathway involves a 
CuI/CuIII oxidative addition/reductive elimination process (via II and II’, Scheme 70), as 
suggested by Ribas and co-workers.152 
 
 
Scheme 70: Possible mechanism pathways for the reaction of a CuI-NHC with PhI. 
 
To better understand the feasibility of some of these mechanistic proposal and the effect of 
steric bulk of the N-substituent on reactivity, DFT calculations were conducted at the M06 
level of theory for different NHC ligands (L) with L = benzyl (Bn), phenyl (Ph) and mesityl 
(Mes). Calculations were made in collaboration with the University of Leeds, the Azad 
University and the University of Tasmania. They were conducted initially on the structure of 
carbenes 64a, 64b and 64c in order to find a possible trend of the reactivity of these copper-
carbenes in the arylation with PhI (2) in the absence of Pd. 
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 Initial calculations revealed that the carbene insertion pathway was unfeasible, and the 
oxidative addition/reductive elimination sequence was found to be most likely. For example, 
PhI (2) can oxidatively add to CuI to give two different CuIII species II_R and II'_R, where 
the former has a phenyl group that is trans to the NHC ligand and the latter where the phenyl 
group is cis to the NHC ligand (Scheme 71). Interestingly, these two intermediate species 
(II_R and II'_R) were computed to be competitive. Crucially, the oxidative addition reactions 
are endoergonic, supporting the fact that the oxidation state of +3 at copper is unstable. 
 
 
Scheme 71: Possible mechanistic pathways for the reaction of a CuI-NHC with PhI (2) to form halo-imidazolium 
(pathway A) or phenyl-imidazolium (pathway B). 
 
The intermediate II_R can undergo the C-I (or C-Br) reductive elimination process to 
produce a_R or b_R (Scheme 71, pathway A). The formation of halo-imidazolium salts from 
Cu-NHCs has recently been reported by Willans and co-workers, with the presence of a CuII-
NHC and excess CuBr2 appearing to drive the successive disproportionation and reductive 
elimination reaction.153 In the case of this work, calculations indicate that the C-I (or C-Br) 
couplings are energetically unfavorable (shown in Figure 37 for R = Bn, pathway A), 
explaining why the C-I and C-Br couplings are not observed experimentally under the 
conditions described earlier. By contrast, the intermediate II'_R (Scheme 71, pathway B) can 
undergo the C-C reductive elimination to produce the initial product 86_R. The 
corresponding reaction is entirely exoergonic and has a small activation barrier of 2.8 
kcal/mol for R = Ph, of 6.0 kcal/mol for R = Mes (Figure 38) and of 5.7 kcal/mol for R = Bn 
(Figure 37). 
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Figure 37: The calculated energy profile for C-I, C-Br and C-C couplings starting from 64_Bn + PhI (2) via the 
oxidative addition/reductive elimination mechanism. The relative Gibbs energies and electronic energies (in 
parentheses) obtained from the M06/BS2//B3LYP/BS1 calculations in toluene are given in kcal/mol. 
 
Interestingly, the stability of II’_R is affected by the steric bulk of the R groups; for the less 
bulky R groups such as Bn and Ph, intermediate II’_R is relatively stable (Figure 37 and 
Figure 38), and as a result the C-C reductive elimination reactions can occur with overall 
energy barriers being accessible under the reaction conditions: 32.2 and 27.5 kcal/mol for R = 
Bn and Ph, respectively. For comparability, we also computed a pathway for the hypothetical 
coompound 64c where R = Mes (Figure 38). In this case the C-C reductive elimination 
requires an overall activation barrier of 39.4 kcal/mol, which is too high in energy. This is 
presumably due to the steric bulk of the Mes groups decreasing the stability of intermediate 
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II’_Mes, in turn, leading to an increase in the overall activation barrier of the C-C reductive 
elimination reaction. 
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Figure 38: The calculated energy profile for C-C couplings starting from 64_R + PhI (2) (R = Ph, Mes) via the 
oxidative addition/reductive elimination mechanism. The relative Gibbs energies and electronic energies (in 
parentheses) obtained from the M06/BS2//B3LYP/BS1 calcultaions in toluene are given in kcal/mol. 
 
 The calculations showed also that the Cu-C(NHC) bonds are lengthened upon going 
from 64_R to II′_R (Figure 39). Although, the lengthening of the Cu-C(NHC) bond for the 
cases of R = Bn (0.039 Å) and R = Ph (0.043 Å) is comparable, it is more significant for R = 
Mes (0.118 Å). This result suggests that the steric hindrance of the mesityl groups renders the 
Cu-NHC bond in II′_Mes significantly weak, thereby leading to a more destabilization of 
II′_R relative to 64_R, ultimately diminishing the reactivity of 64_Mes. 
 
86_  64_R 
II’_R 
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Figure 39: The calculated Cu-C(NHC) bond distances for 64_R (r1) and II’_R (r2) and the CuC(NHC) distance 
variations (Δr) upon moving from 64_R to II’_R. 
 
 As already specified in paragraph 1.1 of this chapter, we were not able to synthesize the 
Cu-NHC 64c in order to verify the viability of the computational calculations. Therefore, 
analyses on the imidazolium derivative 65 were afterwards made. 
Calculations on derivative 65 were run (Figure 40) and from these data we could observe that 
with the imidazole ring the activation barrier resulted to be even higher than the parent 
benzimidazole system 64c, being of 7 kcal/mol. 
 The reaction with Pd(OAc)2 involves transmetalation of the NHC ligand from CuI to 
PdII, which is well established. Indeed, as noted earlier, the arylation121a-c and alkylation121e of 
NHC ligands at PdII are reported. 
 
 
4. Conclusions. 
 
 In conclusion, we have demonstrated that after CuI-NHC complex 64a, even 64b 
undergoes a direct reaction with PhI (2), in the presence and absence of Pd(OAc)2, to give 
arylated product 86b. Arylation of complex 65 was also observed in the presence of Pd(OAc)2 
but more investigations are necessary in order to verify the yield and to characterized the 
arylation product. 
 DFT calculations show that the energy barrier for direct arylation from complex 65, is 
too high due to steric bulk destabilizing the intermediates; hence the ligand requires transfer 
to PdII to enable the reaction to proceed. 
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Figure 40: The calculated energy profile for C-C coupling starting from 65 + PhI (2) via the oxidative 
addition/reductive elimination mechanism. The relative Gibbs energies and electronic energies (in parentheses) 
obtained from the M06/BS2//B3LYP/BS1 calculations in toluene are given in kcal/mol. 
 
Although these reactions are less effective in the absence of Pd(OAc)2, our work represents 
the first successful reaction of Cu-NHCs with an aryl halide, and provides a valuable insight 
into the effect of N-substituent in these reactions. This study indicates that CuI-NHC species 
are viable intermediates in catalytic C-H bond functionalization processes involving 
(benz)azoles. 
 Finally, the DFT studies have demonstrated that an oxidative addition/reductive 
elimination pathway involving CuIII species is energetically feasible. 
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Experimental part 
 
As regards Chapter 1 and Chapter 2: 
 
GLC analyses were performed on a Dani GC 1000 instrument with a PTV injector, that was 
equipped with a Dani DDS 1000 data station. Two types of capillary columns, an Alltech AT-
35 bonded FSOT column (30 m x 0.25 mm i.d.) and an Alltech AT-1 bonded FSOT column 
(30 m x 0.25 mm. i.d.) were used. Fluka precoated 60 F254 aluminium silica gel sheets were 
used for TLC analyses. Purifications by flash-cromatography were performed using silica gel 
Merck 60 (particle size 0.040-0.063 mm). GLC-MS analyses were performed using an 
Agilent 6890 Network GC system interfaced with an Agilent 5973 Network mass selective 
detector. NMR spectra were recorded at room temperature on a Varian Gemini 200 at 200 
MHz (1H) and 50.3 MHz (13C), and we referred to TMS or to the residual protons of 
deuterated solvents. 
All reactions with air- and water-sensitive materials were performed under argon and in 
flame-dried glassware when it was necessary, by standard syringe and septa technique. The 
completion of the reactions and the composition of the reaction mixtures were established on 
the basis of GLC and GLC-MS analyses of samples of the crude reaction mixtures filtered 
through a short plug of celite and eluted with additional AcOEt or CH2Cl2. 
Dimethylacetamide (DMA) and CH2Cl2 were distilled from CaH2. Anhydrous toluene, 
dimethylformamide (DMF), dioxane, N-methylpyrrolidinone (NMP) were commercially 
available (Aldrich) and were used as received. Pivalic acid and pyridine were distilled before 
the use. All the chemicals, unless specified, are commercially available from Aldrich. 
Oxazole (4), thiazole (8), 1-methyl-1H-imidazole (12), 1-methyl-1H-pyrazole (15), 1-phenyl-
1H-pyrazole (23), 4-bromotoluene (26a), 4-bromoanisole (26b), 4-bromophenol (26c), 4-
bromoaniline (26d) (Carlo Erba), 4-nitro-benzene (26e), 1-bromo-4-
(trifluoromethyl)benzene (26f), ethyl-4-bromobenzoate (26g), 2-bromotoluene (26h), 1-
bromo-2-chlorobenzene (26i), methyl-2-bromobenzoate (26j), 1-bromonaphtalene (26k), 2-
bromoanisole (26l), 5-bromo-1,2,3-trimethoxybenzene (26m) (Alfa Aesar), 3-bromopyridine 
(26n), 5-bromopyrimidine (26o), 5-bromo-1H-indole (26p), 2-bromo-5-methylthiophene 
(26q), bromobenzene (26r) (Carlo Erba), 4-bromobenzonitrile (26s), 4-bromo-1,2-
dimethoxybenzene (26t) (Fluka), 5-bromobenzo[d][1,3]dioxole (26u), 5-bromo-1,3-
dimethoxybenzene (26v), Pd(OAc)2, Pd2(dba)2, PdCl2, PdCl2(dppb), CuI, P(2-furyl)3, PPh3, 
Chiara Manzini 
 132 
P(o-Tol)3, PBuAd2 (5) (Stream Chemicals), PCy3 (Stream Chemicals), P(tBu)2biphenyl 
(Stream Chemicals), P(tBu3)⋅HBF4 (Lancaster), Xantphos, Oxydiphenylene(PPh2)2, dppb, 
dppf, phenantroline, naphtalene (Riedel-de Haën), Ag2CO3, Na2CO3, Cs2CO3, K2CO3 (Carlo 
Erba), KHCO3 (Carlo Erba), Bu4NOAc, NaOAc, CsOAc, KOAc, AgOAc (Fluka), K3PO4 
(Riedel-de Haën), KF, tBuOK, BnBu3NCl, Bu4NBr and BnEt3NCl, were commercially 
available and were used without further purification. 
PdCl2(MeCN)2 was prepared according to the literature.154  
 
 
 As regards Chapter 3: 
 
All air sensitive procedures were carried out using Schlenk techniques (high vacuum, liquid 
nitrogen trap on a standard in-house built dual line). When necessary a glove (dry) box was 
used (<0.5 ppm O2). Room temperature upper and lower limits are stated as 13-25 °C, but 
typically 21-23 °C was recorded. Commercial chemicals were purchased from Sigma-
Aldrich® and Alfa Aesar® and used directly unless otherwise stated in the text. TLC analysis 
was carried out on Merck TLC aluminium sheets (silica gel 60 F254) and visualized with UV 
light (at 254 nm), iodine vapour or an aqueous solution of potassium permanganate. Flash 
chromatography was run on silica gel 60 according to the method reported by W. C. Still et 
al.155 Melting points were recorded using a Stuart digital SMP3 machine and are uncorrected 
values. NMR spectra were obtained in the solvent indicated, using a JEOL ECX400 (400 
MHz and 101 MHz for 1H and 13C, respectively). Chemical shifts are reported in ppm and 
were referenced to the residual undeuterated solvent of the deuterated solvent used. Spectra 
were typically run at a temperature of 300 K. All 13C NMR spectra were obtained with 1H 
decoupling. NMR spectra were processed using MestrNova software (version 8.01). The 
spectra given below were saved as either .BMP or .PNG files in MestrNova and inserted 
directly into a Microsoft Word Document. For the 1H NMR spectra the resolution varies from 
0.15 to 0.5 Hz; the coupling constants have been quoted to ±0.5 Hz in all cases for 
consistency. 1H NMR chemical shifts are quoted to 2 decimal places; 13C NMR chemical 
shifts are quoted to 1 decimal place. Numbers were rounded to the nearest value, e.g. 1.237 ≈ 
1.24, 1.232 ≈ 1.23. 
MS spectra were measured using a Bruker Daltronics micrOTOF MS, Agilent series 1200LC 
with electrospray ionization (ESI and APCI) or on a Thermo LCQ using electrospray 
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ionization, with < 5 ppm error recorded for all HRMS samples. LIFDI mass spectrometry was 
carried out using a Waters GCT Premier MS Agilent 7890A GC (usually for analysis of 
organometallic compounds when ESI or APCI are not satisfactory ionization methods). Mass 
spectral data is quoted as the m/z ratio along with the relative peak height in brackets (base 
peak = 100). 
 
X-Ray crystallography. Diffraction data were collected at 110 K on a Bruker Smart Apex 
diffractometer with Mo-Kα radiation (λ = 0.71073 Å) using a SMART CCD camera. 
Diffractometer control, data collection and initial unit cell determination was performed using 
“SMART” (v5.625 Bruker-AXS). Frame integration and unit-cell refinement software was 
carried out with “SAINT+” (v6.22, Bruker AXS). Absorption corrections were applied by 
SADABS (v2.03, Sheldrick). Structures were solved by direct methods using SHELXS-97 
(Sheldrick, 1990) and refined by full-matrix least squares using SHELXL-97 (Sheldrick, 
1997). All non-hydrogen atoms were refined anisotropically. Hydrogen atoms were placed 
using a “riding model” and included in the refinement at calculated positions.  
 
DFT calculations. Gaussian 09156 was used to fully optimize all structures of Chapter 3 at the 
B3LYP level of density functional theory (DFT).157 The effective core potential of Hay and 
Wadt with a double-ξ valence basis set (LANL2DZ)158 was chosen to describe Cu and I. The 
6-31G(d) basis set was used for other atoms.159 Polarization functions for Cu (ξf = 3.525) and 
I (ξd = 0.289) were also added.160 This basis set combination will be referred to as BS1. 
Frequency calculations were carried out at the same level of theory as for structural 
optimization. IRC161 calculations were used to confirm the connectivity between transition 
structures and minima. Because recent studies have established that M06162 predicts the 
activation energies more accurately than B3LYP,163 we carried out single-point energy 
calculations for all the structures with a larger basis set (BS2) at the M06 level. BS2 utilizes 
the quadruple-ζ valence def2-QZVP164 basis set on Pt and the 6-311+G(2d,p) basis set on 
other atoms. The solvation energies were calculated using BS2 on optimized geometries with 
the CPCM solvation model using DMF as solvent.165 To estimate the corresponding Gibbs 
free energies, ΔG, the entropy corrections were calculated at the B3LYP/BS1 level, adjusted 
by the method proposed by Okuno166 and finally added to the M06/BS2 total energies. We 
have used the potential and Gibbs free energies obtained from the M06/BS2//B3LYP/BS1 
calculations in DMF unless otherwise stated. 
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1. General procedure for the screening of the reaction conditions for the 
Pd-catalyzed C-5 arylation of 1-methyl-1H-pyrazole (15) with 4-
bromotoluene (26a). 
 
 A mixture of 1-methyl-1H-pyrazole (15) (83 µL, 82 mg, 1.0 mmol), palladium catalyst 
(0.05 mmol), ligand (if any) (0.10 mmol), 4-bromotoluene (26a) (0.26 g, 1.5 mmol), base (2.0 
mmol) in the selected solvent (5 mL) was stirred under argon for 24 h at the temperature 
reported in Table 1-Table 3. After cooling to room temperature, the crude reaction mixture 
was diluted with AcOEt, naphthalene was added as internal standard, and the resulting 
mixture was analyzed by GLC and GLC-MS. Table 1-Table 3 summarize the results of this 
screening. 
 
1.1. 1-Methyl-5-(p-tolyl)-1H-pyrazole (21a) and 1-methyl-4,5-di-p-tolyl-1H-pyrazole 
(27a). 
 
 The crude reaction mixture was concentrated under reduced pressure and the residue 
was purified by flash chromatography on silica gel with a mixture of toluene and AcOEt 
(70:30 + 0.1 % Et3N) as eluent. Concentration of the first eluted chromatographic fractions 
allowed isolation of compound 27a (23 mg, 12 % yield, entry 9, Table 2) as a pale-yellow 
solid, m.p. 162–164 °C. 1H NMR (200 MHz, CDCl3): δ = 7.70 (s, 1H), 7.20 (m, 4H), 7.04 (m, 
4H), 3.79 (s, 3H), 2.41 (s, 3H), 2.28 (s, 3H) ppm. 13C NMR (50.3 MHz, CDCl3): δ = 139.7, 
138.5, 137.3, 135.4, 130.2, 129.9, 129.4, 129.0, 127.5, 127.1, 120.7, 31.2, 21.4, 21.0 ppm. MS 
(EI): m/z (%) = 263 (21), 262 (100), 261 (19), 247 (10), 232 (6), 202 (4), 189 (4), 130 (4). 
C18H18N2 (262.35): calcd. C 82.41, H 6.92, N 10.68; found C 82.84, H 6.89, N 10.73. 
 
 Concentration of the last eluted chromatographic fractions allowed isolation of 
compound 21a (89 mg, 52 %, entry 9, Table 2) as a light-yellow oil. 1H NMR (200 MHz, 
CDCl3): δ 7.49 (d, J = 1.9 Hz, 1H), 7.27 (m, 4H), 6.26 (d, J = 1.9 Hz, 1H), 3.87 (s, 3H), 2.39 
(s, 3H) ppm. 13C NMR (50.3 MHz, CDCl3) δ 143.4, 138.3, 138.2, 129.2 (2C), 128.5 (2C), 
127.7, 105.7, 37.4, 21.2 ppm. MS (EI): m/z (%) = 173 (13), 172 (100), 171 (33), 157 (9), 144 
(10), 130 (9), 128 (9), 115 (9). The spectral properties of this compound are in agreement with 
those previously reported.167 This compound was also obtained in isolated yield of 47 % from 
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the Pd-catalyzed reactions of 15 and 26a carried out at 110 °C (entry 12, Table 2) or in 58 % 
from the reaction at 70 °C (entry 17, Table 3). 
 
1.2. General procedure for the palladium-catalyzed direct 5-arylation of 1-methyl-
1H-pyrazole (15), oxazole (4), thiazole (8), and 1-methyl-1H-imidazole (12) with 
aryl bromides 26a–s. 
 
 Pd(OAc)2 (11.2 mg, 0.05 mmol), Bu4NOAc (0.60 g, 2.0 mmol), and aryl bromide 26 
(1.5 mmol), if a solid, were placed in a flame-dried reaction vessel. The reaction vessel was 
fitted with a silicon septum, evacuated, and back-filled with argon. This sequence was 
repeated twice. DMA (5 mL), aryl bromide 26 (1.5 mmol), if a liquid, and the appropriate 
azole 15, 4, 8, or 12 (1.0 mmol) were then added successively under a stream of argon by 
syringe at room temperature. The resulting mixture was stirred at 70 °C (for azoles 15, 4, and 
8) or at 110 °C (for azole 12) under argon for the period of time reported in Table 3. After 
cooling to room temperature, the reaction mixture was diluted with EtOAc, filtered through a 
plug of Celite, and eluted with additional EtOAc and CH2Cl2. The filtrate was concentrated 
under reduced pressure and the residue purified by flash chromatography on silica gel. This 
procedure was used to prepare compounds 21b-q, 30a-h, 31a-h, 32a-h and 32r-s (Table 4-
Table 6). 
 
1.2.1. 5-(4-Methoxyphenyl)-1-methyl-1H-pyrazole (21b). 
 
 The crude reaction product, which was obtained by Pd-catalyzed reaction of 15 with 
26b (entry 2, Table 4), was purified by flash chromatography on silica gel with a mixture of 
toluene and AcOEt (60:40 + 0.1% Et3N) as eluent to give 21b (0.11 g, 58 %) as a yellow oil. 
1H NMR (200 MHz, CDCl3): δ 7.48 (d, J = 1.9 Hz, 1H), 7.32 (m, 2H), 6.97 (m, 2H), 6.24 (d, 
J = 1.9 Hz, 1H), 3.85 (s, 3H), 3.83 (s, 3H) ppm. 13C NMR (50.3 MHz, CDCl3): δ 159.1, 
138.3, 133.0, 129.5 (2C), 127.1, 121.8, 113.9 (2C), 55.1, 32.1 ppm. MS (EI): m/z (%) = 189 
(13), 188 (100), 174 (7), 173 (61), 145 (10). The spectral properties of this compound are in 
agreement with those previously reported.59 
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1.2.2. 4-(1-Methyl-1H-pyrazol-5-yl)phenol (21c). 
 
 The crude reaction product, which was obtained by Pd-catalyzed reaction of 15 with 
26c (entry 3, Table 4), was purified by flash chromatography on silica gel with a mixture of 
toluene and AcOEt (1:1) as eluent to give 21c (48 mg g, 28 %) as a white solid, m.p. 180-184 
°C. 1H NMR (200 MHz, CDCl3): δ 8.75 (br, 1H), 7.57 (d, J = 1.8 Hz, 1H), 7.28 (m, J = 8.4 
Hz, 2H), 6.98 (m, J = 8.4 Hz, 2H), 6.29 (d, J = 1.8 Hz, 1H), 3.89 (s, 3H) ppm. 1H NMR (200 
MHz, CD3OD/CDCl3): δ 7.47 (d, J = 1.8 Hz, 1H) 7.25 (d, J = 8.4 Hz, 2H), 6.92 (d, J = 8.4 
Hz, 2H), 6.24 (d, J = 1.8 Hz, 1H), 3.84 (s, 3H). 13C NMR (50.3 MHz, CD3OD/CDCl3): δ 
157.3, 144.0, 138.1, 129.9 (2C), 121.3, 115.4 (2C), 105.4, 36.9. MS (EI): m/z (%) = 175 (12), 
174 (100), 173 (25), 131 (11), 119 (12). C10H10N2O (174.20): calcd. C 68.95, H 5.79, N 
16.08; found C 69.01, H 3.90, N 12.29. 
 
1.2.3. 1-Methyl-5-(4-nitrophenyl)-1H-pyrazole (21e). 
 
The crude reaction product, which was obtained by Pd-catalyzed reaction of 15 with 26e 
(entry 5, Table 4), was purified by flash chromatography on silica gel with a mixture of 
CH2Cl2 and acetone (98:2) as eluent to give 21e (0.20 g, 46 %) as a yellow solid, m.p. 75-
77°C. 1H NMR (200 MHz, CDCl3): δ 8.33 (m, 2H), 7.65 (m, 2H), 7.57 (d, J = 1.9 Hz, 1H), 
6.47 (d, J = 1.9 Hz, 1H), 3.98 (s, 3H) ppm. 13C NMR (50.3 MHz, CDCl3): δ 147.6, 141.4, 
139.0, 136.9, 129.4 (2C), 124.0 (2C), 107.4, 38.0 ppm. MS (EI): m/z (%) = 204 (12), 203 
(100), 173 (20), 103 (11), 89 (10). The physical and spectral properties of this compound are 
in agreement with those previously reported.59 
 
1.2.4. 5-[4-(Trifluoromethyl)phenyl]-1-methyl-1H-pyrazole (21f). 
 
 The crude reaction product, which was obtained by Pd-catalyzed reaction of 15 with 26f 
(entry 6, Table 4), was purified by flash chromatography on silica gel with a mixture of 
toluene and AcOEt (85:15 + 0.1% Et3N) as eluent to give 21f (68 mg, 30 %) as a pale-yellow 
oil. 1H NMR (200 MHz, CDCl3): δ 7.72 (m, 2H), 7.55 (m, 2H), 7.54 (d, J = 1.9 Hz, 1H), 6.37 
(d, J = 1.9 Hz, 1H), 3.92 (s, 3H) ppm. 13C NMR (50.3 MHz, CDCl3): δ 142.0, 138.7, 134.3, 
130.1, 129.0 (2C), 125.6 (q, J = 3.7 Hz, 2C), 123.9 (q, J = 272 Hz, CF3), 106.6, 37.6 ppm. 
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MS (EI): m/z (%) = 227 (13), 226 (100), 225 (47), 207 (9), 198 (9). C11H9F3N2 (226.20): 
calcd. C 58.41, H 4.01, N 12.38; found C 58.35, H 3.99, N 12.42. 
 
1.2.5. Ethyl 4-(1-methyl-1H-pyrazol-5-yl)benzoate (21g). 
 
 The crude reaction product, which was obtained by Pd-catalyzed reaction of 15 with 
26g (entry 7, Table 4), was purified by flash chromatography on silica gel with a mixture of 
toluene and AcOEt (80:20) as eluent to give 21g (95 mg, 41 %) as a yellow oil. 1H NMR (200 
MHz, CDCl3): δ 8.13 (m, 2H), 7.53 (d, J = 1.6 Hz, 1H), 7.51 (m, 2H), 6.38 (d, J = 1.6 Hz, 
1H), 4.41 (q, J = 7.2 Hz, 2H), 3.92 (s, 3H), 1.42 (t, J = 7.2 Hz, 3H) ppm. 13C NMR (50.3 
MHz, CDCl3): δ 165.9, 142.4, 138.6, 134.8, 130.2, 129.8 (2C), 128.4 (2C), 106.5, 61.1, 37.7, 
14.3 ppm. MS (EI): m/z (%) = 231 (11), 230 (78), 202 (24), 186 (16), 185 (100). C13H14N2O2 
(230.27): calcd. C 67.81, H 6.13, N 12.17; found C 67.89, H 6.11, N 12.21. 
 
1.2.6. 1-Methyl-5-(o-tolyl)-1H-pyrazole (21h). 
 
 The crude reaction product, which was obtained by Pd-catalyzed reaction of 15 with 
26h (entry 8, Table 4), was purified by flash chromatography on silica gel with a mixture of 
toluene and AcOEt (70:30 + 0.1% Et3N) as eluent to give 21h (80 mg, 47 %) as a pale-yellow 
oil. 1H NMR (200 MHz, CDCl3): δ 7.53 (d, J = 1.9 Hz, 1H), 7.28 (m, 4H), 6.19 (d, J = 1.9 Hz, 
1H), 3.65 (s, 3H), 2.16 (s, 3H) ppm. 13C NMR (50.3 MHz, CDCl3): δ 142.3, 138.2, 137.4, 
130.4, 130.1 (2C), 128.9, 125.6, 106.2, 36.5, 19.8 ppm. MS (EI): m/z (%) = 172 (100), 171 
(57), 144 (70), 128 (16), 115 (20). C11H12N2 (172.23): calcd. C 76.71, H 7.02, N 16.27; found 
C 76.65, H 7.06, N 16.22. 
 
1.2.7. 5-(2-Chlorophenyl)-1-methyl-1H-pyrazole (21i). 
 
 The crude reaction product, which was obtained by Pd-catalyzed reaction of 15 with 26i 
(entry 9, Table 4), was purified by flash chromatography on silica gel with a mixture of 
toluene and AcOEt (90:10 + 0.1 % Et3N) as eluent to give 21i (82 mg, 42 %) as a pale-yellow 
oil. 1H NMR (200 MHz, CDCl3): δ 7.54 (d, J = 1.9 Hz, 1H), 7.34 (m, 5H), 6.27 (d, J = 1.9 Hz, 
1H), 3.72 (s, 3H) ppm. 13C NMR (50.3 MHz, CDCl3): δ 140.2, 138.2, 134.2, 131.8, 130.3, 
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129.94, 129.71, 126.7, 106.9, 36.9 ppm. MS (EI): m/z (%) = 194 (32), 193 (23), 192 (100), 
191 (33), 156 (12). C10H9ClN2 (192.65): calcd. C 62.35, H 4.71, N 14.54; found C 62.40, H 
4.69, N 14.59. 
 
1.2.8. 1-Methyl-5-(1-naphthyl)-1H-pyrazole (21k). 
 
 The crude reaction product, which was obtained by Pd-catalyzed reaction of 15 with 
26k (entry 11, Table 4), was purified by flash chromatography on silica gel with a mixture of 
toluene and AcOEt (80:20 + 0.1 % of Et3N) as eluent to give 21k (0.11 g, 50 %) as a pale-
yellow solid, m.p. 87-90 °C. 1H NMR (200 MHz, CDCl3): δ 7.88 (m, 2H), 7.63 (d, J = 1.8 Hz, 
1H), 7.47 (m, 5H), 6.34 (d, J = 1.8 Hz, 1H), 3.61 (s, 3H) ppm. 13C NMR (50.3 MHz, CDCl3): 
δ 141.2, 138.4, 133.4, 132.00, 129.2, 128.3, 128.2, 128.1, 126.7, 126.1, 125.2, 124.9, 107.5, 
36.9 ppm. MS (EI): m/z (%) = 209 (16), 208 (100), 207 (40), 180 (23), 153 (27). The spectral 
properties of this compound are in agreement with those previously reported.59 
 
1.2.9. 3-(1-Methyl-1H-pyrazol-5-yl)pyridine (21n). 
 
 The crude reaction product, which was obtained by Pd-catalyzed reaction of 15 with 
26n (entry 14, Table 4), was purified by flash chromatography on silica gel with a mixture of 
AcOEt and MeOH (90:10) as eluent to give 21n (53 mg, 33 %) as a brown oil. 1H NMR (200 
MHz, CDCl3): δ 8.71-8.65 (m, 2H), 7.79-7.74 (m, 1H), 7.55 (d, J = 1.6 Hz, 1H), 7.46-7.39 
(m, 1H), 6.38 (d, J = 1.8 Hz, 1H), 3.91 (s, 3H). 13C NMR (50.3 MHz, CDCl3): δ 149.8, 149.0, 
141.1, 137.9 136.5, 122.6, 122.1, 106.3, 39.2 ppm. MS (EI): m/z (%) = 160 (11), 159 (100), 
158 (20), 131 (51), 104 (12). The spectral properties of this compound are in agreement with 
those previously reported.168 
 
1.2.10. 1-Methyl-5-(5-methylthiophen-2-yl)-1H-pyrazole (26q) 
 
 The crude reaction product, which was obtained by Pd-catalyzed reaction of 15 with 
26q (entry 17, Table 4), was purified by flash chromatography on silica gel with a mixture of 
AcOEt and MeOH (90:10) as eluent to give 21q (19.5 mg, 11 %) as a brown oil. 1H NMR 
(200 MHz, CDCl3): δ 7.45 (d, J = 1.8 Hz, 1H), 6.95 (d, J = 3.6 Hz, 1H), 6.77 (dq, J1 = 3.4 Hz, 
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J2 = 1 Hz, 1H), 6.33 (d, J = 2.2 Hz, 1H), 3.96 (s, 3H), 2.52 (d, J = 1 Hz, 3H) ppm. 13C NMR 
(50.3 MHz, CDCl3): δ 141.3, 138.4, 136.9, 129.0, 126.8, 125.8, 106.4, 37.8, 15.3 ppm.  MS-
(EI): m/z (%) = 179 (13), 178 (100), 177 (49), 163 (8), 145 (8). 
 
1.2.11. 5-(p-Tolyl)oxazole (30a). 
 
 The crude reaction product, which was obtained by Pd-catalyzed reaction of 4 with 26a 
(entry 1, Table 5), was purified by flash chromatography on silica gel with a mixture of 
toluene and AcOEt (90:10) as eluent to give 30a (92 mg, 58 %) as a yellow solid, m.p. 38-41 
°C. 1H NMR (200 MHz, CDCl3): δ 7.88 (s, 1H), 7.51 (m, 2H), 7.28 (s, 1H), 7.19 (m, 2H), 
2.35 (s, 3H) ppm. 13C NMR (50.3 MHz, CDCl3): δ 151.7, 150.2, 138.7, 129.5 (2C), 124.9, 
124.3 (2C), 120.6, 21.4 ppm. MS (EI): m/z (%) = 159 (100), 131 (26), 130 (38), 104 (34), 103 
(21), 91 (21). The spectral properties of this compound are in agreement with those previously 
reported.169 
 
1.2.12. 5-(4-Methoxyphenyl)oxazole (30b). 
 
 The crude reaction product, which was obtained by Pd-catalyzed reaction of 4 with 26b 
(entry 2, Table 5), was purified by flash chromatography on silica gel with a mixture of 
toluene and AcOEt (80:20) as eluent to give 30b (85 mg, 49 %) as a yellow solid, m.p. 45-48 
°C. 1H NMR (200 MHz, CDCl3): δ 7.89 (s, 1H), 7.57 (m, 2H), 7.23 (s, 1H), 6.94 (m, 2H), 
3.82 (s, 3H) ppm. 13C NMR (50.3 MHz, CDCl3): δ 159.7, 151.4, 149.7, 125.8 (2C), 120.5, 
119.9, 114.2 (2C), 55.3 ppm. MS (EI): m/z (%) = 176 (11), 175 (100), 160 (37), 132 (27), 77 
(22). The spectral properties of this compound are in agreement with those previously 
reported.33 
 
1.2.13. 4-(Oxazol-5-yl)phenol (30c). 
 
 The crude reaction product, which was obtained by Pd-catalyzed reaction of 4 with 26c 
(entry 3, Table 5), was purified by flash chromatography on silica gel with a mixture of 
toluene and THF (80:20) as eluent to give 30c (58 mg, 36 %) as a colorless solid, m.p. 229-
230 °C. 1H NMR (200 MHz, [D6]DMSO): δ 9.85 (s, OH), 8.35 (s, 1H), 7.56 (m, 2H), 7.47 (s, 
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1H), 6.89 (m, 2H) ppm. 13C NMR (50.3 MHz, [D6]DMSO): δ 157.6, 150.8, 150.6, 125.6 
(2C), 119.4, 118.5, 115.6 (2C) ppm. MS (EI): m/z (%) = 161 (100), 133 (20), 121 (19), 106 
(30), 105 (29). C9H7NO2 (161.16): calcd. C 67.07, H 4.38, N 8.69; found C 66.91, H 4.40, N 
8.62. 
 
1.2.14. 5-(4-Nitrophenyl)oxazole (30e). 
 
 The crude reaction product, which was obtained by Pd-catalyzed reaction of 4 with 26e 
(entry 4, Table 5) was purified by flash chromatography on silica gel with a mixture of 
toluene and AcOEt (80:20) as eluent to give 30e (0.11 g, 57 %) as a yellow solid, m.p. 135-
137 °C. 1H NMR (200 MHz, CDCl3): δ 8.31 (m, 2H), 8.06 (s, 1H), 7.84 (m, 2H), 7.59 (s, 1H) 
ppm. 13C NMR (50.3 MHz, CDCl3): δ 151.9, 149.5, 147.4, 133.4, 124.9 (2C), 124.7, 124.5 
(2C) ppm. MS (EI): m/z (%) = 190 (100), 160 (43), 132 (25), 89 (91), 63 (21). The spectral 
properties of this compound are in agreement with those previously reported.170 
 
1.2.15. 5-(o-Tolyl)oxazole (30h). 
 The crude reaction product, which was obtained by Pd-catalyzed reaction of 4 with 26h 
(entry 5, Table 5), was purified by flash chromatography on silica gel with a mixture of 
toluene and AcOEt (90:10) as eluent to give 30h (0.11 g, 72 %) as a pale-yellow oil. 1H NMR 
(200 MHz, CDCl3): δ 7.96 (s, 1H), 7.67 (m, 1H), 7.27 (m, 4H), 2.48 (s, 3H) ppm. 13C NMR 
(50.3 MHz, CDCl3): δ 150.8, 150.1, 134.9, 131.0, 128.5, 127.0, 126.9, 126.1, 124.1, 21.7 
ppm. MS (EI): m/z (%) = 159 (100), 132 (35), 131 (44), 130 (49), 104 (36). The spectral 
properties of this compound are in agreement with those previously reported.33 
 
1.2.16. 5-(p-Tolyl)thiazole (31a). 
 
 The crude reaction product, which was obtained by Pd-catalyzed reaction of 8 with 26a 
(entry 6, Table 5), was purified by flash chromatography on silica gel with a mixture of 
toluene and AcOEt (90:10 + 0.1 % Et3N) as eluent to give 31a (0.11 g, 65 %) as a pale-
yellow solid, m.p. 82-84 °C. 1H NMR (200 MHz, CDCl3): δ 8.69 (s, 1H), 8.02 (s, 1H), 7.44 
(m, 2H), 7.18 (m, 2H), 2.35 (s, 3H) ppm. 13C NMR (50.3 MHz, CDCl3): δ 151.4, 139.3, 
138.4, 138.3, 129.6 (2C), 128.1, 126.7 (2C), 21.2 ppm. MS (EI): m/z (%) = 176 (12), 175 
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(100), 148 (32), 147 (43), 115 (17). The spectral properties of this compound are in agreement 
with those previously reported.171 
 
1.2.17. 5-(4-Methoxyphenyl)thiazole (31b). 
 
 The crude reaction product, which was obtained by Pd-catalyzed reaction of 8 with 26b 
(entry 7, Table 5), was purified by flash chromatography on silica gel with a mixture of 
toluene and AcOEt (92:8) as eluent to give 31b (0.13 g, 67 %) as a bright-yellow solid, m.p. 
89-92 °C. 1H NMR (200 MHz, CDCl3): δ 8.68 (s, 1H), 7.97 (s, 1H), 7.48 (m, 2H), 6.92 (m, 
2H), 3.82 (s, 3H) ppm. 13C NMR (50.3 MHz, CDCl3): δ 159.8, 151.2, 139.2, 138.0, 128.2 
(2C), 123.6, 114.5 (2C), 55.4 ppm. MS (EI): m/z (%) = 191 (100), 176 (58), 149 (20), 148 
(27), 121 (20). The spectral properties of this compound are in agreement with those 
previously reported.47 
 
1.2.18. 4-(Thiazol-5-yl)phenol (31c). 
 
 The crude reaction product, which was obtained by Pd-catalyzed reaction of 8 with 26c 
(entry 8, Table 5), was purified by flash chromatography on silica gel with a mixture of 
toluene and AcOEt (60:40) as eluent to give 31c (29 mg, 17 %) as a yellow solid, 205-210 °C. 
1H NMR (200 MHz, CD3OD): δ 8.85 (s, 1H), 7.99 (s, 1H), 7.48 (m, 2H), 6.84 (m, 2H) ppm. 
13C NMR (50.3 MHz, CDCl3): δ 159.3, 153.1, 141.1, 138.0, 129.3 (2C), 123.3, 117.0 (2C) 
ppm. MS (EI): m/z (%) = 178 (13), 177 (100), 150 (37), 121 (23), 77 (10). The spectral 
properties of this compound are in agreement with those previously reported.172 
 
1.2.19. 5-(4-Nitrophenyl)thiazole (31e). 
 
 The crude reaction product, which was obtained by Pd-catalyzed reaction of 8 with 26e 
(entry 9, Table 5), was purified by flash chromatography on silica gel with a mixture of 
toluene and AcOEt (80:20) as eluent to give 31e (0.14 g, 70 %) as a yellow solid, m.p. 139-
141 °C. 1H NMR (200 MHz, CDCl3): δ 8.93 (s, 1H), 8.29 (m, 2H), 8.26 (s, 1H), 7.76 (m, 2H) 
ppm. 13C NMR (50.3, CDCl3): δ 154.2, 147.4, 141.1, 137.4, 127.4 (2C), 126.2, 124.5 (2C) 
ppm. MS (EI): m/z (%) = 206 (100), 176 (26), 148 (20), 133 (27), 89 (53). C9H6N2O2S 
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(206.22): calcd. C 52.42, H 2.93, N 13.58; found C 52.35, H 2.95, N 13.63. 
1.2.20. 5-(o-Tolyl)thiazole (31h). 
 
 The crude reaction product, which was obtained by Pd-catalyzed reaction of 8 with 26h 
(entry 10, Table 5), was purified by flash chromatography on silica gel with a mixture of 
toluene and AcOEt (90:10) as eluent to give 31h (0.10 g, 59 %) as a pale-yellow oil. 1H NMR 
(200 MHz, CDCl3): δ 8.79 (s, 1H), 7.84 (s, 1H), 7.27 (m, 4H), 2.37 (s, 3H) ppm. 13C NMR 
(50.3 MHz, CDCl3): δ 152.5, 141.5, 137.3, 136.3, 130.7, 130.6, 130.1, 128.5, 126.0, 21.0 
ppm. MS (EI): m/z (%) = 176 (12), 175 (95), 148 (49), 147 (100), 115 (52). C10H9NS 
(175.25): calcd. C 68.53, H 5.18, N 7.99; found C 68.59, H 5.15, N 8.06. 
 
1.2.21. 4-(Thiazol-5-yl)benzonitrile (31s). 
 
 The crude reaction product, which was obtained by Pd-catalyzed reaction of 8 with 26s 
(Table 10), was purified by flash chromatography on silica gel with a mixture of toluene and 
AcOEt (90:10) as eluent to give 31s (113 mg, 61 %) as a yellow solid, m.p. 101-102 °C [Lit. 
102 °C].47 1H NMR (200 MHz, CDCl3): δ 8.86 (s, 1H), 8.19 (s, 1H), 7.70 (m, 4H) ppm. 13C 
NMR (50.3 MHz, CDCl3): δ 153.7, 140.5, 137.2, 132.7, 135.3, 127.1, 118.2, 111.6 ppm. MS 
(EI): m/z (%) = 187 (%), 186 (100), 160 (10), 115 (10), 114 (12). The spectral properties of 
this compound are in agreement with those previously reported.46 
 
1.2.22. 1-Methyl-5-(p-tolyl)-1H-imidazole (32a). 
 
 The crude reaction product, which was obtained by Pd-catalyzed reaction of 12 with 
26a (entry 1, Table 6), was purified by flash chromatography on silica gel with a mixture of 
CH2Cl2 and MeOH (96:4) as eluent to give 32a (0.14 g, 81 %) as a yellow oil. 1H NMR (200 
MHz, CDCl3): δ 7.49 (s, 1H), 7.26 (m, 2H), 7.25 (m, 2H), 7.07 (s, 1H), 3.63 (s, 3H), 2.39 (s, 
3H) ppm. 13C NMR (50.3 MHz, CDCl3): δ 138.7, 137.6, 133.3, 129.3 (2C), 128.3 (2C), 127.6, 
126.7, 32.4, 21.2 ppm. MS (EI): m/z (%) = 173 (13), 172 (100), 171 (17), 144 (14), 130 (16). 
The spectral properties of this compound are in agreement with those previously reported.51 
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1.2.23. 5-(4-Methoxyphenyl)-1-methyl-1H-imidazole (32b). 
 
 The crude reaction product, which was obtained by Pd-catalyzed reaction of 12 with 
26b (entry 2, Table 6), was purified by flash chromatography on silica gel with a mixture of 
CH2Cl2 and MeOH (96:4) as eluent to give 32b (0.15 g, 82 %) as a light-yellow solid, m.p. 
73-75 °C. 1H NMR (200 MHz, CDCl3): δ 7.48 (s, 1H), 7.30 (m, 2H), 7.02 (s, 1H), 6.96 (m, 
2H), 3.83 (s, 3H), 3.61 (s, 3H) ppm. 13C NMR (50.3 MHz, CDCl3): δ 159.1, 138.3, 132.3, 
129.6 (2C), 127.1, 121.8, 113.9 (2C), 55.1, 32.1 ppm. MS (EI): m/z (%) = 189 (12), 188 
(100), 174 (10), 173 (82), 145 (17). The spectral properties of this compound are in agreement 
with those previously reported.50c 
 
1.2.24. 1-Methyl-5-(4-nitrophenyl)-1H-imidazole (32e). 
 
 The crude reaction product, which was obtained by Pd-catalyzed reaction of 12 with 
26e (entry 4, Table 6), was purified by flash chromatography on silica gel with a mixture of 
CH2Cl2 and MeOH (96:4) as eluent to give 32e (92 mg, 45 %) as a yellow-orange solid, m.p. 
169-171 °C. 1H NMR (200 MHz, CDCl3): δ 8.30 (m, 2H), 7.63 (s, 1H), 7.61 (m, 2H), 7.28 (s, 
1H), 3.81 (s, 3H) ppm. 13C NMR (50.3 MHz, CDCl3): δ 146.7, 140.1, 136.2, 131.3, 130.2, 
128.1 (2C), 124.1 (2C), 33.1 ppm. MS (EI): m/z (%) = 203 (100), 173 (19), 130 (17), 103 
(16), 89 (32). The spectral properties of this compound are in agreement with those previously 
reported.173 
 
1.2.25. 1-Methyl-5-(o-tolyl)-1H-imidazole (32h). 
 
 The crude reaction product, which was obtained by Pd-catalyzed reaction of 12 with 
26h (entry 5, Table 6), was purified by flash chromatography on silica gel with a mixture of 
CH2Cl2 and MeOH (98:2) as eluent to give 32h (0.12 g, 68 %) as a light-brown oil. 1H NMR 
(200 MHz, CDCl3): δ 7.55 (s, 1H), 7.27 (m, 4H), 6.97 (s, 1H), 3.42 (s, 3H), 2.19 (s, 3H) ppm. 
13C NMR (50.3 MHz, CDCl3): δ 138.0, 137.8, 131.9, 131.0, 130.1, 129.0, 128.7 (2C), 127.9, 
125.6 (2C), 31.6, 20.0 ppm. MS (EI): m/z (%) = 172 (100), 171 (24), 144 (50), 131 (24), 130 
(62). C11H12N2 (172.23): calcd. C 76.71, H 7.02, N 16.27; found C 76.77, H 6.99, N 16.24. 
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1.2.26. 1-Methyl-5-phenyl-1H-imidazole (32r). 
 
 The crude reaction product, which was obtained by Pd-catalyzed reaction of 12 with 
26r (entry 6, Table 6), was purified by flash chromatography on silica gel with a mixture of 
CH2Cl2 and MeOH (96:4) as eluent to give 32r (0.12 g, 75 %) as a pale-yellow oil. 1H NMR 
(200 MHz, CDCl3): δ = 7.42 (s, 1H), 7.32 (m, 5H), 7.01 (s, 1H), 3.58 (s, 3H) ppm. 13C NMR 
(50.3 MHz, CDCl3): δ = 139.1, 128.8, 128.7 (2C), 128.5 (2C), 128.1, 127.9, 127.0, 32.5 ppm. 
MS (EI): m/z (%) = 158 (100), 130 (17), 116 (13), 103 (12), 89 (12). The spectral properties 
of this compound are in agreement with those previously reported.50c 
 
1.2.27. 4-(1-Methyl-1H-imidazol-5-yl)benzonitrile (32s). 
 
 The crude reaction product, which was obtained by Pd-catalyzed reaction of 12 with 26s 
(entry 7, Table 6), was purified by flash chromatography on silica gel with a mixture of 
CH2Cl2 and MeOH (96:4) as eluent to give 32s (0.13 g, 69 %) as a light-yellow solid, m.p. 
148-151 °C. 1H NMR (200 MHz, CDCl3): δ = 7.73 (m, 2H), 7.59 (s, 1H), 7.53 (m, 2H), 7.22 
(s, 1H), 3.75 (s, 3H) ppm. 13C NMR (50.3 MHz, CDCl3): δ = 140.5, 134.3, 132.5 (2C), 131.6, 
129.8, 128.3 (2C), 118.5, 111.2, 33.0 ppm. MS (EI): m/z (%) = 159 (12), 158 (100), 130 (16), 
116 (13), 103 (13), 89 (12). The spectral properties of this compound are in agreement with 
those previously reported.51 
 
 
2. General procedure for the screening of the reaction conditions for the 
Pd-catalyzed C-5 arylation of 1-phenyl-1H-pyrazole (23) with 4-
bromotoluene (26a). 
 
 A mixture of 1-phenyl-1H-pyrazole (23) (0.13 mL, 0,14 g, 1.0 mmol), palladium 
catalyst (0.05 mmol), ligand (if any) (0.10 mmol) 4-bromotoluene (26a) (0.26 g, 1.5 mmol), 
base (2.0 mmol), pivalic acid (if any) (34 µL, 31 mg, 0.3 mmol), phase transfer agent (if any) 
(0.2 mmol) in the selected solvent (5 mL) was stirred under argon for 24 h at the temperature 
reported in Table 7-Table 9. After cooling to room temperature, the crude reaction mixture 
was diluted with AcOEt, naphthalene was added as internal standard, and the resulting 
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mixture was analyzed by GLC and GLC-MS. Table 7-Table 9 summarize the results of this 
screening. 
 
2.1. 1-Phenyl-5-(p-tolyl)-1H-pyrazole (36a), 1-(4'-methyl-[1,1'-biphenyl]-2-yl)-1H-
pyrazole (37a) and 1-(4'-methyl-[1,1'-biphenyl]-2-yl)-5-(p-tolyl)-1H-pyrazole 
(38a). 
 
 The crude reaction mixture was concentrated under reduced pressure and the residue 
was purified by a first flash chromatography on silica gel with a mixture of toluene and 
AcOEt (95:5) as eluent. Then, after the concentration from the forth to the fifth eluted 
chromatographic fractions, these were newly purified by a second flash chromatography on 
silica gel with a mixture of petroleum ether and THF (95:5) as eluent. Concentration of the 
first eluted chromatographic fractions allowed isolation of compound 37a as a pale-yellow 
oil. 1H NMR (200 MHz, CDCl3): δ 7.64 (d, J = 2 Hz, 1H), 7.62-7.57 (m, 1H), 7.46-7.44 (m, 
3H), 7.11-7.08 (m, 3H), 7.01-6.97 (m, 2H), 6.20 (t, J = 2 Hz, 1H), 2.34 (s, 3H) ppm. 13C 
NMR (50.3 MHz, CDCl3): δ 140.4, 138.7, 137.4, 136.8, 135.7, 131.5, 131.2, 129.4, 128.5, 
128.4, 128.3, 126.7, 106.5, 21.4 ppm. MS (EI): m/z (%) = 234 (35), 233 (100), 218 (6), 191 
(6), 165 (7), 116 (7). The spectral properties of this compound are in agreement with those 
previously reported.174 
 
 Concentration of the second eluted chromatographic fractions allowed isolation of 
compound 36a (90 mg, 38 %, entry 13, Table 9) as a light-yellow oil. 1H NMR (200 MHz, 
CDCl3): δ 7.71 (d, J = 2 Hz, 1H), 7.40-7.22 (m, 5H), 7.15-7.02 (m, 4H) 6.47 (d, J = 2 Hz, 1H) 
2.33 (s, 3H) ppm. 13C NMR (50.3 MHz, CDCl3): δ 143.0, 140.2, 138.0, 129.1, 128.8, 128.6, 
127.7, 127.3, 125.2, 107.6, 21.3 ppm (11 of 12 carbons were observed). MS (EI): m/z (%) = 
235 (18), 234 (100), 233 (68), 219 (10), 77 (13). The spectral properties of this compound are 
in agreement with those previously reported.175 This compound was also obtained in isolated 
yield of 22 % from the Pd-catalyzed reactions of 23 and 26a carried out at 140 °C (entry 5, 
Table 7) or in 21 %, 27 % and 29 % from the reactions at 110 °C (entry 13, Table 8 and 
entries 4 and 9,Table 9). 
 
 Concentration of the third eluted chromatographic fractions allowed isolation of 
compound 38a as a light-pink solid, m.p. 115-120 °C. 1H NMR (200 MHz, CDCl3): δ 7.71-
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7.61 (m, 2H), 7.51-7.39 (m, 2H), 7.32-7.27 (m, 1H), 6.85 (d, J = 7.2 Hz, 4H), 6.51 (dd, J = 
8.4 Hz, 4H), 6.25 (d, J = 1.8 Hz, 1H), 2.27 (s, 3H), 2.26 (s, 3H) ppm. 13C NMR (50.3 MHz, 
CDCl3) δ: 139.3, 139.0, 138.0, 136.8, 135.1, 130.7, 129.5, 129.3, 128.7, 128.0, 127.7, 106.1, 
29.9, 21.3 ppm. MS (EI): m/z (%) = 325 (14), 324 (65), 323 (100), 234 (18), 233 (98). 
C23H20N2 (324.42): calcd. C 85.15, H 6.21, N 8.63; found C 84.98, H 6.32, N 8.70. 
 
2.2. Preparation of PdCl(C3H5)dppb catalyst. 
 
 A 50 mL double-necked round-bottom flask, equipped with a magnetic bar, was 
charged with 25 mL of distilled water in which argon was bubbled. After this time, the flask 
was opened under argon flow; PdCl2 (0,18, 1 mmol) and KCl (0.15 g, 2 mmol) were added in 
turn; and the flask was sealed with a rubber septum. The mixture was allowed to stir for 1 h, 
and an excess of allyl chloride (3-chloroprop-1-ene) (0.25 mL, 0.23 g, 3 mmol) was then 
injected through the septum. The mixture was allowed to stir for 24 h. After this time, the 
reaction mixture was extracted with three portions of chloroform (3 x 30 mL), and the organic 
layers were gathered, dried over MgSO4, filtered, and reduced to yield the intermediate 
product [Pd(C3H5)Cl]2 as a crystalline yellow solid.176 An oven dried 50 mL Schlenk tube 
equipped with a magnetic stirring bar under argon atmosphere was then charged with 
[Pd(C3H5)Cl]2 (0.12 mg, 0.33 mmol) and dppb (0.28 g, 0.66 mmol). 7 mL of anhydrous 
CH2Cl2 were added, then the solution was stirred at room temperature for 20 minutes. The 
solvent was removed under vacuum. The yellow product [PdCl(C3H5)dppb] was used without 
purification.177 
 
 
3. One-pot synthesis of Balsoxin (39a) and Texaline (39b). 
 
3.1. 5-(3,4-Dimethoxyphenyl)-2-phenyloxazole (Balsoxin, 39a). 
 
 Pd(OAc)2 (11.2 mg, 0.05 mmol) and Bu4NOAc (0.60 g, 2.0 mmol) were added to a 
flame-dried reaction vessel. The reaction vessel was fitted with a silicone septum, evacuated, 
and back-filled with argon. This sequence was repeated twice. DMA (5 mL), 4-bromo-1,2-
dimethoxy-benzene (26t) (0.14 mL, 0.22 g, 1.0 mmol), and oxazole (4) (72 mL, 76 mg, 1.1 
mmol) were then added successively under a stream of argon by syringe at room temperature. 
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The resulting mixture was stirred at 70 °C under argon for 24 h. CuI (0.38 g, 2.0 mmol) and 
bromobenzene (26r) (0.16 mL, 0.24 g, 1.5 mmol) were then sequentially added to the 
resulting deep-orange solution under a stream of argon. The reaction mixture was heated to 
110 °C and stirred at this temperature for 8 h. After cooling to room temperature, the reaction 
mixture was diluted with AcOEt and poured into a saturated aqueous NH4Cl solution. The 
resulting mixture was basified with a few drops of aqueous NH4OH, stirred in the open air for 
0.5 h, and then extracted with AcOEt. The organic extract was washed with water, dried, and 
concentrated under reduced pressure, and the residue was purified by flash chromatography 
on silica gel with a mixture of toluene and AcOEt (70:30) as eluent. The chromatographic 
fractions containing the required compound were collected and concentrated to give 39a (0.11 
g, 39 %) as a light-yellow solid, m.p. 97–98 °C. 1H NMR (200 MHz, CDCl3): δ 8.11 (m, 2H), 
7.49 (m, 3H), 7.35 (s, 1H), 7.30 (dd, J = 1.9, 8.4 Hz, 1H), 7.20 (d, J = 1.9 Hz, 1H), 6.95 (d, J 
= 8.4 Hz, 1H), 3.99 (s, 3H), 3.94 (s, 3H) ppm. 13C NMR (50.3 MHz, CDCl3): δ 160.5, 151.1, 
149.3, 149.2, 130.1, 128.7, 127.4, 126.1, 122.1, 121.0, 117.2, 111.4, 107.3, 55.99, 55.95 ppm. 
MS (EI): m/z (%) = 282 (20), 281 (100), 266 (23), 238 (11), 107 (11). The spectral properties 
of this compound are in agreement with those previously reported.81b 
 
3.2. 5-(Benzo[d][1,3]dioxol-5-yl)-2-(pyridin-3-yl)oxazole (Texaline, 39b). 
 
 Pd(OAc)2 (11.2 mg, 0.05 mmol) and Bu4NOAc (0.60 g, 2.0 mmol) were added to a 
flame-dried reaction vessel. The reaction vessel was fitted with a silicon septum, evacuated, 
and back-filled with argon. This sequence was repeated twice. DMA (5 mL), 5-bromo- 
benzo[d][1,3]dioxole (26u) (0.12 mL, 0.20 g, 1.0 mmol), and oxazole (4) (72 mL, 76 mg, 1.1 
mmol) were then added successively under a stream of argon by syringe at room temperature. 
The resulting mixture was stirred at 70 °C under argon for 48 h. CuI (0.38 g, 2.0 mmol) and 
3-bromopyridine (26n) (0.15 mL, 0.24 g, 1.5 mmol) were then sequentially added to the 
resulting brown solution under a stream of argon. The reaction mixture was heated to 110 °C 
and stirred at this temperature for 24 h. After cooling to room temperature, the reaction 
mixture was diluted with AcOEt and poured into a saturated aqueous NH4Cl solution. The 
resulting mixture was basified with a few drops of aqueous NH4OH, stirred in the open air for 
0.5 h, and then extracted with AcOEt. The organic extract was washed with water, dried, and 
concentrated under reduced pressure, and the residue was purified by flash chromatography 
on silica gel with a mixture of toluene and AcOEt (50:50) as eluent. The chromatographic 
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fractions containing the required compound were collected and concentrated to give 39b (0.10 
g, 38 %) as a light- yellow solid, m.p. 167–169 °C. 1H NMR (200 MHz, CDCl3): δ 9.30 (br. s, 
1H), 8.67 (d, J = 3.7 Hz, 1H), 8.31 (dt, J = 8.0, 1.9 Hz, 1H), 7.40 (dd, J = 8.0, 4.8 Hz, 1H), 
7.32 (s, 1H), 7.22 (dd, J = 8.1, 1.7 Hz, 1H), 7.14 (d, J = 1.6 Hz, 1H), 6.87 (d, J = 8.1 Hz, 1H), 
6.01 (s, 2H) ppm. 13C NMR (50.3 MHz, CDCl3): δ 158.2, 152.0, 150.9, 148.4, 148.3, 147.5, 
133.3, 123.8, 123.7, 122.6, 121.8, 118.7, 109.0, 105.0, 101.6 ppm. MS (EI): m/z (%) = 267 
(16), 266 (100), 181 (11), 153 (27), 63 (9). The spectral properties of this compound are in 
agreement with those previously reported.81b 
 
 
4. General procedure for the synthesis of resveratrol derivatives 48 by 
sequential one-pot C-5 and C-2 direct arylations. 
 
 Pd(OAc)2 (11.2 mg, 0.05 mmol) and Bu4NOAc (0.60 g, 2.0 mmol) were added to a 
flame-dried reaction vessel. The reaction vessel was fitted with a silicon septum, evacuated, 
and back-filled with argon. This sequence was repeated twice. DMA (5 mL), an aryl bromide 
26b or 26v (1.0 mmol), and 1-methyl-1H-imidazole (12) (93 mL, 90.3 mg, 1.1 mmol) were 
then added successively under a stream of argon by syringe at room temperature. The 
resulting mixture was stirred at 110 °C under argon for 24 h. CuI (0.38 g, 2.0 mmol) and an 
aryl bromide 26v or 26b (1.5 mmol) were then sequentially added to the resulting brown 
solution under a stream of argon. The reaction mixture was heated to 110 °C and stirred at 
this temperature for 24 h. After cooling to room temperature, the reaction mixture was diluted 
with AcOEt and poured into a saturated aqueous NH4Cl solution. The resulting mixture was 
basified with a few drops of aqueous NH4OH, stirred in the open air for 0.5 h, and then 
extracted with AcOEt. The organic extract was washed with water, dried, and concentrated 
under reduced pressure, and the residue was purified by flash chromatography on silica gel. 
The chromatographic fractions containing the required compound were collected and 
concentrated. This procedure was employed to prepare 2,5-diaryl-1-methyl-1H-imidazoles 
48a and 48b in 48 and 38% yield, respectively. 
 
4.1. 2-(3,5-Dimethoxyphenyl)-5-(4-methoxyphenyl)-1-methyl-1H-imidazole (48a). 
 
 The crude reaction product obtained by Pd-catalyzed and Cu-mediated one pot 
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sequential direct arylation reactions involving 4-bromoanisole (26b) in the first step and 5-
bromo-1,3-dimethoxy-benzene (26v) in the second step was purified by flash chromatography 
on silica gel with a mixture of AcOEt and toluene (60:40) as eluent to give 48a (0.16 g, 48%) 
as a light yellow solid, m.p. 121–123 °C. 1H NMR (200 MHz, CDCl3) δ 7.33 (m, 2H), 7.10 (s, 
1H), 6.95 (m, 2H), 6.81 (d, J = 2.0 Hz, 2H), 6.49 (t, J = 2.0 Hz, 1H), 3.80 (s, 9H), 3.62 (s, 
3H). 13C NMR (50.3 MHz CDCl3) δ 160.5 (2C), 159.3, 148.4, 135.2, 132.5, 129.9 (2C), 
126.6, 122.3, 114.0 (2C), 106.6 (2C), 100.8, 55.4 (2C), 55.2, 33.6. MS (EI): m/z (%) = 325 
(21), 324 (100), 323 (59), 309 (22), 294 (7). C19H20N2O3 (324.37): calcd. C 70.35, H 6.21, N 
8.64; found C 71.98, H 6.19, N 8.85. 
 
4.2. 5-(3,5-Dimethoxyphenyl)-2-(4-methoxyphenyl)-1-methyl-1H-imidazole (48b). 
 
 The crude reaction product obtained by Pd-catalyzed and Cu-mediated one pot 
sequential direct arylation reactions involving 5-bromo-1,3-dimethoxy-benzene (26v) in the 
first step and 4-bromoanisole (26b) in the second step was purified by flash chromatography 
on silica gel with a mixture of AcOEt and toluene (90:10) as eluent to give 48b (0.12 g, 38%) 
as a light yellow oil; 1H NMR (200 MHz, CDCl3) δ 7.61 (m, 2H), 7.17 (s, 1H), 7.00 (m, 2H), 
6.58 (d, J = 2.2 Hz, 2H), 6.48 (t, J = 2.2 Hz, 1H), 3.85 (s, 3H), 3.83 (s, 6H), 3.65 (s, 3H); 13C 
NMR (50.3 MHz, CDCl3) δ 160.8 (2C), 159.9, 149.6, 135.2, 132.0, 130.1 (2C), 127.2, 123.2, 
113.9 (2C), 106.7 (2C), 106.7, 99.7, 55.4 (2C), 55.3, 33.8; MS (EI): m/z (%) = 325 (21), 324 
(100), 323 (28), 309 (23), 281 (6). C19H20N2O3 (324.37): calcd. C 70.35, H 6.21, N 8.64; 
found C 72.46, H 6.17, N 8.91. 
 
 
5. General procedure for the synthesis of resveratrol derivatives 49 by 
demethylation with BBr3. 
 
 To a solution of O-methoxyphenyl imidazoles 48 (0.3 mmol) in dry CH2Cl2 (40 ml), 
which was stirred at -78 °C, was added a 1 M solution of BBr3 in CH2Cl2 (2.7 ml, 2.7 mmol). 
The reaction mixture was allowed to warm up to room temperature and stirred at this 
temperature for 48 h. After cooling to 0 °C, the reaction mixture was diluted with methanol 
(1.5 mL), and AcOEt (10 mL) and a 10% aqueous solution of NaOH (10 mL) were 
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sequentially added. The organic phase was recovered and acidified with a 10% solution of 
HCl cooled at 0 °C. The formed precipitated was collected by filtration and dried in vacuo, to 
give the title compounds chemically pure. This procedure was employed to prepare 
polyphenolic imidazoles 49a and 49b in 89 and 65% yield, respectively. 
 
5.1. 5-(5-(4-Hydroxyphenyl)-1-methyl-1H-imidazol-2-yl)benzene-1,3-diol (49a). 
 
 Pale grey solid, m.p. 175-178 °C. 1H NMR (200 MHz, CD3OD): δ 7.30 (m, 2H), 6.96 
(s, 1H), 6.89 (m, 2H), 6.56 (s, 2H), 6.37 (s, 1H), 3.60 (s, 3H). 13C NMR (200 MHz, CD3OD): 
δ 159.8 (2C), 158.8, 149.8, 136.8, 133.2, 131.3 (2C), 125.8, 122.1, 116.6 (2C), 108.5 (2C), 
104.3, 34.0. MS (EI): m/z [M + H]+ = 283, [M - H]– = 281. C16H14N2O3 (282.29): calcd. C 
68.08, H 5.00, N 9.92; found C 65.72, H 4.95, N 10.07. 
 
5.2. 5-(2-(4-Hydroxyphenyl)-1-methyl-1H-imidazol-5-yl)benzene-1,3-diol (49b). 
 
 Pale brown solid, m.p. 181-184 °C. 1H NMR (200 MHz, CD3OD): δ 7.49 (m, 2H), 7.05 
(s, 1H), 6.92 (m, 2H), 6.42 (s, 2H), 6.33 (s, 1H), 3.64 (s, 3H). 13C NMR (200 MHz, CD3OD): 
δ 159.9 (3C), 150.4, 136.7, 132.5, 131.5 (2C), 125.4, 121.9, 116.5 (2C), 108.2 (2C), 103.5, 
34.3. MS (EI): m/z [M + H]+ = 283, [M - H]– = 281. C16H14N2O3 (282.29): calcd. C 68.08, H 
5.00, N 9.92; found C 65.72, H 5.04, N 9.64. 
 
 
6. Synthesis of fluorophores 50, 51 and 52. 
 
6.1. 2-(4-Bromophenyl)benzo[d]thiazole (53). 
 
A three–necked 500 mL flask equipped with air condenser and magnetic stirrer was charged 
with 2-aminothiophenol (58) (0.67 mL, 0.78 g, 6.25 mmol), 4-bromobenzaldehyde (59) (0.93 
g, 5 mmol) and DMSO (150 mL). The mixture was stirred under air at reflux of the solvent 
(190 °C). The progress of the reaction was monitored by GLC and after 2 h the conversion 
was complete. The reaction mixture was poured into water and the resulting white-greenish 
precipitate was recovered by filtration, purified by crystallization in ethanol giving 53 as a 
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white solid (1.34 g, 92 %), m.p. 51-53 °C [Lit. 52-53 °C]. 1H NMR (200 MHz, CD3Cl3): δ 
8.09-8.05 (m, 1H), 8.00-7.89 (m, 3H), 7.66-7.60 (m, 2H), 7.51 (dt, J1 = 8 Hz, J2 = 1.4 Hz, 
1H), 7.40 (dt, J1 = 8 Hz, J2 = 1.4 Hz, 1H) ppm. MS (EI): m/z (%) = 291 (100), 290 (20), 289 
(99), 210 (30), 108 (19). The spectral properties of this compound are in agreement with those 
previously reported.110,111 
 
6.2. 2-(4-Bromophenyl)-1-methyl-1H-benzo[d]imidazole (54). 
 
 A 250 mL flask equipped with an air condenser and a magnetic stirrer was charged with 
N-methyl-1,2-benzendiamine (2.27 mL, 20 mmol), 4-bromobenzaldehyde (59) (3.7 g, 20 
mmol), cetyltrimethylammonium bromide (346.5 mg, 1 mmol) and deionized water (100 
mL). The mixture was stirred under air at 40 °C. The progress of the reaction was monitored 
by 1H NMR spectroscopy. After 88 h the conversion was judged complete and the reaction 
mixture was saturated with NaCl and extracted with AcOEt (100 mL + 3 x 50 mL). The 
combined organic extracts were dried on anhydrous sodium sulphate and concentrated under 
reduced pressure yielding a mixture containing 65 % of the required compound 54 and 35 % 
of the benzimidazolines (55), as estimated by 1H NMR analysis. 
The crude reaction mixture was dissolved into 250 mL of dioxane. Air was bubbled into the 
solution for 15 minutes. The solution was refluxed overnight and then the solvent was 
removed under reduced pressure. The residue was purified by recrystallization from 
CH2Cl2/hexane. The required 54 was recovered as a light brown needles (4.52 g, 79 %), m.p. 
112-114 °C [lit. 115-116 °C]. 1H NMR (300 MHz, CDCl3): δ 7.84-7.66 (m, 1H), 7.67-7.65 
(m, 4H), 7.40-7.31 (m, 3H), 3.85 (s, 3H) ppm. MS (EI): m/z (%) = 288 (79), 287 (100), 286 
(82), 285 (91), 206 (37). The spectral properties of this compound are in agreement with those 
previously reported.178 
 
6.3. General procedure for the synthesis of 2-(4-aryl-1-methyl-1H-imidazol-2-
yl)phenyl)-1-methyl-1H-benzo[d]imidazoles (50). 
 
 A two-necked flask equipped with a magnetic stirrer and a reflux condenser was 
charged with the appropriate 5-aryl-1-methyl-1H-imidazole 32 (0.75 mmol), 2-(4-
bromophenyl)-1-methyl-1H-benzo[d]imidazole 54 (323 mg, 1.13 mmol), Pd(OAc)2 (8.4 mg, 
0.04 mmol) and CuI (286 mg, 1.50 mmol). The apparatus was fitted with a silicone septum, 
evacuated and backfilled with argon three times. Anhydrous DMA (4 mL) was added by 
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syringe against a positive pressure of argon. The reaction mixture was stirred at 160 °C. The 
degree of completion of the reaction and the composition of the reaction mixture was 
established on the basis of GLC and GLC-MS analyses of samples of the crude reaction 
mixtures diluted in CH2Cl2 and washed with saturated NH4Cl solution to which a few drops 
of concentrated aqueous ammonia had been added. After cooling at room temperature, the 
reaction mixture was diluted with CH2Cl2 (200 mL) and poured into a saturated aqueous 
NH4Cl solution to which 5 mL of concentrated aqueous ammonia had been added. The 
resulting mixture was stirred in the open air for 30 minutes and then extracted with CH2Cl2. 
The organic extracts were washed with saturated brine, dried, filtered over Celite and the 
filtrate was concentrated under reduced pressure. The residue was purified by flash 
chromatography on silica gel with CH2Cl2 and MeOH (95:5) as eluent. The chromatographic 
fractions containing the required compound 50 were collected and concentrated under 
reduced pressure. The solid compound so obtained was triturated with Et2O, isolated by 
filtration and dried under vacuum. This procedure was employed to prepare compounds 
50.23c,37a,50d 
 
6.3.1. 1-Methyl-2-(4-(1-methyl-5-p-tolyl-1H-imidazol-2-yl)phenyl)-1H-
benzo[d]imidazole (50a). 
 
 The reaction between 54 and 32a according to the general procedure (92 h) gave 50a as 
an off-white amorphous solid (250.8 mg, 88 %), m.p. 245-252 °C. 1H NMR (200 MHz, 
CDCl3): δ 7.93-7.82 (m, 5H), 7.44-7.28 (m, 7H), 7.23 (s, 1H), 3.92 (s, 3H), 3.73 (s, 3H), 2.42 
(s, 3H) ppm. 13C NMR (50.3 MHz, CDCl3): δ 153.3, 143.2, 138.3, 136.9, 136.3, 132.3, 130.5, 
129.9, 129.1, 128.9, 127.7, 127.3, 123.2, 122.8, 120.2, 109.9, 34.2, 32.1, 21.6 ppm. MS (EI): 
m/z (%) = 379 (25), 378 (100), 377 (66). C25H22N4 (378.47): calcd. C 79.34, H 5.86; found C 
79.01, H 5.89. 
 
6.3.2. 2-(4-(5-(Methoxyphenyl)-1-methyl-1H-imidazol-2-yl)phenyl)-1-methyl-
1H-benzo[d]imidazole (50b). 
 
 The reaction between 54 and 32b according to the general procedure (72 h) gave 50b as 
an off-white amorphous solid (195 mg, 66 %), m.p. 265-269 °C. 1H NMR (200 MHz, CDCl3): 
δ 7.89-7.82 (m, 5H), 7.42-7.31 (m, 5H), 7.19 (s, 1H), 7.01 (d, J = 8.5 Hz, 2H), 3.93 (s, 3H), 
3.87 (s, 3H), 3.72 (s, 3H) ppm. 13C NMR (50.3 MHz, CDCl3): δ 159.6, 153.2, 148.0, 143.0, 
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136.7, 135.9, 132.3, 130.2, 129.5, 129.3, 128.7, 128.4, 127.4, 123.0, 122.6, 120.4, 119.9, 
119.5, 114.3, 109.6, 55.6, 34.0, 29.7 ppm. MS (EI): m/z (%) = 395 (27), 394 (100), 393 (51). 
C25H22N4O (394.47): calcd. C 76.12, H 5.62; found C 76.63, H 5.58. 
 
6.3.3. 4-(1-Methyl-2-(4-(1-methyl-1H-benzo[d]imidazol-2-yl)phenyl)-1H-
imidazol-5-yl)benzonitrile (50s). 
 
 The reaction between 54 and 32s according to the general procedure (92 h) gave 50s as 
an off-white amorphous solid (123 mg, 42 %), m.p. 279-282 °C. 1H NMR (200 MHz, CDCl3): 
δ 7.96-7.75 (m, 7H), 7.60 (d, J = 8.3 Hz, 1H), 7.44-7.33 (m, 4H), 3.93 (s, 3H), 3.77 (s, 3H) 
ppm. 13C NMR (50.3 MHz, CDCl3): δ 153.0, 150.3, 143.1, 136.9, 134.7, 134.4, 133.0, 131.7, 
131.1, 130.0, 129.8, 129.3, 128.7, 123.4, 122.9, 120.1, 118.8, 111.6, 110.0, 34.6, 32.2 ppm. 
MS (EI): m/z (%) = 391 (27), 389 (100), 388 (83). C25H19N5 (389.45): calcd. C 77.10, H 4.92; 
found C 76.96, H 4.96. 
 
6.4. General procedure for the synthesis of 2-(4-(5-aryl-1-methyl-1H-imidazol-2-
yl)phenyl)benzo[d]thiazoles (51) and 2-(4-(5-arylthiazol-2-
yl)phenyl)benzo[d]thiazoles (52). 
 
 The appropriate 5-aryl-thiazole 31 (0.5 mmol) or 5-aryl-1-methyl-1H-imidazole 32 (0.5 
mmol), 2-(4-bromophenyl)benzo[d]thiazole 53 (218 mg, 0.75 mmol) were placed in a two-
necked flask equipped with a reflux condenser and a magnetic stirrer. The apparatus was 
fitted with a silicone septum, evacuated and backfilled with argon three times. Anhydrous 
DMA (3.5 mL) was then added by syringe against a positive pressure of argon. The reaction 
mixture was stirred at 160 °C under argon for 72 h, then it was cooled to room temperature 
and diluted with 100 mL of AcOEt. To the resulting mixture, 100 mL of a saturated NH4Cl 
solution and 5 mL of concentrated ammonia were added, and the biphasic mixture was stirred 
in the open air for 30 minutes. The two phases were separated and the aqueous phase was 
extracted with AcOEt (3 x 50 mL). The organic extract was washed with water (2 x 50 mL), 
dried and concentrated under reduced pressure and the residue was purified by flash 
chromatography on silica gel. Compounds 51 and 52 were obtained following this protocol. 
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6.4.1. 2-(4-(1-Methyl-5-(p-tolyl)-1H-imidazol-2-yl)phenyl)benzo[d]thiazole (51a). 
 
 The crude reaction product obtained by Pd- and Cu-mediated reaction of 32a and 53 
was purified by flash chromatography on silica gel with a mixture of toluene and AcOEt 
(60:40) as eluent to give 51a as an iridescent yellow-greenish solid (122 mg, 66 %), m.p. 204-
206 °C. 1H NMR (200 MHz, CDCl3): δ 8.21 (d, J = 8.0 Hz, 2H), 8.10 (d, J = 8.0 Hz, 1H), 
7.93 (d, J = 7.6 Hz, 1H), 7.86 (d, J = 8.4 Hz, 1H), 7.56-7.23 (m, 8H), 3.74 (s, 3H), 2.42 (s, 
3H) ppm. 13C NMR (50.3 MHz, CDCl3): δ 167.2, 154.1, 148.1, 138.0, 136.2, 135.1, 133.4, 
133.2, 129.5, 129.0, 128.8, 128.6, 127.7, 127.0, 126.4, 125.3. 123.3, 121.6, 34.0, 21.3 ppm. 
MS (EI): m/z (%) = 383 (9), 382 (30), 381 (100), 380 (49), 190 (14). 
 
6.4.2. 2-(4-(5-(4-Methoxyphenyl)-1-methyl-1H-imidazol-2-
yl)phenyl)benzo[d]thiazole (51b). 
 
 The crude reaction product obtained by Pd- and Cu-mediated reaction of 32b and 53 
was purified adding a mixture of toluene and AcOEt (70:30), filtrating the barely soluble 
product and performing a flash chromatography on silica gel of the filtrate to give 51b as a 
yellow solid (141 mg, 66 %), m.p. 244-248 °C. 1H NMR (200 MHz, CDCl3): δ 8.21 (d, J = 
8.4 Hz, 2H), 8.10 (d, J = 8.0 Hz, 1H), 7.95-7.84 (m, 3H), 7.55-7.37 (m, 4H), 7.20 (s, 1H), 
7.01 (d, J = 8.8 Hz, 2H), 3.87 (s, 3H), 3.71 (s, 3H) ppm. 13C NMR (50.3 Hz, CDCl3): δ 167.2, 
159.5, 154.1, 147.9, 135.9, 135.1, 133.4, 133.3, 130.2, 129.0, 127.7, 127.5, 126.4, 125.3, 
123.3, 122.3, 121.7, 114.3, 55.4, 34.0 ppm. MS (EI): m/z (%) = 398 (30), 397 (100), 396 (27), 
382 (15), 198 (13). 
 
6.4.3. 4-(2-(4-(Benzo[d]thiazole-2-yl)phenyl)-1-methyl-1H-imidazol-5-
yl)benzonitrile (51s). 
 
 The crude reaction product obtained by Pd- and Cu-mediated reaction of 32s and 53 
was purified by flash chromatography on silica gel with a mixture of toluene and AcOEt 
(40:60) as eluent to give 51s as a yellow solid (153 mg, 83 %), m.p. 217-220 °C. 1H NMR 
(200 MHz, CDCl3): δ 8.24 (d, J = 8.0 Hz, 2H), 8.11 (d, J = 7.4 Hz, 1H), 7.94 (d, J = 8.4 Hz, 
1H), 7.86 (d, J = 8.0 Hz, 2H), 7.77 (d, J = 8.4 Hz, 2H), 7.62-7.37 (m, 5H), 3.78 (s, 3H) ppm. 
13C NMR (50.3 Hz, CDCl3): δ 166.9, 154.1, 150.0, 135.1, 134.4, 134.3, 134.0, 132.7, 132.4, 
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129.7, 129.3, 128.5, 127.8, 126.5, 125.5, 123.4, 121.7, 118.5, 111.4, 34.4 ppm. MS (EI): m/z 
(%) = 394 (9), 393 (27), 392 (100), 391 (66), 196 (10). 
 
6.4.4. 2-(4-(5-(p-Tolyl)thiazole-2-yl)phenyl)benzo[d]thiazole (52a). 
 
 The crude reaction product obtained by Pd- and Cu-mediated reaction of 31a and 53 
was purified adding a mixture of toluene and AcOEt (95:5), filtrating an insoluble residual 
and performing a flash chromatography on silica gel of the filtrate to give 52a as a yellow 
solid (47 mg, 25 %), m.p. 207-210 °C. 1H NMR (200 MHz, CDCl3): δ 8.21-8.16 (m, 2H), 
8.12-8.06 (m, 3H), 8.03 (s, 1H), 7.93 (d, J = 8.0 Hz, 1H), 7.56-7.40 (m, 4H), 7.24 (d, J = 8.0 
Hz, 2H), 2.40 (s, 3H) ppm. 13C NMR spectrum was not recorded due to the very low 
solubility of the compound in common organic solvents. MS (EI): m/z (%) = 385 (26), 384 
(100), 192 (12), 148 (26), 147 (31). 
 
6.4.5. 2-(4-(5-(4-Methoxyphenyl)thiazole-2-yl)phenyl)benzo[d]thiazole (52b). 
 
 The crude reaction product obtained by Pd- and Cu-mediated reaction of 31b and 53 
was purified by (i) filtration of a solid component and treatment of it with hot CH2Cl2 to 
obtain a clean product and (ii) flash chromatography on silica gel of the filtrate with a mixture 
of CH2Cl2 and AcOEt (96:4) as eluent to give 52b as an iridescent yellow solid (143 mg, 72 
%), m.p. 196-199 °C. 1H NMR (200 MHz, CDCl3): δ 8.20-8.05 (m, 5H), 7.97-7.91 (m, 2H), 
7.58-7.37 (m, 4H), 6.96 (d, J = 8.8 Hz, 2H), 3.86 (s, 3H) ppm. 13C NMR spectrum was not 
recorded due to the very low solubility of the compound in common organic solvents. MS 
(EI): m/z (%) = 400 (100), 281 (22), 207 (38), 149 (32), 44 (24). 
 
6.4.6. 4-(2-(4-(Benzo[d]thiazole-2-yl)phenyl)thiazole-5-yl)benzonitrile (52s). 
 
 The crude reaction product obtained by Pd- and Cu-mediated reaction of 31s and 53 
was purified by (i) filtration of a solid component and treatment of it with hot CH2Cl2 to 
obtain a clean product and (ii) flash chromatography on silica gel of the filtrate with a mixture 
of toluene and AcOEt (90:10) as eluent to give 52s as a yellow solid (96 mg, 53 %), m.p. 233-
235 °C. 1H NMR (200 MHz, aquired at 40 °C, CDCl3): δ 8.23-8.08 (m, 6H), 7.93 (d, J = 7.6 
Hz, 1H), 7.71 (s, 4H), 7.56-7.38 (m, 2H) ppm. 13C NMR spectrum was not recorded due to 
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the very low solubility of the compound in common organic solvents. MS (EI): m/z (%) = 397 
(12), 396 (29), 395 (100), 197 (8), 159 (52). 
 
 
7. One-pot synthesis of fluorophores 50w and 51w. 
 
 Pd(OAc)2 (11.2 mg, 0.05 mmol) and Bu4NOAc (0.60 g, 2.0 mmol) were added to a 
flame-dried reaction vessel. The reaction vessel was fitted with a silicone septum, evacuated, 
and back-filled with argon. This sequence was repeated twice. DMA (5 mL), 1-bromo-4-((2-
ethylhexyl)oxy)benzene 26w (0.31 g, 1.1 mmol), and 1-methyl-1H-imidazole (12) (80 µ, 82 
mg, 1 mmol) were then added successively under a stream of argon by syringe at room 
temperature. The resulting mixture was stirred at 110 °C under argon for 24 h. CuI (0.38 g, 
2.0 mmol) and the aryl bromide 53 or 54 (1.5 mmol) were then sequentially added to the 
resulting solution under a stream of argon. The reaction mixture was heated to 110 °C and 
stirred at this temperature for 24 h. After cooling to room temperature, the reaction mixture 
was diluted with AcOEt and poured into a saturated aqueous NH4Cl solution. The resulting 
mixture was basified with a few drops of aqueous NH4OH, stirred in the open air for 0.5 h, 
and then extracted with AcOEt. The organic extract was washed with water, dried, and 
concentrated under reduced pressure, and the residue was purified by recrystallization. This 
procedure was employed to prepare 2,5-diaryl-1-methyl-1H-imidazoles 50w and 51w in 18 
and 40% yield, respectively. 
 
7.1. 1-Bromo-4-((2-ethylhexyl)oxy)benzene (26w).179 
 
 In a 500 mL three-necked flask, K2CO3 (8.29 g, 60 mmol) and 4-bromophenol (26c) 
(6.92 g, 40 mmol) were added to acetone (93 mL) and the mixture was heated at refluxing 
temperature. After 30 minutes, 2-ethyl-hexyl bromide (10.7 mL, 11.6 g, 60 mmol) was 
dropped into the reaction mixture. After the reaction was complete, it was cooled to room 
temperature, washed with H2O and extracted with Et2O The organic layers were washed with 
brine, exctracted again and dried with anhydrous magnesium sulphate (MgSO4), filtered and 
concentrated under reduced pressure. The crude product was purified by distillation (131.8 
°C, 2 mmHg) and compound 26w was obtained as a colourless oil (6.72 g, 59 %). 1H NMR 
(200 MHz, CDCl3): δ 7.33 (m, 2H), 6.76 (m, 2H), 3.77 (d, J = 5.4 Hz, 2H), 1.69 (ept, J = 6 
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Hz, 1H), 1.53-1.21 (m, 8H), 0.94-0.87 (m, 6H) ppm. The spectral properties of this compound 
are in agreement with those previously reported.180 
 
7.2. 2-(4-(5-(4-((2-Ethylhexyl)oxy)phenyl)-1-methyl-1H-imidazol-2-yl)phenyl)-1-
methyl-1H-benzo[d]imidazole (50w). 
 
 The crude reaction product obtained by Pd-catalyzed and Cu-mediated one pot 
sequential direct arylation reactions involving 1-bromo-4-((2-ethylhexyl)oxy)benzene (26w) 
in the first step and 2-(4-bromophenyl)-1-methyl-1H-benzo[d]imidazole (54) (1.5 mmol) in 
the second step was purified by crystallization from CH2Cl2/hexaneto give 50w (91 mg, 18%) 
as a iridescent white solid, m.p. 201-204 °C. 1H NMR (200 MHz, CDCl3): δ 7.96-7.82 (m, 
5H), 7.44-7.28 (m, 5H), 7.19 (s, 1H), 7.00 (d, J = 8.8 Hz, 2H) 3.91-3.88 (m, 5H), 3.70 (s, 3H), 
1.82-1.68 (m, 1H), 1.58-1.26 (m, 8H), 0.99-0.89 (m, 6H) ppm. 13C NMR (50.3 MHz CDCl3) δ 
167.2, 159.5, 154.2, 147.8, 136.1, 135.2, 133.5, 133.4, 130.2, 129.0, 127.7, 127.4, 126.4, 
125.4, 123.4, 122.1, 121.7, 114.9, 70.8, 39.5, 33.9, 30.7, 29.2, 24.0, 23.1, 14.1, 13.8, 11.2. 
ppm. C32H36N4O (492.65): calcd. C 78.01, H 7.37, N 11.37; found C 77.89, N 7.12, N 11.57. 
 
7.3. 2-(4-(5-(4-((2-Ethylhexyl)oxy)phenyl)-1-methyl-1H-imidazol-2-
yl)phenyl)benzo[d]thiazole (51w). 
 
 The crude reaction product obtained by Pd-catalyzed and Cu-mediated one pot 
sequential direct arylation reactions involving 1-bromo-4-((2-ethylhexyl)oxy)benzene (26w) 
in the first step and 2-(4-bromophenyl)benzo[d]thiazole (53) (1.5 mmol) in the second step 
was purified by crystallization from CH2Cl2/hexane to give 51w (340 mg, 40%) as a yellow 
solid, m.p. 65-67 °C. 1H NMR (200 MHz, CDCl3): δ 8.20 (d, J = 8 Hz, 2H), 8.09 (d, J = 8.2 
Hz, 1H), 7.93-7.84 (m, 3H), 7.54-7.35 (m, 4H),7.19 (s, 1H), 7.00 (d, J = 8.4 Hz, 2H), 3.91-
3.81 (m, 2H), 3.71 (s, 3H), 1.85-1.63 (m, 1H), 1.60-1.26 (m, 8H), 0.98-0.92 (m, 6H) ppm. 13C 
NMR (50.3 MHz CDCl3) δ 159.3, 153.0, 147.9, 142.9, 136.6, 135.9, 132.2, 130.1 (2C), 129.5 
(2C), 128.7 (2C), 127.3, 122.9, 122.5, 122.0, 119.8, 114.8 (2C), 109.6, 70.6, 39.4, 33.8, 31.8, 
30.6, 29.7, 29.1, 23.9, 23.1, 14.2, 11.2 ppm. C31H33N4O (495.68): calcd. C 75.12, H 6.71, N 
8.48; found C 75.34, H 6.49, N 8.80. 
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8. Synthesis of Cu-NHC 64a, 64b, 65. 
 
8.1. Synthesis of benzimidazolium salts 73a and 73b. 
 
8.1.1. 1,3-Dibenzyl-1H-benzo[d]imidazol-3-ium bromide (73a).139 
 
 To a round-bottom flask was added benzimidazole (75) (10 g, 85 mmol), benzyl 
bromide (76) (20 mL, 29 g, 170 mmol), K2CO3 (17.5 g, 127 mmol) and acetonitrile (200 mL). 
This mixture was stirred for 3 d at ambient temperature. Solvent was removed under reduced 
pressure. Water (200 mL) was added, and the mixture stirred. The reaction mixture was 
filtered to give product 73a as a white solid (31.9 g, 99% yield), m.p. 228-229 °C [Lit. 210-
212 °C]. 1H NMR (400 MHz, (CD3)2SO): δ 9.98 (s, 1H), 7.96-7.90 (m, 2H), 7.64-7.57 (m, 
2H), 7.50-7.46 (m, 4H), 7.43-7.33 (m, 6H), 5.75 (s, 4H). 13C NMR (101 MHz, (CD3)2SO): δ 
134.0, 131.1, 129.0, 128.8, 128.3, 126.8, 114.0, 50.0 (note: C2 not observed). ESI-MS: m/z = 
299 [M-Br]. ESI-HRMS: m/z = 299.1539 [M-Br]. C21H19N2: calcd. 229.1543. 
 
8.1.2. N,N-Diphenylbenzene-1,2-diamine (78).141 
 
 In a two-necked flask under nitrogen atmosphere, Pd(OAc)2 (32 mg, 0.143 mmol) and 
solid PtBu3 (85 mg, 0.421 mmol) were combined in toluene (15 mL) and stirred for 5 min. 
Dibromobenzene (79) (0.65 mL, 5.39 mmol) was added followed by aniline (80) (1.46 mL, 
16 mmol) and NaOtBu (1.538 g, 16 mmol). Upon addition of the NaOtBu a brown colour was 
observed. The reaction mixture was heated to 110 °C for 14 h. After several hours a 
precipitated formed. The flask was opened and the reaction mixture was quickly quenched 
with an aqueous NH4Clsat solution (30 mL). Then, other 15 mL of toluene were added and the 
organic layer was separated and washed with deionized water (2 x 30 mL). The aqueous layer 
was washed with fresh toluene (3 x 15 mL) and the organic phases were collected. The 
toluene layer was dried over MgSO4 for 1 h, then filtered and concentrated under vacuum. 
The solid obtained was dissolved in 6 mL of toluene again; hexane was added until a 
precipitate formed. The solution was cooled overnight at -20 °C. Dark purple crystals were 
isolated. The product 78 was crystallized again from EtOH as white off solid (1.091 g, 78 % 
yield), m.p. 111-114 °C [Lit. 109 °C].181 1H NMR (400 MHz, CDCl3): δ 7.33-7.24 (m, 6H), 
7.01-6.90 (m, 8H), 5.64 (s, 2H). 13C NMR (101 MHz, CDCl3): δ 144.08, 135.07, 129.50, 
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123.16, 120.76, 120.40, 117.40. ESI-HRMS: m/z = 261.1394 [M + H+]. C18H17N2: calcd. 
261.1386. 
 
8.1.3. 1,3-Diphenyl-1H-benzo[d]imidazol-3-ium bromide (73b). 
 
 To a 50 mL round bottom flask, N,N-diphenylbenzene-1,2-diamine (78) (260 mg, 1 
mmol), trimethyl orthoformate (81) (7 mL), HBrconc. (0.2 mL) and formic acid (1 drop) were 
added. The resulting mixture was stirred under nitrogen at 80 °C for 2 h. Once the reaction 
was cooled, the solvent was removed and the solid residue of compound 73b was purified by 
recrystallization from AcOEt/CH2Cl2 to provide slight yellow microcrystals (350 mg, 99 % 
yield), m.p. compound 73b starts to decompose around 235 °C. 1H NMR (400 MHz, CDCl3): 
δ 11.06 (s, 1H), 8.19 (d, J = 8 Hz, 4H), 7.82-7.78 (m, 2H), 7.73-7.69 (m, 6H), 7.66-7.63 (m, 
2H). 13C NMR (101 MHz, CDCl3): δ 141.6, 132.77, 131.74, 131.20, 130.80, 128.29, 125.71, 
114.20. ESI-HRMS: m/z = 271.1237 [M + Br]. C19H15N2+: calcd. 271.1230. IR (solid-state 
ATR, cm-1): 3156, 3066, 2995, 2898, 2787, 1588, 1548, 1478, 1356, 1308, 1255, 1226, 1081, 
754, 691, 619, 571, 495, 433. 
 
8.2. Synthesis of CuI-NHC 64a, 64b and 65. 
 
8.2.1. (1,3-Dibenzylbenzo[d]imidazolin-2-ylidene)copper(I) bromide (64a). 
 
 A Schlenk flask was charged with 1,3-dibenzylbenzo[d]imidazolium bromide (73a) 
(389 mg, 1 mmol), Cu2O (286 mg, 2 mmol) and 4Å MS. These were dried and degassed 
thoroughly in vacuo. Anhydrous CH2Cl2 (20 mL) was added via cannula and the mixture was 
stirred at reflux for 24 h. After this time, the mixture was allowed to cool and was removed 
from the filtrate in vacuo to give the product 64a as a white crystalline solid (440 mg, 99% 
yield). 1H NMR (500 MHz, CD2Cl2): δ 7.40-7.32 (m, 12H), 7.30-7.27 (m, 2H), 5.69 (s, 4H). 
13C NMR (126 MHz, CD2Cl2): δ 135.9, 129.6, 129.0, 128.0, 124.7, 112.5, 53.4 (7 of the 9 
carbon environments observed). C21H18BrCuN2: calcd. C 57.09, H 4.11, N 6.34; found C 
56.90, H 4.05, N 6.15. LIFDI-MS: m/z (%) 440 (67) [63Cu79BrM], 441 (12) [63Cu79Br13CM], 
442 (100) [63Cu81BrM and 65Cu79BrM], 442 (22) [63Cu81Br13CM or 65Cu79Br13CM], 443 (28) 
[65Cu81BrM] (observed as monomer only). 
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8.2.2. (1,3-Diphenylbenzo[d]imidazolin-2-ylidene)copper(I) bromide (64b). 
 
 A Schlenk flask was charged with 1,3-diphenylbenzimidazolium bromide (73b) (527 
mg, 1.5 mmol), Cu2O (429 mg, 3 mmol) and 4Å MS. These were dried and degassed 
thoroughly in vacuo. Anhydrous CH2Cl2 (30 mL) was added via cannula and the mixture was 
stirred at reflux for 24 h. After this time, the mixture was allowed to cool and was removed 
from the filtrate in vacuo to give the product as a white-off solid (630 mg, 99 % yield), m.p. 
205-208 °C. 1H NMR (400 MHz, CD2Cl2): δ 7.78-7.75 (m, 4H), 7.70-7.65 (m, 4H), 7.64-7.60 
(m, 2H), 7.56-7.51 (m, 2H), 7.48-7.43 (m, 2H). 1H NMR (400 MHz, CD3CN): δ 7.77-7.74 
(m, 4H), 7.69-7.60 (m, 6H), 7.55-7.50 (m, 2H), 7.48-7.44 (m, 2H). 13C NMR (101 MHz, 
CD2Cl2): δ 138.04, 134.61, 130.61, 130.06, 126.60, 125.52, 112.78 (only 7 of 8 resonance 
observed). ESI-HRMS: m/z = 603.1616 (observed as a dimer, 2 NHC linked to the same Cu, 
calcd. for C38H28CuN4). LIFDI-MS: m/z (%) 603.21 (100), 605.23 (45), 606.23 (18). IR 
(solid-state ATR, cm-1): 3041, 2962, 1590, 1482, 1357, 1259, 1047, 796, 740, 693, 603, 501. 
 
8.2.3. (1,3-Bis(2,4,6-trimethylphenyl)imidazolin-2-yliden)copper(I) chloride (65). 
 
 A Schlenk flask was charged with 1,3-bis(2,4,6-trimethylphenyl)imidazolium chloride 
(74) (511 mg, 1.5 mmol), Cu2O (429 mg, 3 mmol) and 4Å MS. These were dried and 
degassed thoroughly in vacuo. Anhydrous CH2Cl2 (30 mL) was added via cannula and the 
mixture was stirred at reflux for 24 h. After this time, the mixture was allowed to cool and 
was removed from the filtrate in vacuo to give the product as a white-off solid (600 mg, 99 % 
yield). 1H NMR (400 MHz, CD2Cl2): δ 7.11 (s, 2H), 7.07 (s, 4H), 2.38 (s, 6H), 2.12 (s, 12 H). 
13C NMR (101 MHz, CD2Cl2): δ 140.19, 135.80, 135.36, 129.87, 122.98, 21.44, 18.13 (only 7 
of 8 resonance observed). 
 
 
9. Reaction of CuI-NHC complexes 64a, 64b and 65 with PhI (2), with and 
without Pd(OAc)2. 
 
9.1. Arylation procedure: Method A.  
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 To a Young’s NMR tube in the glove-box was added Cu(NHC)Br (64b or 65) (0.0145 
mmol) and dissolved in anhydrous C6D6 (0.7 ml) (distilled from Na). A 1H NMR spectrum 
(400 MHz) was recorded. In the glove-box, PhI (2) (8 µL, 14.7 mg, 0.0724 mmol) was added 
to the C6D6 solution. A 1H NMR spectrum was recorded and the sample was then heated to 90 
oC. 1H NMR spectra were recorded at 2 h and 24 h to monitor any chemical change. The C6D6 
solvent was removed in vacuo and the solid (no mass loss) was re-dissolved in CD3CN (for 
ease of referencing with authentic standards of the potential products), and a 1H NMR 
spectrum recorded. 
 
9.2. Arylation procedure: Method B. 
 
 To a Young’s NMR tube in the glove-box was added Cu(NHC)Br (64b or 65) (0.0145  
mmol) dissolved in anhydrous C6D6 (0.7 ml) (distilled from Na). A 1H NMR spectrum (400 
MHz) was then recorded. In the glove-box, PhI (2) (8 µL, 14.7 mg, 0.0724 mmol) was added, 
followed by a second 1H NMR spectrum. In the glove-box, Pd(OAc)2 (3 mg, 0.0146 mmol) 
was added, followed by a third 1H NMR spectrum. The sample was then heated to 90 oC for 
24 h. Concomitant Pd black and product precipitation occurred, preventing any further in situ 
spectroscopic analysis. The solvent was removed in vacuo to give a brown solid (no mass 
loss), which was analysed by ESI-MS. This brown solid was re-dissolved in CD3CN (for ease 
of referencing with authentic standards of the potential products), and a 1H NMR spectrum 
recorded. 
 
9.3. (1,3-Diphenyl)-2-phenylbenzo[d]imidazolium copper(II)diiodide (86b). 
 
 A Schlenk flask was charged in the glovebox with (1,3-diphenylbenzo[d]imidazolin-2-
ylidene)copper(I) bromide (64b) (60 mg, 0.145 mmol), PhI (2) (80 µL, 0.724 mmol) and dry 
C6H6. Then, the reaction was heated at 90 °C. After 24 h the product 86b precipitated as a 
white solid (51 mg, 99 % yield), m.p. 274-277 °C. 1H NMR (400 MHz, CD3CN): δ 7.77-7.72 
(m, 2H), 7.67-7.57 (m, 12H), 7.51-7.47 (m, 1H), 7.45-7.42 (m, 2H), 7.36-7.32 (m, 2H). 13C 
NMR (101 MHz, CD3CN): δ 137.48, 133.86, 133.63, 133.56, 132.17, 132.09, 131.40, 129.84, 
129.05, 128.49, 122.11, 114.46. ESI-HRMS: m/z = 347.1552, (calc. for C25H19N2+ 347.1543). 
IR (solid-state ATR, cm-1): 3042, 1591, 1494, 1442, 1166, 1028, 750, 695, 584, 506. 
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Preliminary screening on the palladium-catalyzed direct arylation of 1-
phenyl-1H-pyrazole (23): supplementary reactions. 
 
 As already stated in the Chapter 1, in Table 14 and Table 15 are reported all the data on 
the preliminary study of the Pd-catalyzed direct arylation of 1-phenyl-1H-pyrazole (23). The 
entries in bold are the supplementary reactions to those reported in Table 8 and Table 9. 
From the data summarized in Table 14 it clearly emerges as Cs2CO3 resulted completely 
ineffective in toluene as well as in dioxane and in N-methyl-pyrrolidone (NMP) (entries 1-3, 
Table 14). Moreover, in order to verify that Bu4NOAc be effective or not for this reaction 
model even in the presence of ligands, we tried to perform the direct arylation of 23 with 26a 
in the presence of P(o-Tol)3, P(tBu)3⋅HBF4 and PBuAd2 (entries 19-21, Table 14). Only 
P(tBu)3⋅HBF4 showed a slight activity giving a yield lower than 10 %, while other two 
phosphines did not showed activity. 
 In addition to all the reactions performed, we also wanted to verify if, with a lower 
temperature, Bu4NOAc and Cs2CO3 could promote the direct arylation of 1-phenyl-1H-
pyrazole (23) with 4-bromotoluene (26a). Once more, the two bases did not result effective 
for our reaction model (entries 1-2, Table 15). Furthermore, the addition of the PBuAd2 at 110 
°C did not contribute to an enhancement of the yield of 36a (entry 4, Table 15), and also the 
selectivity resulted comparable with that obtained in entry 3. 
When we found that PdCl2(MeCN)2 resulted the best catalyst, we also tested three type of 
ligands with this palladium catalyst. The PBuAd2 did not influence significantly both the 
yield and the regioselectivity of compound 36a. Then, we attempt to use N-containing 
ligands, as phenantroline or pyridine, because we wanted to verify if the presence of the 
nitrogen on the ligand could inhibit the ortho-arylation on the phenyl ring of 23 directed by 
the N-2 atom of pyrazole system. As we can note from entry 9 of Table 15, pyridine gave the 
product in 29 % yield but the selectivity of 5-aryl-pyrazole 36a did not experience an 
enhancement. Moreover, phenantroline resulted to be ineffective for the promotion of our 
model reaction taking to a yield of only 5 %. 
With the choice of PdCl2(MeCN)2 as the new catalyst precursor, we wanted to verify if it was 
possible to have some change in the yield or in the regioselectivity by rising again the reaction 
temperature to 140 °C. The reactions in the presence and in the absence of pyridine as ligand 
gave a yield of 30 and 35 %, respectively, but we observed again that with a higher reaction 
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temperature the selectivity decrease significantly (entries 11-12, Table 15). Finally, even 
though we changed the catalyst precursor, the Bu4NOAc still remained ineffective for our 
model reaction (entry 13, Table 15). 
 
Table 14: Screening of the solvents and the ligands for the direct C-5 arylation of 1-phenyl-1H-pyrazole (23) 
with 4-bromotoluene (26a). 
 
 
Entry[a] Ligand Base Solvent Yield of 36a 
(%)[b] 
36a:37a:38a 
1[c] - Cs2CO3 Toluene[d] - - 
2 - Cs2CO3 Dioxane[e] - - 
3 - Cs2CO3 NMP - - 
4[c] - K2CO3 Toluene[d] - - 
5 - K2CO3 Dioxane[e] < 2 100:0:0 
6 - K2CO3 NMP < 5 49:51:0 
7 - K2CO3 DMSO - - 
8 - K2CO3 Chlorobenzene 18 100:0:0 
9 - K2CO3 DMF 18 48:37:15 
10 PPh3 K2CO3 DMA 21 40:27:33 
11 P(o-Tol)3 K2CO3 DMA 10 15:74:11 
12 P(2-furyl)3 K2CO3 DMA 17 38:43:19 
13 PCy3 K2CO3 DMA 23 44:26:30 
14 P(tBu)3⋅HBF4 K2CO3 DMA 20 40:36:24 
15 PBuAd2 K2CO3 DMA 21 58:31:11 
16[c] PBuAd2 K2CO3 DMA (21) 57:18:25 
17 dppf K2CO3 DMA 22 48:34:18 
18 Xantphos K2CO3 DMA 21 44:32:24 
19 P(o-Tol)3 Bu4NOAc DMA - - 
20 P(tBu)3⋅HBF4 Bu4NOAc DMA < 10 66:25:9 
21 PBuAd2 Bu4NOAc DMA - - 
[a] Unless otherwise stated, the reactions were carried out using 23 (1.0 mmol), 26a (1.5 equiv), 
Pd(OAc)2 (5 mol %), ligand (10 mol %) (if any), base (2 equiv) in solvent (5 mL) for 48 h at 140 °C. 
[b] GLC yields. In parenthesis, isolated yields. [c] Reaction was carried out in the presence of 30 mol % 
PivOH. [d] Reaction was carried out at 110 °C. [e] Reaction was carried out at 100 °C. 
N
N
+
Pd(OAc)2 (5 mol %)
Ligand (10 mol %)
K2CO3 (2 equiv)
Solvent, T °C
48 h
N
N
Me
+ N
N
+
Br
Me
Me
N
N
Me
Me
23 26a 36a 37a 38a
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Table 15: Screening of the reaction temperature, the palladium precatalyst, the presence of additive and 23/26a 
molar ratio for the direct arylation of 1-phenyl-1H-pyrazole (23) with 4-bromotoluene (26a). 
 
 
Entry[a] Catalyst Base Ligand Additive 
23/26a 
ratio 
T 
(°C
) 
Yield of 
36a 
(%)[b] 
36a:37a:38a 
1[c] Pd(OAc)2 Bu4NOAc - - 1/1.5 110 < 10 83:17:0 
2 Pd(OAc)2 Cs2CO3 - - 1/1.5 110 - - 
3 Pd(OAc)2 K2CO3 - - 1/1.5 110 29 71:22:7 
4 Pd(OAc)2 K2CO3 PBuAd2 - 1/1.5 110 29 77:15:8 
5 Pd(PPh3)4 K2CO3 - - 1/1.5 110 16 61:28:11 
6 PdCl2(dppb) K2CO3 - - 1/1.5 110 19 48:40:12 
7 PdCl2(MeCN)2 K2CO3 - - 1/1.5 110 29 (27) 82:13:5 
8 PdCl2(MeCN)2 K2CO3 PBuAd2 - 1/1.5 110 25 84:11:5 
9 PdCl2(MeCN)2 K2CO3 Pyridine[d] - 1/1.5 110 29 77:15:8 
10 PdCl2(MeCN)2 K2CO3 Phenantroline[d] - 1/1.5 110 5 79:21:0 
11 PdCl2(MeCN)2 K2CO3 - - 1/1.5 140 30 60:14:26 
12 PdCl2(MeCN)2 K2CO3 Pyridine[d] - 1/1.5 140 35 59:13:28 
13 PdCl2(MeCN)2 Bu4NOAc - - 1/1.5 110 < 5 91:9:0 
14 PdCl2(MeCN)2 K2CO3 - - 1/2 110 28 73:14:13 
15 PdCl2(MeCN)2 K2CO3 - BnBu3NCl 1/1.5 110 35 69:14:13 
16 PdCl2(MeCN)2 K2CO3 - BnBu3NCl 1/2 110 40 77:15:8 
17 PdCl2(MeCN)2 K2CO3 - BnBu3NCl 1/1.5 70 - - 
18 PdCl2(MeCN)2 K2CO3 - Bu4NBr 1/1.5 110 38 (29) 78:11:11 
19 PdCl2(MeCN)2 K2CO3 - Bu4NBr 1/2 110 43 70:12:18 
20 PdCl2(MeCN)2 K2CO3 - Bu4NBr 1/1 110 31 80:10:10 
21[e] PdCl2(MeCN)2 K2CO3 - Bu4NBr 1/1.5 110 33 78:12:10 
22 PdCl2(MeCN)2 K2CO3 - Bu4NBr 2/1 110 43 (38) 83:17:0 
23 PdCl(C3H5)dppb KOAc - - 1/1.5 150 6 69:31:0 
[a] Unless otherwise stated, the reactions were carried out using 23 and 26a with the ratio reported for each entries, 
Pdcat (5 mol %), ligand (10 mol %) (if any), base (2 equiv), PivOH (30 mol %), additive (if any) (20 mol %) in 
DMA (5 mL) for 48 h at 110 °C. [b] GLC yields. In parenthesis, isolated yields. [c] Reaction was carried out in the 
absence of PivOH. [d] Reaction was carried out with a Pd/Ligand ratio 1:1. [e] Reaction was carried out in the 
presence of 10 mol % Pd(OAc)2.  
N
N
Pdcat (5 mol %)
Ligand (10 mol %)
Base (2 equiv)
PivOH (0.3 equiv)
Additive (0.2 equiv)
DMA, 110 °C
24 h
N
N
Me
N
N
Br
Me
Me
N
N
Me
Me
23 26a 36a 37a 38a
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